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ABSTRACT 
Ryan Alexander Ellis Hallett: Design, Improvement, and Benchmarking of a  
Light-Induced Heterodimer: The Awakening of iLID  
(Under the direction of Brian Kuhlman) 
 
Cellular optogenetic tools are engineered protein photoreceptors that allow 
researchers to probe intricate protein-protein interaction networks with the flip of a light 
switch. These tools can be turned on with high spatial and temporal resolution to change the 
activity or localization of a protein inside a cell.  In order for a tool to be widely useful it 
should be generalizable for multiple applications, orthogonal to the system it is used in, and 
have low levels of activity in the inactive state.  Light-inducible heterodimerization is one of 
the most general optogenetic approaches.  Each half of the pair can be fused with any 
intracellular protein or localization sequence, imparting light induced control over a wide 
variety of signaling pathways.  However, utility of existing light inducible dimers is still limited 
due to poor dynamic range between active and inactive states or unknown mechanism of 
action, which can impede analysis.    
It is the aim of this thesis to design a general cellular optogenetic tool with large 
dynamic range, usable in eukaryotic systems, and clear mechanism of activity.  In order to 
create a tool fitting these criteria, we have engineered a light inducible heterodimer pair from 
the SsrA peptide – SspB protein interaction, using the blue light sensitive photoreceptor, 
LOV2 from Avena sativa.  Irradiation of AsLOV2 with blue light induces a conformational 
change in its C-terminal Jα helix.  Our initial incorporation of the SsrA peptide into the Jα 
helix resulted in a modest change in affinity for SspB with light.  Using a protocol of 
computational library design, phage display screening, and high-throughput binding assays 
iv 
we were able to engineer an improved light-inducible dimer system, iLID, that exhibits over 
50-fold increase in affinity for its partner upon irradiation with blue light.  The iLID system 
comes with two partners, SspB nano and SspB micro, which enables researchers to induce 
interactions in the nanomolar or micromolar ranges.  We have further showed that both iLID 
pairs can be used to reversibly co-localize proteins of interest in mammalian cells and 
control small GTPase signaling.  
Despite their proposed modularity, successful control of in cell activity depends on 
compatibility between characteristics of the chosen heterodimer pair and its application.  To 
examine the in vivo functional significance of in vitro characteristics for light-inducible dimer 
pairs, we measured in vitro affinities and kinetics, light induced gene transcription in S. 
cerevisiae, and lamellipodia protrusion in mammalian cell culture.  The results demonstrate 
a correlation between affinity, kinetics, and dynamic range with cellular activity and highlight 
the need for thorough benchmarking.  This work has yielded valuable insight on how to 
select optogenetic tools appropriate for specific applications and generated two powerful 
optogenetic heterodimer pairs, iLID nano and micro, available for use in cell biology.  
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Chapter 1 
Introduction 
This dissertation is primarily focused on advancing the optogenetic field through 
creation of new light activated tools, the benchmarking of existing tools, and application of 
such tools to novel cellular uses.  This introduction will cover the origins of optogenetics, the 
underpinnings of blue-light sensitive protein domains, an overview of uses, and evaluation of 
current limitations. 
1.1 The Origin of Optogenetics 
1.1.1 Initial Neurobiology Applications 
Optogenetics broadly describes the fusion of engineering and biology that uses the 
input of light to control a particular cellular response.  Francis Crick described the need for 
such tools initially in 1979 and again in 1999 as a way to dissect the function of individual 
components of the brain1,2.  It was not until 2002 when this became a reality for the 
neuroscience field when neurons expressing Drosophilia arrestin-2, rhodopsin, and the α 
subunit of the corresponding G-protein (together, the chARGe system) were shown to 
produce a light induced action potential3.  This work was based on importing the invertebrate 
rhodopsin signal cascade, which is naturally light sensitive, to mammalian neurons, which 
are typically light insensitive.  This advancement, gave researchers the power to control a 
subset of neurons with light, simply by introducing a few exogenous genes.  This technique 
was expanded upon a few years later with the development of synthetic photoisomerizable 
azobenzene-regulated K+ (SPARK) channels4.  SPARK channels were engineered through 
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incorporation of a photoactive moiety into the Drosophilia K+ Shaker channel.  It was known 
that Shaker voltage gated ion channels are blocked by the binding of quaternary ammonium 
ions.  Using available structural information, an azobenzene moiety with a cysteine reactive 
group on one end and an ammonium ion on the other, was incorporated into an extracellular 
loop of the Shaker channel approximately 15-18 Å away.  Azobenzene is a photoreactive 
molecule, two phenyl groups connected by an N=N double bond.  Irradiation with light ~360 
nm causes the double bond to isomerize from the trans to cis conformation5.  The trans 
state can be reverted to cis through exposure to ~500 nm light or will decay naturally 
through thermal conversion5.  Once incorporated, the azobenzene acts as a photoactive ion 
gatekeeper, with trans-azobenzene positioning the ammonium ion to block the ion channel.  
Photoisomerization of the moiety releases inhibition and allows for ion transfer.  Using this 
strategy, researchers demonstrated the ability to induce action potentials with short-
wavelength light and silence them with long-wavelength light in rat hippocampal neurons 
expressing the chemically modified SHAKER constructs4.  The downside to this method was 
the need for chemical modification post-expression in addition to incorporation of the 
SHAKER gene.  While these pioneering techniques gave a new level of spatial control to 
neurobiologists, there was still the issue of timescale.  Both techniques operated on the 
second to minute timescale, about a thousand fold slower than necessary to induce single 
action potentials.  A third innovation to the field less than a year later reduced the timescale 
of control to the millisecond level6, and solidified optogenetics as more than just a passing 
trend.  This advancement was made possible through use of an algal photoreceptor, 
Channelrhodopsin-2 (ChR2).  ChR2 had recently been discovered as a naturally occurring 
light-regulated cation channel from Chlamydomonas reinhardtii7, and using lentiviral 
incorporation into mammalian neurons, it was shown that ChR2 could be induced in as little 
as 50 µs after a flash with blue light6.  This enabled the control of single depolarization 
events with commonly available microscopy equipment, as the same lasers used for GFP 
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excitation could be used to excite ChR2.  These three initial optogenetic milestones 
demonstrated simple and viable methods for control of mammalian neurons with light and 
paved the way for the decade of advancement that would follow.   
1.1.2 Promise of Tools in Cell Biology 
While initially limited to neurobiology, the promise of optogenetic cellular control 
extended into almost all cell biology fields.  The aforementioned initial experiments set the 
precedent for what characteristics of optogenetic tools are needed to be useful in studying 
biological questions.  In order to be useful, optogenetic tools need to be genetically 
encoded, respond quickly to external stimuli, respond reversibly, and be designed such that 
they are simple to use for a variety of applications.  While these initial optogenetic tools were 
only really useful in the neurobiology field, they highlighted the degree of spatial and 
temporal control that light afforded researchers.  As the field expanded to create 
generalizable tools that could be used by any cell biologist, the design strategies seen in 
those first optogenetics tools surfaced again; structure based design of novel 
photoreceptors, direct harnessing of naturally occurring photoreceptors, and incorporation of 
photoactive moieties into functional protein domains.  A researcher’s view of a given cellular 
pathway is limited by the resolution and capabilities of the technology they use to probe their 
system.  To meet these needs, novel tools with a variety of spectral properties, kinetic rates, 
and molecular characteristics have been engineered from a wide assortment of natural 
photoactive macromolecules. 
1.2 Light Reactive Protein Domains 
The vast majority of currently used photoactivatable protein tools are powered by a 
naturally occurring protein photoreceptor.  Existing photoreceptors are chosen for their ease 
of genetic incorporation into a host organism and wide array of domains with multiple 
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functionalities to choose from.  Protein photoreceptors vary in the wavelength of activation, 
timescale of reversion, response upon activation, chromophore usage, and compatibility 
within host organism.  This diversity has allowed for many different cellular uses and 
highlights the importance of photoreceptor selection for a given application.  Surprisingly, 
use and reengineering of a photoreceptor to become a molecular tool is not contingent upon 
detailed understanding of its mechanism of action; as such newly discovered and poorly 
understood protein domains have been added to the optogenetic toolkit.  However, for many 
applications this is a drawback and should contribute to the selection criteria for a given 
photoreceptor.  It is noteworthy to mention that there are a wide variety of photoactive 
chemical moieties8 (like azobenzene for one), which have been used to control cellular 
processes like protein expression9,10 and cell cycle progression11, however they are outside 
the scope of this work.  
1.2.1 LOV Domains 
Light-oxygen-voltage (LOV) domains are a broad family of proteins involved in 
relaying extracellular signals of light to intracellular effector domains12.  LOV domains belong 
to the Per-ARNT-Sim (PAS) superfamily of proteins that are involved in a wide variety of 
signaling pathways in archaea, bacteria, and eukaryotic organisms13.  The first LOV 
domains were discovered as the blue light photoreceptor domains of phototropin 1 and 
phototropin 2, two large multi-domain proteins responsible for chloroplast relocation and 
phototropism in higher plants14.  Common, but not exclusive to all LOV domains is the 
binding of a single cofactor, flavin mononucleotide (FMN)12.  The absorption spectrum of 
FMN gives LOV domains their ability to perceive blue-light, characterized by maxima at 360 
nm and 450 nm15.  Upon excitation with blue light, the FMN cofactor is excited to a transient 
triplet state within 30 ns, which decays to a metastable intermediate with a half-life of 4 µs15.  
For some LOV domains, the C(4a) carbon atom in the FMN cofactor forms a covalent bond 
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with a nearby cysteine residue in the LOV domain while in this metastable intermediate 
state15,16.  After formation, the covalent adduct and FMN cofactor thermally reverts back to 
their ground states.  The kinetics of this process vary widely among LOV domains, from 
seconds to minutes to hours and even days15,17,18.  In their natural context, the formation of 
this covalent adduct propagates a conformational change throughout the protein, and 
modulates the activity of a response domain at the carboxyl-terminus of the LOV domain.  
Known response elements regulated by LOV domains are histidine kinases, transcription 
factors, phosphodiesterases, and proteins that regulate circadian rhythm12.  In the 
optogenetics engineering field, a handful of LOV domains have been plucked out of their 
native habitat to be used as the basis for creating novel molecular switches; of most 
important to this work is the LOV2 domain from Avena Sativa (AsLOV2).  AsLOV2 regulates 
its carboxyl-terminal kinase domain through light-dependent displacement of the Jα helix, a 
helix connecting the FMN-containing PAS fold with the kinase (Figure 1.1)19,20.  It is currently 
unknown exactly how the signal is transduced from the FMN-cysteine adduct to the Jα helix, 
however key residues involved in this process have been identified21,22.  As its role in the 
photoactivation process is paramount, many groups have studied the dynamics of the Jα 
helix extensively.  In one study, NMR was used to measure the free energy change of the 
transition from dark to lit state.  They measured the equilibrium of AsLOV2 to be 1.6% Jα-
unbound / 98.4% Jα-unbound in the dark, and 8% Jα-unbound / 92% Jα-bound under blue 
light; an approximately 3.8 kcal mol-1 change in free energy between lit and dark states23.  It 
was also found that the amino terminal helix of AsLOV2, the A’α helix, unfolds upon 
irradiation with blue light22,24.  This was first proposed based on small structural 
rearrangements of the A’α helix between AsLOV2 structures solved from crystals bathed in 
blue light and those kept in darkness22.  Later, the mechanistic relationship between the two 
helices was more thoroughly probed through extensive mutational analysis of the AsLOV2, 
including deletions of both the Jα and A’α helices24.  Based on helicity change as measured 
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by circular dichroism, change in tryptophan fluorescence, and correlations of residue 
specific CPMG values all measured in both the light and dark, it was concluded that the A’α 
helix undocked first, which then allowed the Jα helix to undock24. This work was followed up 
shortly thereafter with an even more extensive list of mutations and various biophysical 
characterizations, indicating a wide variety of photocycle half-lives, from ~23 minutes to 2 
seconds, as well as the promise of some mutations that increase the signal change between 
the lit and dark states25.  This breadth of structural information and biophysical 
characterization concerning AsLOV2 and other LOV domains, have rendered them some of 
the most popular photoreceptor domains in the optogenetic repertoire.   
1.2.2 Cryptochromes 
Cryptochromes are another class of blue light sensing photoreceptors and the first to 
be studied at the protein level26.  Best studied in Arabidopsis thaliana, three cryptochromes 
have been discovered: CRY1, CRY2, and CRY327–29.  In recent years, CRY2 has emerged 
as one of the most useful photoreceptors in optogenetics.  Similar to the LOV domains of 
the phototropins, cryptochromes absorb blue light, with a maximum absorption at 450 nm 
and smaller absorption peaks in the near ultraviolet (UV) range30.  Their absorption 
spectrum is largely imparted by their cofactor, flavin adenine dinucleotide (FAD), which 
similar to FMN, absorbs maximally at 450 nm27.  Distinct from LOV domains, cryptochromes 
have an additional cofactor, 5,10-methyltetrahydrofolate (MTHF) used in harvesting 
additional light in the UV range30.  Cryptochromes generally consist of two domains, an 
amino terminal photolyase homology region (PHR) and a specialized cryptochrome 
carboxyl-terminus (CCT), which varies between cryptochrome variants (and is missing from 
CRY3)31.  Despite their structural similarity to photolyase domains, the cryptochromes in 
Arabidopsis do not have DNA repair activity.  The cryptochrome PHR domain of CRY1 and 
CRY3 has been resolved by x-ray crystallography (Figure 1.2)32,33, however there is no 
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structural information for CRY2 PHR or either CRY1 or CRY2 CCT domain currently.  The 
overall topology of CRY1 PHR and CRY3 PHR are very similar (RMS of 1.9 Å, PDB codes: 
1u3d & 2j4d), both consist of an amino terminal α/β domain, a short linker, and an α domain.  
However, one interesting difference is the presence of a MTHF binding site in CRY3, but not 
in CRY1 (Figure 1.2B).  Additionally, an adenosine triphosphate (ATP) binding site is seen in 
the CRY1 structure (Figure 1.2A), which corroborates previous in vitro data32.  The 
cryptochrome PHR domain binds all cofactors noncovalently, which is the most frequent 
explanation for why either ATP or MTHF are not found in purified protein samples34.  The 
FAD binding site is made up of three conserved tryptophan residues within the α domain, 
but their specific role in photoactivation is somewhat unclear35.  Mutation of each of these 
residues in CRY1 results in decreased ability to respond to blue light, however, in CRY2 
similar mutations result in constitutive activation36.  Recently, an electron transfer pathway 
not utilizing the canonical tryptophan triad has been proposed37.  In any case, when 
irradiated with blue light, the FAD cofactor is reduced to form a neutral semiquinone radical 
(FADH!)38–40.  This species is considered by some to be the active signaling state of 
AtCRY1 and AtCRY2.  Post excitation and activation, the cryptochromes undergo a 
conformational change, leading to the displacement of the CCT domain41.  It has also been 
shown that CRY2 PHR domain binds CIB1 after exposure to blue light42.  CRY1 and CRY2 
both become phosphorylated after exposure to blue light43,44, adding another layer of 
complexity to this mechanism.  More recently, CRY2 has been shown to oligomerize in a 
light dependent fashion, but through currently unknown means45.  Despite a general 
uncertainty on the overarching mechanism, site of conformational change, and 
stoichiometry, both light induced CRY2/CIB1 binding and CRY2 oligomerization have been 
widely used as optogenetic modifiers45,46.   Additionally, a variant of CRY2 optimized for 
oligomerization applications, CRY2olig, has been engineered47. 
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1.2.3 Phytochrome Domains 
Phytochromes have been found to absorb light across almost the entire spectra of 
visible light, but most commonly sense red and far-red light48–51.  They are found in plants, 
fungi, bacteria, and cyanobacteria.  The phytochrome core photoreceptor is made up of 
three domains: a PAS domain, a GAF (cyclic GMP phosphodiesterase/adenylate 
cyclase/FhlA) domain, and a PHY (phytochrome specific) domain (Figure 1.3)49.  
Phytochromes form a covalent bond with their chromophore between a conserved cysteine 
residue in either the PAS or GAF domain and the C3 carbon of the A-ring in the 
chromophore49.  The bound phytochrome chromophore varies between organisms, but it is 
usually a linear tetrapyrrole (bilin) derivative49.  In plants and cyanobacteria, that derivative is 
phycocyanobilin (PCB) or phytochromobilin (PΦB); in bacteria or fungi the chromophore is 
biliverdin Ixα (BV)49,52.  Irradiation with red light (660 nm - 680 nm) causes an isomerization 
of the chromophore, most frequently about a double bond connecting the C-ring and D-ring 
(Figure 1.3C)49.  This isomerization induces a conformational change in the bound protein 
and is passed along to an effector domain.  The isomerized chromophore is also light 
sensitive, however the spectrum is red-shifted, now responding to far-red light. Irradiation of 
the far-red absorbing (Pfr) state with far-red light (740 nm - 760 nm) causes another 
isomerization of the D-ring back to the red light absorbing (Pr) state49.  This Pfr to Pr 
reversion will occur thermally if not activated with far-red light, albeit much slower, on the 
timescale of hours53.  Phytochrome use in optogenetics comes with strong advantages and 
disadvantages.  The commonly used photoreceptor, PhyB, from Arabidopsis thaliana uses a 
cofactor, PCB, which is not naturally expressed in other organisms.  As a result, cofactor 
must be exogenously added to cell culture media or made through genetically encoding a 
set of enzymes needed to synthesize PCB directly into the organism54. This method has 
been demonstrated in E. coli55 and more recently mammalian cells56, however is not optimal.  
An advantage of phytochromes is that they fold and remain stable in the absence of their 
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chromophore, rendering them light insensitive until chromophore addition.  This has been 
sold as an advantage since steps are normally taken to prevent early exposure of a 
photoreceptor to light before an experiment.  The other major advantage of the PhyB 
photoreceptor is independent control over both the Pr and Pfr states. This gives users direct 
control of reversion timescale and allows them to be synced in either state with a flash of 
light.  It has been shown that the Pfr state of PhyB interacts with PIF3, but not the Pr state57.  
In the field of optogenetics, the red light dependent PhyB interaction with PIF3 and PIF6 has 
been utilized for light-dependent heterodimerization53,57,58.  However, many specific 
applications involving phytochromes from bacteria (bacteriophytochromes) have been 
reported utilizing either their native effector domains or engineering domains from other 
organisms leading to red light induced activity, including transcription59 and adenylate 
cyclase activity60.  An in-depth look at light-induced dimerizing applications will be reviewed 
in section 1.3.   
1.2.4 BLUF proteins and Xanthopsins 
While LOV domains, cryptochromes, and phytochromes are the most prevalent 
photoreceptors used in cell biology, it is important to mention the remaining classes of 
photoreceptors: blue-light sensors using flavin adenine dinucleotide (BLUF) and 
xanthopsins.  BLUF domains are small protein domains (~100 - 250 amino acids) similar in 
size to LOV domains (Figure 1.4).  The BLUF chromophore, FAD, becomes excited upon 
absorbing a photon of blue light, which rearranges a hydrogen bond network involving a 
conserved tyrosine and glutamine61,62.  This rearrangement is propagated through a nearby 
β-scaffold, changing interactions with a C-terminal α-helix, Ccap, which changes interactions 
with effector domains or interaction partners63.  Interestingly, it has been shown that AppA, 
PixD, and YcgF all form protein-protein interactions in the dark, but these complexes 
dissociate in blue light63.  Xanthopsins are also small protein domains absorbing light in the 
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blue and near-uv region of visible light64.  Xanthopsins use 4-hydroxy-cinnamic acid (p-
Coumaric acid) as their chromophore64.  Absorption of a photon causes a cis- to trans- 
isomerization of the chromophore, which after a number of intermediate states, becomes 
deprotonated65.  It is the negative charge formed by this deprotonation that is thought to 
cause a partial unfolding event in the amino terminal cap that induces signaling65.  The most 
widely known xanthopsin, photoactive yellow protein (PYP) from Halorhodospira halophila, 
has been used to control light dependent DNA binding66,67. 
1.3 Successful Optogenetic Dimerization Applications 
While traditional optogenetics aims to modulate the potential across a cell 
membrane, cellular optogenetics aims to modulate protein-protein interaction networks in 
order to better understand the cellular signaling environment.  While many proteins have 
been engineered to be light sensitive through incorporation of a photoreceptor68–71, this 
section will focus on more generic applications.  Specifically, the use of dimerization to 
control a variety of processes like transcription, degradation, and motility will be covered.  
Additionally, the CRY2/CIB1 and TULIP heterodimerization pairs will be reviewed in detail 
due to their characterization in chapter 4. 
1.3.1 Dimerization Strategies 
Cellular homeostasis depends on many protein – protein interactions occurring in 
specific locations all around the cell simultaneously.  In order to better study these 
interactions, a few strategies using light induced dimerization have been devised to control 
protein activity including: direct co-localization of two proteins, inducing changes in protein 
localization, sequestration or activation through oligomerization, and reconstitution of a split 
protein (Figure 1.5).   
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Direct co-localization of two proteins is the broadest category, useful for inducing 
protein – protein interactions that have a direct effect.  One great example of direct co-
localization was seen in the development of photoactivatable protein degradation tags72.  In 
this instance a target protein was fused to a LOV2 domain from Arabidopsis thaliana with an 
ornithine decarboxylase degron incorporated into its carboxyl-terminus.  Light induced 
changes from AtLOV2 allowed the degron to interact with the proteasome and caused 
degradation of the target protein72.  Using this technique they showed almost complete 
ubiquitin-independent degradation of red fluorescent protein (RFP) in yeast after 4 hours of 
blue light exposure.  Follow up studies to this work later showed this mechanism was 
tunable, allowing for both shorter and longer lived degron variants73.  Gene transcription has 
also been controlled with this strategy through light induced localization of a DNA binding 
protein (zinc finger protein) with an activation domain (VP16)74–76.   
Light induced localization change has most frequently been used as a way to 
regulate cell motility, whether directly through guanosine triphosphatase (GTPase) 
localization or indirectly through guanine nucleotide exchange factor (GEF) localization.   In 
the direct application, one half of a heterodimer pair is plasma membrane localized and the 
other is fused to a constitutively active variant of the GTPase without a membrane 
localization sequence53,77.  As GTPases are natively targeted to the plasma membrane 
through attachment of a prenyl group where they interact with effectors, removal of this 
makes its activity conditional on induced localization (for the constitutively active GTPase 
variant)78.  In the indirect application, a GEF is localized to the plasma membrane with light 
to activate endogenous GTPase.  This strategy has been utilized in yeast to control 
polarized growth79.  In this example, the GEF Cdc24 was fused to one half of a heterodimer 
pair and the other half fused to the transmembrane protein Mid279.  Light induced 
recruitment of the GEF to the membrane led to the formation of a protrusion within 45° of the 
site of irradiation in the majority of the cells tested79. 
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 Sequestration through hetero- and homo-oligomerization has only been achieved 
with a single photoreceptor, CRY245,47,80.  In this approach, a single protein is fused to the 
protein that oligomerizes in response to light.  Oligomerization occurs in such a way to 
sequester or activate the fused proteins’ function, creating a generalizable way to control 
protein function.  This set-up is advantageous since it only requires the addition of a single 
component, instead of the two required from a heterodimer pair.  Homo-oligomerization has 
been used to activate the Wnt/β-catenin pathway, Rac1 activity and RhoA activity through 
direct fusion to CRY245.  Light-induced hetero-oligomerization has also been demonstrated 
by combining the CRY2 oligomerization with CRY2 light-depended CIB1 binding.  Hetero-
oligomerization, with CRY2, CIB1, and an additional multimeric protein, has been used to 
inactivate Tiam1, Vav2, Rac1, RhoG, and Cdc4280.  While clearly powerful, this method is 
less precise as the mechanism of CRY2 oligomerization is unknown.  A more precise and 
still generalizable method of light-induced protein activity uses the fluorescent protein 
Dronpa and its native light inducible monomerization.  In this method, fusion of Dronpa to 
the N- and C- terminus of a protein causes the dimer or tetramer oligomer to occlude access 
to the protein.  Irradiation with light at 490 nm induces monomerization of Dronpa and allows 
for the protein of interest to interact natively.  In this manner, the GEF intersectin and a 
protease were caged, only active after irradiation with light81.   
 Split protein reconstitution has been used as a way to detect protein – protein 
interactions for many years.  Light-induced heterodimerization uses the opposite principle, 
using light to create a protein - protein interface and reconstitute the split protein activity.  By 
far the most common example of this in optogenetics is the reconstitution of the Gal4 DNA 
binding domain and Gal4 activation domains to induce transcription.  This has almost 
become the litmus test for light-induced heterodimer pairs, as almost every widely used pair 
has demonstrated this82–86.  Light induced reconstitution of the Cre-Lox system using a split 
Cre protein has been demonstrated using the CRY2/CIB1 pair86. 
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1.3.2 CRY2-CIB1 
The blue light dependent interaction between CRY2 from Arabidopsis thaliana and 
CIB1 was initially described in 200842 and first utilized as an cellular optogenetics tool in 
201086.  In this initial proof-of-principle and description, the minimal domain elements 
required for functionality were identified using a yeast two-hybrid approach.  The PHR 
domain from CRY2 (residues 1-498) and the N-terminal fragment (residues 1-170) were 
enough to confer light induced transcription86.  This assay showed that CRY2 binding to 
CIB1 and CIB1N resulted in substantially less background activity in the dark (and less 
activity in the light) whereas CRY2 PHR binding to CIB1 and CIB1N resulted in much higher 
dark state activity (and more activity in light).  In all experiments, the CRY2 half of the switch 
was fused to the Gal DNA binding domain and CIB1 fused to the activation domain.  Light 
induced transcription was also shown to be dose-dependent by delivering a series of 10 
second pulses of blue light, 8 minutes apart, and showing a proportional increase of protein 
product to number of blue light pulses86. In mammalian cells, the CRY2-CIB1 interaction was 
demonstrated in two ways.  First, plasma membrane bound CIBN1-GFP (green fluorescent 
protein) and mCherry-CRY2 were transfected and irradiated with blue light.  Within 10 
seconds of illumination, mCherry-CRY2 had fully accumulated at the membrane and after 
~12 minutes of darkness it had returned fully to the cytoplasm86.  This interaction was 
repeated in the same cell to determine if the interaction was reversible and repeated full 
activation was observed.  In a final display of protein control, a Cre recombinase split into 
two halves was reconstituted through CRY2 and CIB1N binding, leading to loxP 
recombination in 16.4% of cells after 24 hours of blue light86.  Since its initial debut, this pair 
has been used by a number of labs in a variety of applications.  The pair is functional in 
zebrafish, where one group showed both light dependent activation and suppression of 
transcription83.  Activation was achieved as previously shown, through colocalization of DNA 
binding and transcription-activating domains while suppression was achieved through light 
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dependent CRY2 binding and blocking of CIB1N’s native transcription activation42,83.  In a 
step toward being more biologically adaptable, CRY2/CIB1 was used to modulate 
transcription of endogenous genes through colocalization of transcription activator-like 
effectors (TALEs) with VP64 (a 4 copy fusion of the transcription activator, VP16)75.  TALEs 
can be engineered to bind any DNA sequence of choice due to a one to one relationship 
between a repeat in the protein and interaction with a single base pair of DNA87.  As a result, 
the CRY2-TALE fusion can be localized to any locus in the genome and CIB1-VP64 
recruitment induces transcription there.  This system, called LITEs (light inducible 
transcriptional effectors), was shown to produce more than 15-fold more mRNA after 8 
hours of exposure to blue light than when left in the dark75.  LITEs were also used to site-
specifically modify histones and modulate expression through localization of 
methyltransferases and deacetylases75.  A similar method of light induced DNA localization 
is now possible by using a deactivated Cas9 (dCas9) to target a specific stretch of DNA88.  
The CRY2-CIB1 system has been used to control cellular cytoskeletal function as well.  
CIB1-Lifeact fusions allowed for light induced CRY2 localization to F-actin.  Light induced 
CRY2-(constitutively active)cofilin localized to F-actin and was shown to increase filopodia 
formation as well as lamellipodia formation and movement89.    
1.3.3 TULIPs: Tunable Light-Controlled Interacting Protein Tags 
 TULIPs were developed by engineering the AsLOV2 domain to selectively bind an 
engineered PDZ domain (ePDZb) in response to light79.  This was achieved by incorporating 
a PDZ binding peptide into the Jα helix of AsLOV2, called LOVpep.  Unfolding of the helix in 
response to blue light frees the peptide and allows binding to ePDZb.  They showed that 
many mutations that had previously tuned the Jα helix lit/dark equilibrium also changed 
dynamics of the LOVpep equilibrium, and thus were able to tune their extent to which the 
peptide was caged79.  These mutations were: T406-7A, which previously shown to increase 
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caging (lower dark state binding), I532A, previously shown to increase Jα helicity and 
increase caging, and V529N, previously shown to decrease caging90.  Therefore, in order 
from expected weakest dark state binding to tightest, the mutation pairs tested were: T406-
7A+I532A, T406-7A, LOVpep alone, and V529N.  This system also came with two other 
protein-binding partners, the starting PDZ domain that binds weaker than ePDZb, and the 
affinity-matured ePDZb1, which has a tighter affinity91.  This modularity gave LOVpep three 
regimes of affinity it could switch over, each with a number of mutations in AsLOV2 to “fine 
tune” for a specific application.  This wide range of switching was demonstrated by 
monitoring colocalization of fluorescent protein fusions with each LOVpep and ePDZ variant 
in the presence and absence of light in yeast.  The dynamic range varied from low levels of 
localization in both the lit and dark states (LOVpepT406-7A,I532A:PDZ) to almost full 
localization in both states (LOVpep V529N:ePDZb1)79.  These findings directly correlated 
relative affinity and caging (albeit absolute affinities values unknown) to in vivo function.  
Applying these tools to functional activity, they were able to light-dependently control MAPK 
activation and cell polarity79.  Since their public debut, TULIPs have only been used in a 
handful of applications.  In a truly novel application, researchers fused LOVpep to PEX3, a 
peroxisome localization sequence and ePDZb1 to either kinesin or dynein.  They found that 
blue light induced localization of kinesin led to peroxisome movement toward the outside of 
the cell and localization of dynein caused peroxisome movement toward the center of the 
cell92.  This was as expected as kinesin directs transport toward the plus end of microtubules 
and dynein directs towards the minus end93.  Light-induced motor protein localization to 
endosome and mitochondria also changed dynamics of each substructure92.  
1.4 Drawbacks and Limitations of the Field 
Cellular optogenetics affords a level of spatial and temporal control over cell 
signaling that has not been possible previously.  However, there are many limitations in the 
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field that next-generation tools and approaches should be mindful of.  As described, most 
existing tools respond to blue light, which does not penetrate more than 1 mm into tissue94.  
Red light penetrates farther, ~3-4 mm94, but this keeps cellular optogenetic tools relegated 
to cell culture and epidermal animal applications, unless light sources are implanted.  In 
order to overcome this, tools that respond to longer wavelengths of light need to be 
developed. 
Each tool discussed has a set of limitations that preclude it from one application and 
ideal for another.  This highlights the needs for a wide variety of tools and methods.  So far 
one of the largest drawbacks is a residual activity in the target off state.  As most 
heterodimer and oligomer tools rely on changes in affinity between states, overexpression of 
one component or both can drastically reduce dynamic range.  This has been noticed 
specifically in a few cases76,82, but undoubtedly would occur in any case where expression 
exceeded dark state affinity.  Therefore, tools with increased dynamic ranges and methods 
to increase dynamic ranges are needed.  Additionally, cellular optogenetic tools need to 
have precise characterization to better aid those who use the tools in choosing the correct 
tools for a given application.  Explicit declaration of limitations and methods of use should be 
provided upon release of any tool.  In order to fully compare tools as they are developed, a 
set of benchmark experiments could be developed to highlight the advantages and 
disadvantages upon release.  Finally, most uses of heterodimerization thus far have been 
proof of principle and validation using known mechanisms of protein signaling.  If the field is 
to survive and leave an impact, it must use the newfound spatial and temporal control push 
the current boundary of cellular knowledge. 
In the work that follows we describe the design (chapter 2), improvement (chapter 3), 
benchmarking (chapter 4), and novel application (chapter 5) of a new light-inducible 
heterodimer tool. 
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1.5 Figures 
 
 
 
 
 
 
Figure 1.1 Structure of AsLOV2. A) AsLOV2 structure, PAS domain in green, Jα helix in 
blue, A’α helix in orange, FMN cofactor shown in black spheres B) Interactions between A’α 
and Jα helix C) C450 in dark state D) C450 in lit state, bound to FMN (PDB IDs A-C: 2v0u; 
D: 2v0w)  
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Figure 1.2 Structure of CRY1 and CRY3 PHR domains from Arabidopsis thaliana. A) 
CRY1 PHR domain with FAD (black) and ATP (magenta) binding site in inset. B) CRY3 PHR 
domain with MTHF (purple) cofactor binding site in inset. (PDB IDs A: 1u3d; B: 2ijg) 
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Figure 1.3 Structure of Arabidopsis thaliana PhyB. A) Dimer PhyB structure showing 
PAS (green), GAF (pink), and PHY (orange) domains.  PCB cofactor is shown in black.  B) 
PhyB showing individual monomer subunits. C) PCB cofactor with pyrrole ring naming 
shown. (PDB: 4our) 
 
 
Figure 1.4 Comparison of xanopsin, BLUF, and LOV domain. PAS family members 
contain similar binding pocket for light sensitive chromophores. A) The xanopsin PYP from 
Halorhodospira halophila (PDB: 2phy), B) the BLUF BlrB from Rhodobacter sphaeroides 
(PDB: 2byc), and C) AsLOV2 (PDB: 2v0u) 
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Figure 1.5 Schematic of light induced heterodimerization and oligomerization. A) Light 
inducible heterodimer pair (Used in B-D) B) Light induced co-localization of green and brown 
proteins. C) Light induced localization of red protein to membrane D) Light induced 
reconstitution of split red protein. E) Light induced oligomerization (left) used to sequester 
the green protein (right).
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Chapter 2 
Designing photoswitchable peptides using the AsLOV2 domain1 
This work was published in the journal Chemistry & Biology, Volume 19, Issue 4, 
p507-517 on 20 April 2012.  Oana Lungu developed the LOV-ipaA switch and performed 
experiments relating to LOV-ipaA.  Ryan Hallett developed the LOV-SsrA switch and 
performed all experiments relating to LOV-SsrA.  Eun Jung Choi developed the peptide 
search algorithm. Mary J. Aiken performed LOV-ipaA binding experiments. This work was 
guided and funded by Klaus Hahn and Brian Kuhlman. 
2.1 Overview  
Photocontrol of functional peptides is a powerful tool for spatial and temporal control 
of cell signaling events. We show that the genetically encoded light-sensitive LOV2 domain 
of Avena Sativa phototropin 1 (AsLOV2) can be used to reversibly photomodulate the 
affinity of peptides for their binding partners. Sequence analysis and molecular modeling 
were used to embed two peptides into the Jα helix of the AsLOV2 domain while maintaining 
AsLOV2 structure in the dark but allowing for binding to effector proteins when the Jα helix 
unfolds in the light. Caged versions of the ipaA and SsrA peptides, LOV-ipaA and LOV-
SsrA, bind their targets with 49- and 8-fold enhanced affinity in the light, respectively. These 
switches can be used as general tools for light-dependent colocalization, which we 
demonstrate with photo-activable gene transcription in yeast. 
                                                
1This chapter previously appeared as an article in Chemistry & Biology.  The original citation is as 
follows: Lungu, O. et al. Designing Photoswitchable Peptides Using the AsLOV2 Domain. Chem Biol 
19, 507–517 (2012) 
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2.2 Introduction 
Peptides regulate a variety of biological processes by acting as competitive 
inhibitors, allosteric regulators, and localization signals95–97. Photocontrol of peptide activity 
is a powerful tool for precise spatial and temporal control of cellular function98,99. Typically, 
photo-activation of peptides has been achieved by covalently modifying peptides with 
chemical groups that inhibit function until they are removed by light10,100. Because such 
derivatized peptides must usually be synthesized in vitro, one challenge of this approach is 
getting the peptides into living cells or animals. Additionally, in most cases the photo-
induced reaction is not reversible. Recently, there has been considerable progress in the 
use of naturally occurring photo-activable proteins to engineer light switches that are 
genetically encoded and reversible46,68,101,102. In the majority of cases, the goal has been to 
regulate the activity of folded protein domains. Here, we examine if the LOV2 domain 
from Avena sativa phototropin 1 (AsLOV2) can be used to photomodulate the affinity of 
peptides for binding partners103. 
AsLOV2 is part of the PAS superfamily of domains16. It contains a flavin 
mononucleotide (FMN) cofactor located in the center of the PAS fold, as well as a large α-
helical region C-terminal to the fold, termed the Jα helix19,104. Upon irradiation with blue light, 
a covalent adduct is formed between a cysteine side chain in the PAS fold and a carbon 
atom of the FMN15,105. Spectroscopy studies indicate that this leads to a large 
conformational change in the domain, including the unfolding of the Jα helix106,107. When 
irradiation ceases, reversion of the thiol bond and conformational change back into the dark 
state occurs spontaneously within seconds to hours, depending on the LOV domain 
ortholog108. 
The large conformation change that occurs within the Jα helix has been previously 
harnessed to create a photoswitchable GTPase termed PA-Rac68; a photoswitchable variant 
of the Escherichia coli trp repressor that has enhanced affinity for DNA in the light termed 
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LOV-TAP69,90; and a photo-activatable DHFR enzyme70. In these studies, entire protein 
domains were fused to the end of the Jα helix in order to sterically occlude binding with 
effector molecules or perturb the conformational state of the attached domain. Upon blue 
light irradiation, unfolding of the Jα helix relieves the steric block or conformational strain. 
Because peptides are more flexible than are folded domains, it may not be sufficient to 
place them at the end of the Jα helix to achieve a steric block; tighter caging may be 
obtained by embedding their functionality within the Jα helix (Figure 2.1). A similar strategy 
has been successful for caging coiled-coil peptides in the light-sensitive photo-active yellow 
protein (PYP)67. In the case of AsLOV2, the challenge is identifying sequences that 
incorporate the target binding of the peptide while maintaining the functionality of the Jα 
helix. One face of the Jα helix is exposed to solvent, while the other face forms hydrophobic 
interactions with a β sheet in the AsLOV2 domain. Residues on the surface of the helix are 
expected to be tolerant to mutation, whereas the buried residues should be more conserved. 
Similarly, most peptides have sets of residues that are required for binding target proteins, 
whereas other positions can be varied. These observations indicate that it may be possible 
to identify chimeric sequences for the Jα helix that maintain key interactions with the 
AsLOV2 domain but incorporate residues critical to peptide function. In this study, we use 
sequence comparisons along with molecular modeling to create AsLOV2 variants that 
embed the binding properties of the ipaA109 and SsrA110 peptides in the Jα helix. 
The usefulness of a photoswitch depends on how much the activity is enhanced by light 
irradiation (dynamic range) as well as the absolute activity in the dark and in the light. 
Naturally occurring protein switches vary considerably with regard to absolute activities and 
dynamic range, indicating that the appropriate switching power for a particular application is 
likely to be system dependent. For instance, the AsLOV2-derived PA-Rac switch binds to its 
effector with an affinity of 2 µM in the dark and 200 nM in the light68, which is appropriate for 
modulating cellular signaling because a similar change in binding affinity occurs when Rac1 
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naturally cycles between the GDP and GTP bound state111. Studies with the wild-type 
AsLOV2 domain indicate that it should be possible to create AsLOV2-based switches that 
show larger changes in activity upon light activation. Nuclear magnetic resonance (NMR) 
studies have shown that light activation changes the ratio of docked to undocked Jα helix 
from 98.4:1.6 in the dark to 9:91 in the lit state23. This corresponds to a 3.8 kcal mol−1change 
in free energy, which if efficiently harnessed could be used to create switches that have 
greater than 100-fold changes in binding affinity for target molecules. In scenarios that 
involve competitive binding to the Jα helix, that is, the helix is either docked against the LOV 
domain or bound to an effector molecule, it may be necessary to stabilize the helix docked 
state in order to take full advantage of the free energy perturbation that light activation 
provides. Strickland et al. (2010) showed that mutations that stabilize the docked Jα helix 
could be used to lower the dark state affinity of LOV-TAP for DNA and improve its dynamic 
range from 5- to 70-fold. Here, we identify further mutations that stabilize a docked Jα helix 
and show that the peptide switches can also be tuned by varying the location in which the 
caged sequence is embedded in the Jα helix and by varying the intrinsic affinity of the 
peptide for its target. 
As an application of our tunable peptide photoswitches, we show that the caged ipaA 
peptide can be used to induce gene expression through light-activated heterodimerization in 
yeast, demonstrating that the caged peptides can be used as general tools for colocalizing 
proteins in living cells. 
2.3 Materials and Methods 
2.3.1 Identifying Peptides Compatible with LOV2 Caging 
The protein database was searched for PDB files that have multiple chains and at 
least one chain with fewer than 30 amino acids.  The goal of this search was to create a 
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comprehensive list of peptides that have been co-crystallized with binding partners. 3137 
peptides were identified.  To evaluate if a peptide was potentially compatible with caging by 
the LOV2 domain we used a sliding window of 6 residues to compare the sequence of the 
Ja-helix with the peptide under consideration.  A favorable score was assigned to an aligned 
residue pair if two residues in the alignment were similar or identical.  The following sets of 
amino acids were considered similar: (K, R),  (D, E), (F, Y, W), (N, Q) and (S, 
T).  Additionally, the score for an aligned residue pair was adjusted depending on how 
buried the LOV2 residue was in the LOV2 domain and how buried the peptide residue was 
in the peptide/protein co-crystal.  The rationale for this scheme was that buried residues are 
more likely to be important for caging and binding to the target protein.  For instance, if the 
alignment under consideration matched a buried position from the Ja helix with a residue 
buried in the peptide/protein complex than the match was considered very favorable if they 
were identical or similar (4 or 3 points respectively), and unfavorable if they were dissimilar 
(- 4 points).  When matching two surface positions there was a weak bonus for identity or 
similarity (2 or 1 point) and no penalty for dissimilarity.  The total score for the alignment was 
the sum of scores from the six residue pairs.  The best scoring alignment had a score of 17 
points, and over 200 alignments scored 9 points or better.  Despite scoring well in this 
scheme, a peptide may still be unsuitable for caging if it includes additional critical residues 
(outside the six residue window) that do not align well with the Ja-helix or do not extend off 
the end of the Ja-helix as in the case of LOV-ipaA. 
2.3.2 Cloning 
The LOV-ipaA gene was synthesized with a six histidine N-terminal tag (Genscript, 
Piscataway, NJ, USA) and cloned into the pET21b vector. The genes for LOV-SsrA and 
monomeric SspB were synthesized (Genscript) and cloned into pQE-80L and pTriEX4 
vectors, respectively. All mutations were performed using site-directed mutagenesis. The 
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vinculin D1 subdomain (residues 1–258) and full-length vinculin (residues 1–1066) were 
cloned into a pET15b vector.  
2.3.3 Protein Expression and Purification 
LOV-ipaA WT and mutants were expressed in E.coli strain BL21(DE3) cells 
(Genese) at 16°C overnight in the dark. Cells were lysed in buffer containing 50 mM sodium 
phosphate pH 7.5, 150 mM NaCl and 5 mM 2-mercaptoethanol. Proteins were purified by 
affinity chromatography over HiTrap HisTrap columns (GE) and eluted with 150 mM 
Imidazole at pH 7.5.  The proteins were further purified through size exclusion 
chromatography over a Sephadex S75 column (GE) equilibrated with 50 mM sodium 
phosphate, 150 mM NaCl and 5 mM 2-mercaptoethanol.  VinculinD1 subdomain was 
expressed in E.coli strain BL21(DE3) cells (Stratagene) at 16°C overnight. Cells were lysed 
in buffer containing 50 mM Tris-HCl pH 8.0, 500 mM NaCl and 5 mM 2-mercaptoethanol. 
The protein was purified by affinity chromatography over HiTrap HisTrap columns (GE) and 
eluted with 500 mM Imidazole at pH 8.0. The protein was further purified by ion exchange 
chromatography using a HiTrap Q column (GE) eluted with a NaCl gradient. VinculinD1 was 
stored in 20 mM Tris-HCl with 2 mm DTT and 2 mM EDTA.   
Vinculin full-length protein was expressed in E.coli strain BL21(DE3) cells (Genese) 
at 37°C for four hours. Cells were lysed in buffer containing 50 mM Tris-HCl pH 8.0, 500 mM 
NaCl and 5 mM 2-mercaptoethanol. The protein was purified by affinity chromatography 
over HiTrap HisTrap columns (GE) and eluted with 500 mM Imidazole at pH 8.0. The protein 
was then purified by ion exchange chromatography using a HiTrap Q column (GE) eluted 
with a NaCl gradient. Vinculin was further purifiedthrough size exclusion chromatography 
over a Sephadex S200 column (GE) equilibrated with 50 mM sodium phosphate, 150 mM 
NaCl and 5 mM 2-mercaptoethanol.   
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LOV-SsrA and SspB Constructs were expressed in BL21 E.coli cells and induced 
with 333mM IPTG overnight at 18°C.  Proteins were purified through binding Ni-NTA 
columns and eluted against an imidazole gradient.  Size exclusion chromatography using an 
S75 column was performed as a final clean-up step and to switch buffer to PBS.    
Protein concentrations for LOV-SsraC, LOV-SsraN, Sspb LOV-ipaA and vinculinD1 were 
determined using Bradford assays (Thermo). Protein concentrations for full-length vinculin 
were determined using absorbance at 280 nm measurements with an extinction coefficient 
of 62,000 M-1cm-1. 
2.3.4 Peptides 
Peptides containing the sequence TANNIIKAAKDATTSLSKVLKNIN, 
TANNIIKAAKDATTSASKVLNIN, TANNIIKAAKDATTSLSKALKNIN, QIEEAANDENY, 
LIKKAANDINYAAK, and HVRDAANDEAYMLIK were synthesized at UNC-Chapel Hill and 
amine labeled using 5-(and-6)-Carboxytetramethylrhodamine (TAMRA) dye (Anaspec, 
Fremont, CA, USA). Peptide concentration was determined by measuring absorbance of the 
TAMRA dye at 555 nm using 65,000 M−1cm−1 extinction coefficient. 
2.3.5 Fluorescence Polarization Experiments 
All fluorescence polarization experiments were conducted using a Jobin Yvon Horiba 
FluoroMax3 fluorescence spectrometer. TAMRA-labeled peptides were excited with 
polarized light at 555 nm, and the polarization of emitted light was measured at 583 nm.  
For LOV-ipaA, Competition assays were conducted using 50 nM TAMRA-ipaA peptide and 
a concentration of vinculin appropriate for binding 85% of the TAMRA- ipaA peptide, as 
determined from the previously measured dissociation constant for TAMRA-ipaA and 
vinculin. Varying concentrations of LOV-ipaA were then added to the reaction. The reaction 
was allowed to proceed for 3 hours at 25°C, with polarization of TAMRA dye emission 
measured at intervals of 5 min. Competition curves were fit using a first order exponential 
 28 
decay equation to determine the polarization at time point zero. The fraction of TAMRA-ipaA 
bound to vinculin was determined by normalizing each curve using the time point zero as 
the calculated 85% bound point and the polarization of TAMRA-ipaA alone as the zero 
fraction bound point in the dark. In the light, each curve was normalized with a zero fraction 
bound point determined by mixing TAMRA-ipaA and LOV-ipaA at the concentration used in 
the titration under blue light and setting the resulting polarization as the zero fraction bound 
point. Normalized curves were fit for kon and KD rates using a numerical integration script in 
Matlab. Six curves were used per fit, and two fits were averaged for each kinetic 
measurement. 
Binding of SspB to TAMRA-labeled peptides was performed in a 1cm quartz cuvette 
with a starting peptide concentration of 25 nM in PBS at 25°C. Increasing concentrations of 
SspB were titrated into the cuvette and polarization was recorded. Binding of LOV-SsrA 
designs to SspB was measured through competition with the TAMRA-labeled peptide. 
Competition binding experiments began with a solution containing 25 nM labeled peptide 
and 40 nM SspB. Titrations of LOV-SsrA designs were exposed to blue light (455nm, 6.0 
mW cm-2) for 2 minutes, and polarization readings were taken the instant the light was 
switched off. After 5 minutes of darkness, a second polarization reading was taken. 
Competition with the peptide-SspB complex allowed for fitting of an IC50 value for the 
design and determination of KD according to Nikolovska-Coleska et al. (Nikolovska-
Coleska, et al., 2004). Reversibility of LOV-SsrAC binding to SspB was performed by 
repeatedly irradiating the 1.5 µM LOV-SsrA titration point from the competition assay with 
blue light (455nm, 6.0 mW cm-2) for 60 seconds and monitoring polarization for 4 minutes. 
2.3.6 Illumination 
For fluorescence polarization assays, all LOV2-containing proteins were continuously 
irradiated for at least 1 min using a collimated blue LED with maximum emission wavelength 
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of 455 nm (ThorLabs, product code LEDC1). The irradiation was directly 10 cm above a 
sample chamber of 0.9 cm diameter. Illumination power was measured to be 6.0 mW cm-2 in 
the sample holder. For yeast two- hybrid experiments, yeast plates were initially grown using 
a set of 50 LED wide angle holiday string lights (Target, 120V, 0.04A) placed in a 41x 46 cm 
array 30 cm above the plates, yielding good colony growth. Optimal growth was observed 
using an array of 32 blue LED lights (Optek) arranged in series on a 5.5x5.5 cm array 
placed 30 cm above the plates. Lights had maximal emission wavelength of 470 nm, and 
were operated at 5 V, 0.5 A. 
2.3.7 LOV-SsrA Design 
Alignments between the SsrA peptide and LOV2 were modeled with the Rosetta 
molecular modeling program. The domain assembly protocol was used to assemble the C-
terminally aligned designs. The fixed backbone design protocol was used to explore 
mutations within LOV2-SsrA. C-terminal extensions to LOV2-SsrA were modeled using the 
floppytail protocol in Rosetta. Designs were sorted by score and the lowest scoring designs 
were examined. Monomeric SspB was developed using the fixed backbone design and 
ridged-body docking protocols in Rosetta. SspB was confirmed to be a monomer using 
SEC-MALS. 
2.3.8 LOV-SsrA Thermal Reversion 
Photocycle kinetics were determined by monitoring recovery of absorbance at 
450nm of 10µM LOV-SsrAC after 60 seconds of irradiation with blue light (455nm, 6.0 mW 
cm-2) with and without 20 µM SspB. All measurements were taken at 25oC. 
2.3.9 Surface Plasmon Resonance 
Surface plasmon resonance experiments were conducted using a Biacore 2000 
machine (GE Healthcare, Waukesha, WI, USA). Vinculin D1 was immobilized through amine 
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coupling to the surface of a CM5 chip (GE Healthcare). Different concentrations of LOV-ipaA 
mutants were flown over the immobilized protein, and the change in response units over 
time was recorded. Data were fit simultaneously for kon and koff to a pseudo-first-order 
binding model. 
2.3.10 Actin Co-sedimentation Assays 
Purified rabbit actin (Invitrogen) was polymerized for 30 min at room temperature in 
10 mM Tris-HCl (pH 7.5) containing 100 mM KCl, 2 mM MgCl2, 2 mM DTT, and 1 mM ATP. 
Vinculin (2 µM) and either ipaA peptide or LOV-ipaA mutants were mixed for vinculin:ipaA 
rations of 1:0, 1:1, 1:2.5, 1:5, 1:10, 1:20, or 1:50 per sample. Polymerized actin (12 µM) was 
added to each sample, within a volume of 45 µl per sample. Samples were incubated at 
room temperature for 1 hr. They were then centrifuged in a TLA-100 rotor in a Beckman 
Coulter Optimax XP ultracentrifuge at an acceleration of 150,000 g for 30 min cooled to 
20°C. Samples were split into supernatant and pellet fractions. Pellets were resuspended 
into 45 µl 2x tris-glycine SDS buffer. All fractions were denatured and run onto an 8% SDS-
PAGE polyacrylamide gel. Gels were Coomassie stained and analyzed using ImageJ 
software to determine the fraction of vinculin present in the pellet versus total vinculin in 
each sample112. 
2.3.11 Analysis of Actin Co-sedimentation Assays 
Apparent binding affinity of ipaA or LOV-ipaA to vinculin was determined by plotting 
the fraction of vinculin bound to actin versus concentration of LOV-ipaA and fitting the curve 
to the equation below using Prism software. A total of 3 gels were quantified and averaged 
for each binding affinity measurement. 
! = ! + ! − ! × ! + !! + !! − ! + !! + !! ! − 4(!!!!)2!!  
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Where F is the fraction of vinculin bound to actin in the pellet, a is the minimum 
fraction bound, b is the plateau for fraction bound (set to 0.39), K is the binding affinity, X0 is 
the concentration of ipaA or LOV- ipaA added to the reaction, and V0 is concentration of 
vinculin in the reaction (set to 2 mM). 
2.3.12 Isothermal Calorimetry Binding Experiments 
All ITC experiments were performed at UNC Chapel Hill in the Macromolecular 
Interaction Facility using a MicroCal Auto ITC200. Purified LOV-ipaA L623A lit state (I532E 
A536E), dark state (C450A) mimetics, and vinculinD1 were dialyzed for four hours in 50 mM 
sodium phosphate, 150 mM NaCl and 5 mM 2-mercaptoethanol buffer. 
2.3.13 Initial LOV-ipaA competition inhibition measurements 
The binding affinity of synthesized TAMRA labeled ipaA peptide to vinculinD1 was 
determined by titrating increasing concentrations of vinculinD1 into 2 nM TAMRA labeled 
ipaA peptide and measuring fluorescence polarization at the emission wavelength of 
TAMRA, 583 nm. The curve was fit using a one site binding model in Sigma Plot software. 
The off rate of TAMRA labeled ipaA peptide binding to vinculinD1 was determined by using 
50 nM TAMRA ipaA peptide 85% bound to vinculinD1 in a 0.3 cm path length cuvette. A 30-
fold excess of unlabeled ipaA peptide was then added to the reaction. The reaction was 
allowed to proceed for 3 hours at 25°C, with polarization of TAMRA dye emission measured 
at intervals of 5 min and was fit to a one phase exponential decay equation to determine the 
first order rate constant. 
2.3.14 Structural Software and Data Presentation Methods 
All model and crystal structure figures were made using Pymol. All gel images were 
taken using a Kodak GelLogic 100 imaging system and slightly adjusted for optimal 
brightness and contrast equally throughout the gel area using Adobe Photoshop. Yeast 
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plates were scanned using an HP ScanJet 4850 scanner and resulting images were 
cropped of whitespace using Adobe Photoshop. 
2.3.15 Yeast Two-Hybrid Assays 
LOV-ipaA L623A WT, lit-state mutants, dark-state mutants, and ipaA were cloned 
into a pGADT7 vector and transformed into S. cerevisiae Y187 strain, whereas the vinculin 
D1 subdomain was cloned into a pGBKT7 vector and transformed 
into S. cerevisiae Y2Hgold strain (Clontech, Mountain View, CA, USA). Empty vectors were 
also transformed into the appropriate strains. Transformed colonies of Y2Hgold and Y187 
were mated at 30°C overnight and plated on synthetic dextrose (SD) –Leu –Trp media. For 
yeast two-hybrid experiments, mated colonies were serially diluted (1:5, from right to left on 
plates shown) and replica plated onto SD –Leu –Trp media; SD –Leu –Trp media with 
auerobasidin A and 5-bromo-4-chloro-3-indolyl-α-D-gactopyranoside (x-α-gal); SD –Leu –
Trp –His media with auerobasidin A and x-α-gal; and SD –Leu –Trp –His –Ade media with 
auerobasidin A and x-α-gal. Plates were grown for three days at 30°C. For Miller assays, 
mated colonies were picked and grown to saturation in SD –Leu –Trp media. Saturated 
colonies were diluted to low-log phase and grown for 4 hr under dark or blue light conditions. 
Cells were lysed open and treated with chlorophenol red-β-D-galactopyranoside (CPRG; 
Roche) substrate to determine β-galactosidase activity in Miller units46. 
2.4 Results 
2.4.1 Identifying Peptides Compatible with AsLOV2 Caging 
To identify protein binding peptides well suited for caging with the AsLOV2 domain, 
we searched the protein database (PDB) for peptide sequences similar to portions of the Jα 
helix. The similarity score for each position in the alignment was weighted based on how 
likely a match or mismatch was to disrupt caging or peptide binding. For instance, if a 
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position in the alignment mapped to residues important for both the AsLOV2-Jα helix 
interaction and the peptide-protein interaction, then a large favorable score was given if the 
amino acids were identical, and a large unfavorable score was given if the amino acids were 
dissimilar. The importance of a residue to the AsLOV2-Jα helix interaction or the peptide-
protein interaction was assigned based on how buried the residue was; residues that were 
more buried were considered more important. There was little reward or penalty for 
conserving amino acids on the surface of the Jα helix. Using a sliding window of six 
residues, the sequence of the Jα helix was aligned with over 3,000 peptide sequences taken 
from crystal structures of peptides co-crystallized with their protein binding partners. 
Peptides from several hundred structures were identified as candidates for caging with the 
AsLOV2 domain. It is worth noting that this approach can be expanded to also consider 
known protein binding peptides that have not been crystallized with their binding partners. 
We picked out two peptide sequences for experimental testing and optimization: a vinculin 
binding peptide from the invasin protein ipaA113 and the SsrA peptide from E. coli, which 
binds the protease delivery protein SspB110. These sequences were chosen for a variety of 
reasons. First, at functionally important residues they align well with the Jα helix (Figures 
2.2A and B). Indeed, several alternative alignments were identified for the SsrA peptide. 
Second, they adopt alternative conformations when binding their targets; ipaA adopts a 
helix, whereas SsrA binds in an extended conformation (Figure 2.3). By testing both 
peptides, we examine if our approach can be used to cage peptides regardless of the 
conformation they adopt when bound to their target protein. Third, the peptides have 
different intrinsic affinities for their target proteins. IpaA binds the D1 domain of vinculin very 
tightly, Kd < 1 nM, whereas SsrA binds SspB with an affinity of ~30 nM. 
Finally, they have complementary advantages for use in controlling cell biology. The SsrA 
and SspB sequences are specific to bacteria, and therefore it is expected that they will not 
interact with other proteins and peptides in higher organisms. Fusing proteins of interest to a 
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photo-activable SsrA and SspB should provide a general approach for light-induced 
heterodimerization, which can be used to localize proteins in the cell and activate cell-
signaling pathways. Vinculin and ipaA-like peptides are found in mammals, and therefore 
caged ipaA should only be useful as a general tool for colocalization in orthogonal systems, 
such as yeast. However, caged ipaA may be useful for probing vinculin biology in 
mammalian cells. Vinculin is a protein that connects integrin binding proteins, such as 
talin114, to the actin cytoskeleton at focal adhesions115 and adherens junctions116, cellular 
structures important for determining cell shape and motility. The ipaA peptide is from the 
IpaA protein of the Shigella flexneri bacterium and binds to the talin binding site on 
vinculin113. It has been proposed that IpaA binding prevents vinculin from binding talin, and 
thus linking integrin signaling to the actin cytoskeleton. Selectively photo-controlling the 
binding of ipaA to vinculin through the LOV-ipaA photoswitch could render it useful as a 
dominant negative inhibitor of vinculin in mammalian cells and an integral tool for studying 
the role of vinculin dynamics in cell motility. 
2.4.2 Design of LOV-ipaA 
In our search of peptides in the protein database, the first ten residues of the ipaA 
VBS1 helical peptide were identified as a close match to the last ten residues of the AsLOV2 
Jα helix (Figure 2.2A). Five of the ten positions are identical, and the hydrophobic residues 
on the Jα helix that make critical contacts with the AsLOV2 domain β sheet at residues 539, 
542, and 543 are conserved in the alignment with ipaA. Additionally, residues in the ipaA 
sequence that make extensive contacts with vinculin are conserved in the alignment (Ile 
612, Ala 615, Ala 616, and Val 619 in ipaA). This analysis suggests that it should be 
possible to design a chimeric sequence for the Jα helix that is compatible with the AsLOV2 
structure and will bind vinculin when undocked from the AsLOV2 structure. 
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To design the chimeric sequence, the Rosetta molecular modeling program was 
used to assess the impact of altering the AsLOV2-Jα and vinculin-ipaA complex 
sequences117. Side-chain optimization simulations were used to thread the first ten residues 
of ipaA onto the last ten residues of the Jα helix. The Rosetta scores of individual residues 
were examined to determine if particular residues in the ipaA sequence packed unfavorably 
against the AsLOV2 domain β sheet. Only the mutation of the residue in position 540 from 
aspartic acid to tyrosine showed unfavorable scores. To search for an alternative amino acid 
to place at this position, Rosetta was used to perform a sequence optimization simulation in 
which position 540 was allowed to adopt alternative identities and neighboring side chains 
were free to adopt new side-chain conformations. One of the best scoring residues in 
the 540 position on the Jα helix was isoleucine. A working model for LOV-ipaA was then 
created by using the threaded AsLOV2-Jα design and adding the remaining eleven residues 
of ipaA onto the C-terminal end of Jα using the fragment insertion capability of Rosetta's 
domain assembly protocol (Figure 2.2C). 
2.4.3 Dark- and Lit-State Binding between LOV-ipaA and Vinculin D1 
We developed a fluorescence polarization competition assay to measure the binding 
affinity and kinetics of LOV-ipaA to the vinculin D1 subdomain under dark, as well as blue 
light, irradiation conditions (Figure 2.4A). LOV-ipaA was titrated into a mixture of the vinculin 
D1 subdomain bound to ipaA peptide labeled with the dye 5-(and-6)-
Carboxytetramethylrhodamine (TAMRA). As LOV-ipaA bound to vinculin the dye-labeled 
peptide was competed off and its fluorescence polarization signal decreased. Initial 
experiments showed that the slow intrinsic off-rate of the ipaA peptide and LOV-ipaA from 
vinculin made it possible to monitor both the kinetics and thermodynamics of binding over a 
time course of several hours. Experiments with varying amounts of LOV-ipaA were fit 
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simultaneously for the on rate and binding affinity of LOV-ipaA to vinculin D1 in Matlab using 
a numerical integration protocol. 
The same concentrations of LOV-ipaA under either blue light irradiation or dark-state 
conditions yielded different kinetic curves (Figure 2.4B and C). The binding affinity of LOV-
ipaA WT in the light is 3.5 nM, whereas it is 69 nM in the dark, a 19-fold change (Table 2.1). 
The change in binding affinity upon light activation is primarily due to changes in the on 
rate for binding; in the dark, the rate constant is 1.3 × 103 M−1 s−1, and in the light it is 1.4 × 
104 M−1 s−1. Similar changes were observed for LOV-ipaA mutants that abolish FMN-thiol 
bond formation (C450A) and lead to a pseudodark state or mutants that destabilized the Jα 
helix (I532E A536E), causing a pseudo-lit-state conformation. These results are consistent 
with the proposed mechanism of caging. In the dark, the Jα helix is primarily docked against 
the AsLOV2 domain, and the peptide is presented less frequently to the target binding site, 
slowing the on rate for binding. In general, the on rates for binding are slow both in the lit 
and dark state. Peptides and proteins often have kon values greater than 1 × 105 M−1 s−1 118. 
The slow rates observed here are consistent with the helix addition mechanism of ipaA 
binding to vinculin, wherein the vinculin D1 4-helix bundle is rearranged into a 5-helix bundle 
through the addition of ipaA119. 
2.4.4 Optimization of LOV-ipaA 
We tested two sets of mutations predicted to enhance the dynamic range of the 
LOV-ipaA photoswitch. The first set of mutations was designed by Strickland et al. (2010) to 
stabilize the helical structure of Jα. The mutations, G528A and N538E, increased the 
dynamic range of the LOV-TAP photoswitch for its effector from 5- to 70-fold. When used in 
the LOV-ipaA system, the mutations did have a large effect on LOV-ipaA dark-state binding 
to vinculin D1, decreasing affinity more than 7-fold to 475 nM (Table 2.1). However, the 
mutations also weakened lit-state binding affinity over 10-fold to 110 nM. The net effect of 
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the G528A and N538E mutations in LOV-ipaA then was a decrease in the photoswitching 
dynamic range of the protein. The weakened affinity for vinculin in the lit state is likely due to 
charge-charge repulsion between Glu538 in LOV-ipaA (G528A and N538E) and a glutamate 
close to the binding site of ipaA in vinculin. 
We designed a second set of mutations to increase the dynamic range of the switch, 
L514K L531E, using the interactive modeling program FoldIt120. These mutations replaced 
two hydrophobic residues, one in the Jα helix, and the other on the β sheet contacting the 
Jα helix, with a salt bridge. The design was meant to stabilize interactions between the β 
sheet and Jα helix and lead to a more tightly bound helix in the dark state. Indeed, the 
binding affinity of LOV-ipaA L514K L531E to vinculin D1 in the dark state weakened to 
245 nM, whereas the lit-state affinity increased only slightly to 5 nM. This set of mutations 
make LOV-ipaA a photoswitch with a 49-fold difference between the lit- and dark-state 
effector binding affinities. 
To independently validate results from the florescence polarization competition 
assay, surface plasmon resonance experiments were also conducted. The on rate, off rate, 
and binding affinity of vinculin D1 to LOV-ipaA L514K L531E were measured. LOV-ipaA 
L514K L531E pseudolit (I532E A536E 20) and pseudodark (C450A 121) states were used. 
Pseudo-dark-state LOV-ipaA L514K L531E (Figure 2.4D) was able to bind vinculin D1 with 
an on rate of 4.5 × 102 M−1 s−1 and an off rate of 2.9 × 10−5 s−1. A binding affinity of 64 nM 
was calculated from the kinetic data. The on rate was identical to that measured for LOV-
ipaA L514K L531E under dark-state conditions using the fluorescence polarization assay. 
The off rate varied slightly, leading to a 4-fold difference in binding affinity between the two 
measurements. In part, the discrepancy might be due to the fact that it is difficult to fit an off 
rate that is so slow. Measuring the LOV-ipaA L514K L531E pseudolit photoswitch binding to 
vinculin D1, an on rate of 3.8 × 104 M−1 s−1 and an off rate of 8.7 × 10−5 s−1 were obtained 
(Figure 2.4E). Fitting indicated that the binding affinity was 2.3 nM. These values are similar 
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to the kinetic rates measured for the LOV-ipaA lit mimetic using the fluorescence 
polarization assay. 
There is a 49-fold increase in binding affinity for vinculin when LOV-ipaA L514K 
L531E is activated with light but binding in the dark is still considerable (245 nM). For some 
applications, it may be useful to have a switch that has weaker binding affinity in the dark. 
To test if we could switch the range of affinities over which LOV-ipaA functions, we made a 
mutation to LOV-ipaA that was predicted to reduce affinity for vinculin but should have 
negligible effect on the interactions between the Jα helix and the LOV domain. This mutant, 
L623A, weakened the affinity of the LOV-ipaA lit-state mimetic for the vinculin D1 domain 
from 3 nM to 2.4 µM, whereas the dark-state mimetic had no detectable binding as 
monitored with isothermal titration calorimetry, suggesting that binding in the dark is weaker 
than 40 µM (Figure 2.5). 
2.4.5 Design and Optimization of LOV-SsrA 
We extended the design strategy used to cage ipaA in order to create a second 
photoswitchable peptide, LOV-SsrA. The SsrA peptide interacts with the protease delivery 
protein SspB from E. coli as a linear epitope using the seven residue sequence 
AANDENY110. Three possible alignments between SsrA and the Jα helix were identified in 
our PDB-wide search, one toward the N-terminal side of the helix (LOV-SsrAN), one near 
the C-terminal end (LOV-SsrAC), and one in the middle of the helix (LOV-SsrAM; Figure 
2.2B). We first tested the C-terminal alignment LOV-SsrAC. 
In LOV-SsrAC, the two alanines from SsrA were aligned with A542 and A543 from 
the last helical turn of the Jα helix, and the final three residues of the Jα helix were replaced 
with residues from the SsrA binding sequence (Figure 2.2D). Except for the last leucine, all 
buried positions in the Jα helix are conserved with this alignment, which only embeds the 
peptide in a single helical turn of the Jα helix. In comparison, the ipaA peptide is embedded 
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within two helical turns in LOV-ipaA. To measure the affinity of LOV-SsrA for SspB in the 
dark and light, a fluorescence polarization competition assay was performed with TAMRA-
labeled SsrA peptide122. Unlike ipaA, SsrA binds rapidly to SspB and only equilibrium 
populations could be measured. The initial LOV-SsrA design showed a 2-fold change in 
affinity of 31 nM to 57 nM when activated with light (Table 2.2). As lit-state binding was near-
native in affinity for SspB, approaches to stabilize the Jα helix and therefore decrease dark-
state affinity were explored. We tested mutations previously shown to stabilize the Jα helix, 
G528A and N538E, as well as extensions to the C terminus of LOV-SsrAC. G528A and 
N538E had the desired effect and lowered dark-state affinity to 570 nM with a 5-fold change 
upon light activation. Extensions of varying lengths were designed with Rosetta123 with the 
goal of binding the surface of the AsLOV2 domain, thereby constraining SsrA to a single, 
nonbinding conformation. The target surface on AsLOV2 was a hydrophobic patch 
immediately adjacent to the C terminus of the Jα helix. Two extensions were experimentally 
tested, the addition of a single phenylalanine and the addition of the sequence GYGNL. The 
longer extension had no detectable effect, whereas the single phenylalanine increased the 
dynamic range of the switch to 8-fold (Figure 2.6A). 
The LOV-SsrAN designs incorporating the N-terminal alignment of SsrA had similar 
dynamic ranges to their corresponding C-terminal alignments. However, all had drastically 
reduced affinity for SspB in both the lit and dark state (>10 µM). The initial N-terminally 
aligned designs showed an approximate 2-fold increase in affinity after exposure to blue 
light. The addition of the G528A and N538E mutations slightly weakened the lit-state affinity 
for SspB to 12.6 µM and the dark-state affinity to 49 µM (Figure 2.6B). Because of 
constraints imposed by the AsLOV2 domain, the SspB binding sequence used in LOV-
SsrAN was AANDEAY instead of AANDENY as used in LOV-SsrAC. To determine if the 
sequence change was responsible for the lower dark- and lit-state affinities for SspB, a 
peptide with the same sequence as LOV-SsrAN was synthesized and binding to SspB was 
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measured. Binding was tight, 38 nM, suggesting that the reduced affinity for SspB was not 
because of changes to the binding sequence but rather because of the location within the Jα 
helix that the peptide was embedded. Results with LOV-SsrAM were more ambiguous, as 
the sequence embedded in the Jα helix, AANDINY, showed reduced affinity for SspB as a 
peptide (1.9 µM). However, lit- (40 µM) and dark-state (156 µM) state affinities were still 
significantly lower than that the isolated peptide, suggesting again that embedding 
sequences deeper in the Jα helix lowers accessibility to the peptide in both dark and light 
states (Figure 2.7). 
The reversibility of LOV-SsrA switches was tested by monitoring their ability to 
compete with a TAMRA-labeled SsraA peptide for binding to SspB over multiple rounds of 
irradiation followed by incubation in the dark (Figure 2.6C). As monitored indirectly from 
following the fluorescence polarization signal from the SsraA peptide, the fraction of LOV-
SsrA molecules switching from a bound to unbound state remained unchanged over multiple 
rounds of illumination, indicating that the switches are reversible. To check that the 
observed results were not an artifact due to interaction between the blue light and the 
TAMRA dye, similar reversion experiments were performed with only SspB and labeled 
peptide. No polarization changes were observed after incubation with blue light. Half-times 
between 27 and 50 s have been reported for the LOV2 domain from Avena sativa15,121. 
Using absorption spectroscopy, we determined the half-life of LOV-SsrAC's photocycle to be 
28.4 ± 0.1 s*; Figure 2.7).  *Note: this half-life has been updated since a contamination was 
found.  The values here were published in an erratum later in 2012.   
2.4.6 LOV-ipaA Binding to Full-Length Vinculin: Actin Cosedimentation Assays 
Having established that the AsLOV2 domain could be used to cage peptides, we 
tested if LOV-ipaA could be used to perturb vinculin in a biologically relevant manner. Actin 
cosedimentation assays were performed to measure the apparent binding affinity of LOV-
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ipaA to full-length vinculin. Vinculin naturally forms an autoinhibited conformation stabilized 
by interactions between the head (including the D1 domain) and tail domains. Binding of the 
ipaA peptide to the head domain competes with the autoinhibited state and releases the tail 
domain to bind with polymerized F-actin113. Actin cosedimentation assays were performed to 
measure the apparent binding affinity of LOV-ipaA in the dark and lit state to full-length 
vinculin. In the assay, polymerized actin, vinculin, and LOV-ipaA (lit- or dark-state mutants) 
were incubated together (Figure 2.8A). Only vinculin that bound to LOV-ipaA should be able 
to interact and bind to F-actin. The resulting mix of bound and unbound vinculin was 
centrifuged at high speeds, resulting in fractionation of F-actin polymers out of solution, 
along with the vinculin-LOV-ipaA complexes that had bound to them. A sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel was used to monitor the amount 
of vinculin that fractionated out of solution along with F-actin as a function of the total 
concentration of vinculin, thereby determining the fraction of full-length vinculin bound to 
LOV-ipaA. The assay was repeated at several concentrations of LOV-ipaA to create a 
binding curve and calculate apparent binding affinities (Figure 2.8B and C). In general, the 
affinities are expected to be considerably weaker with full-length vinculin than those 
observed for binding to the isolated D1 domain, because in the full-length protein there is 
competition with the autoinhibited state of vinculin112. For instance, peptides from the protein 
talin bind to the vinculin D1 domain with an affinity of 15 nM but bind to full-length vinculin 
with an affinity of ∼5 µM112,124. LOV-ipaA with the lit-state mutant bound with an apparent 
affinity of 8 µM to vinculin, whereas the dark-state mimetics bound with an affinity of 56 µM 
(Table 2.3). The binding of vinculin to ipaA in the presence of polymerized actin also gives 
us a window into the reactions that occur in vivo, where full-length vinculin must be bound 
both by talin and by F-actin in order to engage in integrin signaling. The difference in binding 
affinity between lit and dark states of LOV-ipaA to full-length vinculin in the presence of 
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polymerized actin suggests that LOV-ipaA may be a relevant photoswitch for probing such 
signaling in vivo. 
2.4.7 Photo-Activatable Yeast Transcription 
To demonstrate that the caged peptides can be used to colocalize proteins and 
activate signaling events in living cells, we used the LOV-ipaA-vinculin D1 interaction as a 
heterodimerization switch for controlling gene expression. The experiments were performed 
in Saccharomyces cerevisiae, as it is an orthogonal system, lacking proteins that would 
cross-react with the LOV-ipaA-vinculin D1 interaction. We linked LOV-ipaA L623A to the 
GAL4 activation domain (AD), while linking vinculin D1 (vinD1) to the GAL4 binding domain 
(BD), and monitored the GAL4-induced activation of the transcriptional GAL promoter 
through a yeast two-hybrid assay. This is a strategy that has been widely used to identify 
protein-protein interactions. In our case, LOV-ipaA and vinculin D1 should only interact upon 
irradiation with blue light, thus bringing the GAL4 AD and BD into proximity (Figure 2.9A). 
The full GAL4 protein can then activate the expression of reporter genes downstream of 
the GAL promoter. We tested the ability to activate the reporter gene LacZ under both dark- 
and lit-state conditions through quantification of β-galactosidase activity (Figure 2.9B). We 
observed an activity of 5 Miller units under blue light conditions, 20 Miller units with the LOV-
ipaA L623A lit-state mimetic, and 30 units using the ipaA peptide. Almost no activity (0.4 
Miller units) was seen under dark or dark-state conditions, and no activity was seen in empty 
vector negative controls. We also tested activation of genes MEL1, HIS3, and ADE2 under 
dark- and lit-state conditions by replica plating BD-vindD1 colonies mated with AD-LOV-ipaA 
L623A lit- and dark-state mimetic mutants or AD-LOV-ipaA L623A WT (Figure 2.9C). We 
saw strong growth of colonies containing LOV-ipaA L623A lit mimetic or WT grown in blue 
light on plates lacking His, as well as those lacking His and Ade, indicating expression of 
bothHIS3 and ADE2 genes. Furthermore, colonies were blue, indicating expression of 
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the MEL1 gene, whose product, α-galactosidase, interacted with the x-α-gal substrate for 
blue screening. Colonies containing LOV-ipaA L623A dark mimetic or WT grown in the dark 
grew on control plates but did not grow on plates lacking His or Ade, showing low to no 
expression of HIS2, ADE2, or MEL1 genes. This indicates that LOV-ipaA-vinculin D1 
heterodimerization can be used as a tool to photocontrol yeast gene expression. 
The LOV-ipaA L623A mutation was critical to achieving a lit- to dark-state change of 
phenotype in yeast gene expression. When experiments for MEL1 and HIS3 were 
conducted using LOV-ipaA lacking this mutation, no observable growth change was seen 
between colonies containing lit- and dark-state AD-LOV-ipaA mated with BD-vinD1 (Figure 
2.10). The binding affinity of LOV-ipaA to vinculin D1 was hence so tight, even in the dark 
state, as to allow binding events and subsequent yeast gene expression to occur. The 
L623A mutation shifted the binding affinity of LOV-ipaA for vinculin D1 to a range in which 
there was no binding in the dark but significant activation in the light. This result highlights 
the usefulness of being able to tune the switches for specific applications. 
2.5 Discussion 
We have shown that protein-binding peptides can be embedded in the AsLOV2-Jα 
helix so that their affinity for effector proteins is weakened in the dark but is enhanced when 
light-activation releases the Jα helix from the LOV domain. The approach is applicable to a 
variety of peptide sequences because only a subset of residues on the Jα helix need to be 
conserved to maintain favorable interactions with LOV domain. Additionally, most protein-
binding peptides contain residues that can be mutated without significantly weakening 
affinity for binding partners. In the case of LOV-ipaA and LOV-SsrAC, we also took 
advantage of the fact that not all of the peptide needs to be embedded in the Jα helix to 
create a steric block against effector binding. In this scenario, only a few residues from the 
N-terminal portion of the peptide need to be compatible with the folded Jα helix. 
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For some applications, it may be necessary to tune the designed photoswitch to 
have a dark-state activity and dynamic range compatible with the desired outcome. In the 
yeast two-hybrid experiments with LOV-IpaA, we found that we needed to weaken dark-
state binding in order to prevent gene expression in the dark. We accomplished this by 
introducing a mutation that weakens the baseline affinity of IpaA for vinculin. Whereas the 
initial design switched from 3.5 nM to 69 nM affinity for vinculin, the mutant switched from 
2.4 µM to >40 µM. The switching power of the LOV-peptide switches were also manipulated 
by introducing mutations that stabilize the interaction between the Jα helix and the rest of 
the LOV domain, as well as by varying how deeply the caged peptide was embedded in the 
helix. It was somewhat surprising that the SsrA peptide had significantly lower litstate affinity 
for SspB when embedded in the N-terminal portion of the Jα helix than when placed at the C 
terminus. NMR experiments with the WT AsLOV2 domain indicate that the helix undocks as 
a cooperative unit when the protein is activated with light23. This suggests that there should 
be similar levels of access to residues in the N- and C-terminal regions of the Jα helix in the 
lit state; therefore, we expected that lit-state binding affinity for the peptide would be 
relatively insensitive to where the peptide was placed in the Jα helix. Our results indicate 
that the N-terminal portion of the Jα helix may be less accessible in the lit state, perhaps by 
transient interactions with the hydrophobic face of the LOV domain β sheet. Additionally or 
alternatively, the mutations we have made to the Jα helix to create LOV-SsrAN may have 
resulted in stronger interactions between the Jα helix and the rest of the AsLOV2 domain in 
the light. 
Both the LOV-ipaA- vinculin D1 and the LOV-SsrA-SspB photo-activatable binding 
interactions can be harnessed as tools for photo-activatable heterodimerization. The LOV-
ipaA- vinculin switch can be used in bacteria and in yeast cells, as these systems do not 
contain vinculin or vinculin binders that would affect the LOV-ipaA-vinculin interaction. On 
the other hand, the LOV-SsrA-SspB photo-activatable heterodimerization binders should be 
 45 
useful in higher organisms, such as mammalian cells. LOV-ipaA has a very slow off rate for 
vinculin D1, so it is better suited for long timescale applications, such as yeast mating. In 
contrast, LOV-SsrA binding to SspB is rapidly reversible so can be used for more transient 
interactions, such as single cell motility experiments. In these ways, both LOV-ipaA and 
LOV-SsrA should be useful tools to spatially and temporally bring together proteins for 
activating signaling cascades. 
2.6 Supporting Information 
2.6.1 FASTA sequences of LOV-ipaA and LOV-SsrA 
>LOV-ipaA 
MHHHHHHGSLATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNCRFLQGPE
TDRATVRKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTE
HVRDAAEREGVMLIKKTANNIIKAAKDVTTSLSKVLKNIN 
>LOV-ipaA L514K L531E I532E A536E 
MHHHHHHGSLATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNCRFLQGPE
TDRATVRKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQKDGTE
HVRDAAEREGVMEEGKTENNIIKAAKDVTTSLSKVLKNIN 
>LOV-ipaA L514K L531E I532E A536E L623A 
MHHHHHHGSLATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNCRFLQGPE
TDRATVRKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQKDGTE
HVRDAAEREGVMEEGKTENNIIKAAKDVTTSASKVLKNIN 
>LOV-SsrAC 
MRGSHHHHHHGEFLATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNCRFL
QGPETDRATVRKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQL
DGTEHVRDAAEREAVMLIKKTAEEIDEAANDENYF 
>LOV-SsrAM 
MRGSHHHHHHGEFLATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNCRFL
QGPETDRATVRKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQL
DGTEHVRDAAEREAVMLIKKAANDINYAAKEL 
>LOV-SsrAN 
MRGSHHHHHHGEFLATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNCRFL
QGPETDRATVRKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQL
DGTEHVRDAANDEAYMLIKKTAEEIDEAAKEL 
2.6.2 Matlab code for fitting LOV-ipaA polarization competition assay  
clear all 
 46 
%  -------------------------------------------- 
% starting protein concentrations (M) 
ipa_tot = 43e-9; 
vin_tot = 47e-9; 
lov_vin_start = 0.0; 
nlov = 6; 
lov_array = [80e-9 150e-9 300e-9 1000e-9 3000e-9 5000e-9 ]; 
% experimental results (t= seconds) 
tout_exp = dlmread('time.csv'); 
ntout_exp = 38; 
ipa_vin_exp(:,1) = dlmread('D80nm.csv'); 
ipa_vin_exp(:,2) = dlmread('D150nm.csv'); 
ipa_vin_exp(:,3) = dlmread('D300nm.csv'); 
ipa_vin_exp(:,4) = dlmread('D1um.csv'); 
ipa_vin_exp(:,5) = dlmread('D3um.csv'); 
ipa_vin_exp(:,6) = dlmread('D5um.csv'); 
% time steps (seconds) 
dt = 1e-2;    % time step 
nits = 12e5;    % number of time steps 
nout = 1200; 
dt_out = (nits/nout)*dt; 
tout = [0:dt_out:nout*dt_out];   % time points for collecting data 
nk1r = 1;    % dissociation of ipa_vin 
k1r_array = [.0024]; 
kd_ipa_vin = [ 2e-9 ];  % kd of ipa_vin 
nk2f = 1;     %  association of lov_vin 
k2f_array = [1e3];% 
nkd = 1; 
kd_array = [73e-9];  % equilibrium dissociation constant for lov binding to 
vin 
for i_k1r = 1:nk1r 
    for i_k2f = 1:nk2f 
        for i_kd = 1:nkd 
 % initialize kinetic parameters 
        k1r = k1r_array(i_k1r); 
        k1f = k1r/kd_ipa_vin; 
        kd  = kd_array(i_kd); 
for Lov / vin binding 
        k2f = k2f_array(i_k2f); 
k2r = k2f * kd; 
from vin 
  % Rate constant for ipa_vin breakup 
% Rate constant for ipa_vin association 
  % equilibrium dissociation constant 
  % rate constant for 
  % rate constant for Lov dissociating 
% loop over various Lov_tot concentrations 
sum_sqr_deviation_pol = 0; 
for l = 1:nlov 
    %ipa_tot = ipa_tot_start; 
    %vin_tot = vin_tot_start; 
in _out arrays 
ntp = floor(time_point/dt_out)+1;  % how to find time_point 
fraction_bound = ipa_vin_out(ntp,l)/ipa_tot; 
pol = fraction_bound; 
lov_tot = lov_array(l); 
lov = lov_tot; 
% calculating ipa_vin 
a = 1; 
b = -(ipa_tot + vin_tot + kd_ipa_vin); 
c = vin_tot * ipa_tot; 
ipa_vin = (-b - (b*b - 4*a*c)^0.5)/2; 
ipa_vin_start = ipa_vin; 
lov_vin = lov_vin_start; 
vin = vin_tot - ipa_vin - lov_vin; 
ipa = ipa_tot - ipa_vin; 
% output vectors 
ipa_vin_out(:,l) = zeros(1,nout+1); 
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pol_out(:,l) = zeros(1,nout+1); 
% fill output variable for time = 0 
n = 1; 
ipa_vin_out(n,l) = ipa_vin; 
fraction_bound = ipa_vin/ipa_tot; 
%dpol = pol_min - pol_max; 
pol_out(n,l) = fraction_bound; 
% numerical integration of kinetic reaction 
for i = 1:nits 
    delta_k1f = dt*k1f*ipa*vin; 
    delta_k1r = dt*k1r*ipa_vin; 
    delta_k2f = dt*k2f*lov*vin; 
    delta_k2r = dt*k2r*lov_vin; 
    lov_vin = lov_vin + delta_k2f - delta_k2r; 
    ipa_vin = ipa_vin + delta_k1f - delta_k1r; 
    vin = vin + delta_k1r + delta_k2r - delta_k1f - delta_k2f; 
    ipa = ipa + delta_k1r - delta_k1f; 
    lov = lov + delta_k2r - delta_k2f; 
    % collect data for making plots 
    if mod (i,floor(nits/nout)) == 0 
        n = n+1; 
        %lov_vin_out(n,l) = lov_vin; 
        ipa_vin_out(n,l) = ipa_vin; 
        fraction_bound = ipa_vin/ipa_tot; 
        %dpol = pol_min - pol_max; 
        pol_out(n,l) = fraction_bound; 
end end 
% compare rmsd of experiment to simulated curves 
for nt = 1:ntout_exp; 
    time_point = tout_exp(nt); 
square_deviation_pol = ((pol) - ipa_vin_exp(nt,l))^2; 
                sum_sqr_deviation_pol = sum_sqr_deviation_pol + 
square_deviation_pol; 
end end 
        rmsd = (sum_sqr_deviation_pol/(nlov*ntout_exp))^0.5; 
        end % i_kd 
    end  % i_k2f 
end % i_k1r 
plot(tout, pol_out(:,1),'b', tout_exp, ipa_vin_exp(:,1),'ob'); 
hold on 
plot(tout, pol_out(:,2),'r', tout_exp, ipa_vin_exp(:,2),'or'); 
plot(tout, pol_out(:,3),'g', tout_exp, ipa_vin_exp(:,3),'og'); 
plot(tout, pol_out(:,4),'c', tout_exp, ipa_vin_exp(:,4),'oc'); 
plot(tout, pol_out(:,5),'m', tout_exp, ipa_vin_exp(:,5),'om'); 
plot(tout, pol_out(:,6),'k', tout_exp, ipa_vin_exp(:,6),'ok'); 
hold off 
xlabel('time (seconds)'); 
ylabel('fraction bound'); 
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2.7 Tables 
 
 
 
LOV-ipaA Construct kon (M-1s-1) Koff (s-1) KD (nM) 
Dark mimetic (C450A) 1.3 ± 0.3 x 103 8.0 ± 0.7 x 10-5 64 ± 9.5 
WT dark 1.4 ± 0.1 x 103 9.6 ± 0.1 x 10-5 69 ± 0.5 
Lit mimetic (I532E A536E) 2.9 ± 2.0 x 104 8.5 ± 0.3 x 10-5 3.0 ± 1.0 
WT blue light 1.3 ± 0.3 x 104 4.5 ± 1.2 x 10-5 3.5 ± 0.5 
L514K L531E dark 4.5 ± 1.5 x 102 1.1 ± 0.4 x 10-4 245  ± 5.0 
L514K L531E blue light 2.5 ± 0.1 x 103 1.3 ± 0.1 x 10-5 5.0  ± 0.1 
G528A N538E dark 1.8 ± 0.3 x 102 8.2 ± 0.2 x 10-5 475 ± 75 
G528A N538E blue light 8.0 ± 2.0 x 102 1.2 ± 0.1 x 10-4 160 ± 40 
Table 2.1 Kinetic rates of LOV-ipaA binding vinculin D1 
  
LOV-SsrA construct Lit KD (µM) Dark KD (µM) 
Initial LOV-SsrA Fusion 3.1 ± 0.6 x10-2 5.7 ± 0.5 x10-2 
LOV-SsrA G528A & N538E 1.2 ± 0.2 x10-1 5.7 ± 0.8 x10-1 
LOV-SsrAC  1.2 ± 0.1 x10-1 9.0 ± 0.7 x10-1 
LOV-SsrAM 40 ± 2 156 ± 6 
LOV-SsrAN 12.6 ± 0.3 49 ± 3 
WT SsrA- AANDENY NA* 3.5 ± 0.2 x10-2 
SsrA- AANDEAY NA* 3.8 ± 0.8 x10-2 
SsrA- AANDINY NA* 1.9 ± 0.6  
*TAMRA-SsrA binding to SspB only measured in dark.  Error shown is  
  standard error to binding curve fit 
Table 2.2 Lit and dark binding affinities for LOV-SsrA constructs to SspB 
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LOV-ipaA Mutant KD (mM) Error (mM) 
IpaA Peptide 7.8 1.3 
Dark Mimetic (C450A)  54 12 
Lit Mimetic (A532E I536E) 7.4 2.3 
L514K L531E Dark Mimetic 116 34 
L514K L531E Lit Mimetic 8.1 2.1 
G528A N538E Dark Mimetic 315 84 
G528A N538E  Lit Mimetic  12 2.1 
Table 2.3 Apparent binding affinity of LOV-ipaA to full-length vinculin 
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2.8 Figures 
 
 
 
Figure 2.1 Caged peptide schematic. Photoswitches are designed as sequence chimeras 
between the AsLOV2 Ja helix and the peptide to be caged. Residues that are important to 
AsLOV2-Ja interactions (cyan), important to peptide-target interaction (purple), important to 
both interactions (red), and residues that are important to neither interaction (white) are 
identified and mutated accordingly. Irradiation unfolds the Ja helix, and the peptide can bind 
its target. 
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Figure 2.2 Sequence alignment of AsLOV2 and peptides. (A) Sequence alignment of 
AsLOV2-Ja, ipaA, and LOV-ipaA. Ja sequence (blue), ipaA sequence (purple), chimera 
sequence (cyan), and designed residues (red) are indicated. (B) Sequence alignment of 
AsLOV2-Ja helix, SsrA peptide, and three LOV-SsrA designs—LOV- SsrAC, LOV-SsrAN, 
and LOV-SsrAM. Ja helix sequence (blue), SsrA sequence (orange), chimera sequence 
(cyan), designed positions (black), and helix-stabilizing mutations (pink) are indicated. (C) 
Model of LOV-ipaA with residues colored as in (A). Residues N538, I539, A542, and A543 
K544 (cyan) as well as residues N537, K541, D545, V546 (purple), and I540 (red) are 
shown as sticks. (D) Model of LOV-SsrAC with residues colored as in (B). Residues A528 
and E538 (pink) as well as residues A542 and A543 (cyan) and N544, D545, E546, N547, 
and Y548 (orange) are shown as sticks. 
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Figure 2.3 Crystal structures of peptides binding native partners. (A) Structure of ipaA 
(cyan and purple) binding the vinculinD1 subdomain (white). PDB code: 2GWW (B) Crystal 
structure of SsrA (orange/cyan) bound to SspB (grey). PDB code: 1OU8. 
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Figure 2.4 LOV-ipaA binding assays. (A) Schematic of fluorescence polarization 
competition assay is shown. TAMRA-labeled ipaA (ipaA*) is bound to vinculin D1 
subdomain (vinD1). Vinculin dissociates from the complex with rates k-1 and k1 and binding 
affinity KD1. LOV-ipaA (LOVipaA) binds vinculin with rates kon and koff and affinity KD2. 
Fluorescence polarization decreases as the fraction of TAMRA-ipaA bound to vinculin 
decreases. (B and C) Fraction of TAMRA-ipaA bound to vinculin over time with varying 
concentrations of LOV-ipaA titrated in the dark and (C) under blue light. (D and E) Surface 
plasmon resonance measurements and first-order binding fit of LOV-ipaA L514K L531E 
C450A pseudodark and (E) LOV-ipaA L514K L531E I532E A536E pseudolit mutants. 
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Figure 2.5 LOV-ipaA binding to vinculinD1 measured by ITC. Isothermal Titration 
Calorimetry experiment of LOV-ipaA L623A mutation binding the vinculinD1 subdomain in 
the darks state (C450A, left) or lit state (I532E A536E, right). Both experiments were done 
with identical amounts and concentrations of protein. Binding affinity of dark state was too 
weak to fit. Binding affinity of lit state was determined to be 2.4 µM. 
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Figure 2.6 LOV-SsrA binding to SspB. (A and B) Competitive binding assay of LOV-
SsrAC (A) or LOV-SsrAN (B) to an equilibrium solution of SspB and 5(6)TAMRA-SsrA. 
5(6)TAMRA-SsrA becomes unbound as LOV-SsrA competes for SspB binding. Binding to 
SspB was measured immediately after illumination with blue light (open circles) and after 
return to dark state (closed circles). (C) Reversible binding of LOV-SsrAC to SspB. A single 
titration point from the fluorescence polarization competition assay was repeatedly irradiated 
with blue light (blue bar = 60 s) and reversion to dark-state equilibrium was monitored by 
polarization. 
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Figure 2.7 LOV-SsrAM binding to SspB and kinetics of LOV-SsrAC. (Left) Binding of 
LOV-SsrAM to SspB as measured through the fluorescence polarization competition assay 
described in Experimental Procedures. Binding to SspB was determined to be 40 µM 
immediately after irradiation with blue light (open circles) and 160 µM after relaxation to the 
dark state (closed circles). (Right) Thermal reversion of LOV-SsrAC in presence and 
absence of SspB. The recovery of absorbance at 450 nm by LOV-SsrAC (5µM) after 
irradiation with blue light was measured (closed circles) and fit to a single exponential (green 
line). The photocycle half-life was determined to be 28.4 s. 
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Figure 2.8 LOV-ipaA bound to vinculin preferentially binds actin.  (A) Full-length 
vinculin, LOV-ipaA, and polymerized actin are incubated 1 hr at room temperature. Vinculin 
that is bound to LOV-ipaA will bind polymerized actin. The mixture is centrifuged at 150,000 
g, pelleting polymerized actin and all vinculin bound to it out of solution. (B and C) SDS-
PAGE gel of LOV-ipaA C450A and (C) LOV-ipaA I532E A536E actin cosedimentation assay 
with vinculin. Molar ratios from 1:0 to 1:50 vinculin:LOV- ipaA were used. Supernatant (S) 
and pellet (P) fractions are shown side by side. Apparent binding affinity curves of fraction of 
vinculin bound to actin versus concentration of LOV-ipaA are plotted below. Error bars 
represent standard error of the mean. 
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Figure 2.9 LOV-ipaA/VinculinD1 Yeast Two-Hybrid. (A) LOV-ipaA L623A is linked to the 
GAL4 activation domain (AD), whereas vinculin D1 (vinD1) is linked to GAL4 binding domain 
(BD). Irradiation with blue light brings AD-LOV-ipaA into proximity to BD-vinD1, allowing for 
GAL-induced expression of reporter genes LacZ, MEL1, HIS2, and ADE2. (B) LacZ 
expression is quantified. b-galactosidase activity of S. cerevisiae-mated strains containing 
BD and AD linked proteins, as specified, is shown. Error bars represent standard error of the 
mean. (C) S. cerevisiae-mated strains containing BD-vinD1 and AD-LOV-ipaA mutants, as 
indicated, are grown in dark or blue light conditions on SD plates. Difference in levels of 
transcription of MEL1, HIS3, and ADE2 in dark- versus lit-state conditions is seen. 
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Figure 2.10 LOV-ipaA/VinculinD1 yeast two-hybrid controls and mimetics. (A) LOV-
ipaA L623A Lit state and dark state mimetic yeast two-hybrid assay and controls. SD media 
conditions are indicated. S cerevisiae strain Y2Hgold containing the Gal4 activation domain 
(AD) linked to the construct indicated was mated with strain Y187 containing the Gal4 
binding domain (BD) linked to the construct indicated. Mated colonies were serially diluted 
(1:5), replica plated, and grown for 3 days at 30° C. (B) LOV-ipaA L623A WT yeast two-
hybrid assay and controls (Dark state plates are on top, blue light plates on bottom). SD 
media conditions are indicated. S cerevisiae strain Y2Hgold containing the Gal4 activation 
domain (AD) linked to the construct indicated was mated with strain Y187 containing the 
Gal4 binding domain (BD) linked to the construct indicated. Mated colonies were serially 
diluted (1:5), replica plated, and grown for 3 days at 30° C in either blue light or in the dark, 
as indicated. (C) LOV-ipaA WT lit state and dark state mimetic yeast two-hybrid assay and 
controls. SD media conditions are indicated. S cerevisiae strain Y2Hgold containing the 
Gal4 activation domain (AD) linked to the construct indicated was mated with strain Y187 
containing the Gal4 binding domain (BD) linked to the construct indicated. Mated colonies 
were serially diluted (1:5), replica plated, and grown for 3 days at 30° C. 
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Chapter 3 
Engineering an improved light-induced dimer (iLID) for controlling the 
localization and activity of signaling proteins1 
This work was published in the Proceedings of the National Academy of Sciences, 
Volume 112, Issue 1, p112-117 on 6 January 2015.  Gurkan Guntas constructed the DNA 
libraries and performed the phage display and ELISA selections.  Ryan Hallett designed the 
computational library and performed all in vitro experiments.  Seth Zimmerman performed all 
of the mammalian cell culture experiments.  Tishan Williams solved the structure of iLID and 
Hayretin Yumerefendi performed proof of principle phage display work with AsLOV2 
domains.  This work was guided and funded by Brian Kuhlman and James Bear. 
3.1 Overview  
The discovery of light-inducible protein–protein interactions has allowed for the 
spatial and temporal control of a variety of biological processes. To be effective, a 
photodimerizer should have several characteristics: it should show a large change in binding 
affinity upon light stimulation, it should not cross-react with other molecules in the cell, and it 
should be easily used in a variety of organisms to recruit proteins of interest to each other. 
To create a switch that meets these criteria we have embedded the bacterial SsrA peptide in 
the C-terminal helix of a naturally occurring photoswitch, the light-oxygen-voltage 2 (LOV2) 
domain from Avena sativa. In the dark the SsrA peptide is sterically blocked from binding its 
                                                
1This chapter previously appeared as an article in PNAS.  The original citation is as follows: Guntas, 
G. et al. Engineering an improved light-induced dimer (iLID) for controlling the localization and activity 
of signaling proteins. Proc. Natl. Acad. Sci. 112, 112–117 (2015). 
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natural binding partner, SspB. When activated with blue light, the C-terminal helix of the 
LOV2 domain undocks from the protein, allowing the SsrA peptide to bind SspB. Without 
optimization, the switch exhibited a twofold change in binding affinity for SspB with light 
stimulation. Here, we describe the use of computational protein design, phage display, and 
high-throughput binding assays to create an improved light inducible dimer (iLID) that 
changes its affinity for SspB by over 50-fold with light stimulation. A crystal structure of iLID 
shows a critical interaction between the surface of the LOV2 domain and a phenylalanine 
engineered to more tightly pin the SsrA peptide against the LOV2 domain in the dark. We 
demonstrate the functional utility of the switch through light-mediated subcellular localization 
in mammalian cell culture and reversible control of small GTPase signaling. 
3.2 Introduction 
Inducible protein dimers are complexes that form when a specific stimulus is 
provided – for instance the protein FRB binds to the protein FKBP12 in the presence of 
rapamycin 125. They are powerful research tools because with genetic engineering they can 
be used to localize and activate proteins in living systems 101,102,126,127. For example, by 
fusing one half of an inducible dimer to a DNA binding domain and the other half to a 
transcription activation domain, transcription of target genes can be initiated by providing the 
stimulus that induces dimerization. Chemically induced dimers, such as FRB and FKBP12, 
have been used to control a wide variety of biological processes but are limited by 
irreversibility and lack of spatial control within a cell. For this reason, there is strong interest 
in light-inducible dimers that can be activated in specific regions of a cell or an organism 
using light in a reversible manner. 
 Several light-inducible dimers are currently available and have been used to control 
signaling pathways in living cells. In almost all cases, the dimers are derived from naturally 
occurring photoactivable systems. The most widely used pair thus far is cryptochrome 2 
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(Cry2) and CIB1 from Arabidopsis thaliana. The Cry2/CIB1 pair shows blue light induced 
dimerization in both yeast and mammalian cell culture. Association occurs on a sub-second 
time scale and reversion within 10 minutes 126. The mechanism of light-activation is not fully 
understood and it has recently been shown that Cry2 oligomerizes into large clusters under 
blue light in addition to associating with CIB1. This could be a drawback for applications that 
require precise stoichiometry, but the oligomerization itself has been utilized for control of 
protein activation 45. Another dimerization pair is phytochrome B (PhyB) and PIF, also from 
Arabidopsis thaliana. PhyB and PIF interact after irradiation with red light and dissociate with 
exposure to far-red light 101. This system requires a chromophore, phycocyanobilin (PCB), 
that is not naturally present in many organisms, including mammals 55,59. The tunable light-
controlled interacting protein tags (TULIPs) make use of the blue light sensing light-oxygen-
voltage (LOV) domain and an engineered PDZ domain 128. Sub-cellular localization has 
been shown with TULIPs in both yeast and mammalian cells. However, the presence of a 
PDZ binding peptide and PDZ domain in the system could lead to cross talk with 
endogenous signaling pathways. The FKF1/GIGANTEA (GI) heterodimer pair from 
Arabidopsis thaliana also relies on a LOV domain for light activated binding. This pair 
dimerizes in response to blue light in mammalian cells, associating within a few minutes of 
activation and dissociating on the order of a few hours 102. However, GI is a very large 
protein and the switching power of the pair is sensitive to expression levels.  
 An ideal light-inducible dimer would be small and modular, associate quickly in 
presence of signal and quickly dissociate in its absence, and be fully orthogonal to the 
organisms they are to be used in. To fulfill these criteria, we chose to use the LOV2 domain 
of phototropin 1 from Avena sativa as the photoactive element of our light-inducible dimer. In 
its native setting, the AsLOV2 domain senses blue light and activates a C-terminal kinase 
domain. AsLOV2 can be genetically encoded and its chromophore, flavin mononucleotide, is 
abundant in most organisms. It is monomeric in dark state and remains so under activating 
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blue light. The structure of AsLOV2 has been determined, making it amenable to structure 
guided engineering. AsLOV2 is made up of a core per-arnt-sim (PAS) fold with flanking α-
helicies on the N- and C-termini 104. Upon blue light irradiation, a conserved cysteine residue 
in the core of AsLOV2 becomes covalently bound to the flavin cofactor, structural 
rearrangement is passed along through the PAS fold, and ultimately the flanking helices 
unfold from the PAS core 19,24. The covalent bond breaks with a half-life of 30-50 seconds, 
and the helices refold to their dark state conformation 15,129. To reengineer the AsLOV2 
domain to be part of a light-inducible complex, we incorporated a naturally occurring binding 
element within the protein; 7 residues of the E. coli SsrA peptide that bind SspB, a 13kD 
adaptor protein also from E. coli.  Both SsrA and SspB have been structurally characterized 
and the SsrA peptide shares sequence identity with the Jα helix of AsLOV2 110,130,131. We 
previously showed that incorporation of SsrA into the Jα helix of AsLOV2 led to steric 
occlusion of SspB binding in the dark and uncaging with blue light irradiation, yielding a 
light-inducible heterodimer pair 132. Our original light inducible dimer (oLID), while containing 
some of the characteristics desirable for a versatile tool, did not show large changes in 
binding affinity with light stimulation. Original fusions of AsLOV2 and SsrA yielded a two-fold 
change in affinity for SspB. This was improved to an eight-fold switch by incorporating 
mutations known to stabilize the Jα helix in the dark as well as including a C-terminal 
phenylalanine predicted by molecular modeling to further hold the Jα helix against the PAS 
domain in the dark. However, even in its final form, dimerization in the dark at moderate 
protein concentrations prevented large light induced phenotypic changes in vivo.  
 In order to create a generalizable, versatile, and more powerful light-inducible dimer, 
we sought to improve oLID with a novel combination of computational library design and 
phage display screening. Using the Rosetta macromolecular software suite, we ranked point 
mutations within AsLOV2 and created a library of mutations with the goal of improving the 
dynamic range of oLID, specifically reducing dark state binding. We then used phage 
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display and ELISA-based binding assays to screen for mutations that both weakened dark 
state binding and responded to light activation.  Here, we describe two improved light-
inducible (iLID) pairs that we identified with this approach, iLID nano, which switches from 
130 nM under blue light to 4.7 µM in the dark, and iLID micro, which switches from 800 nM 
under blue light to 47 µM in the dark. iLID nano and iLID micro both co-localize under blue 
light within seconds, revert to dark state within minutes, and can be activated sub-cellularly 
in mammalian cell culture. To demonstrate functional utility in cells, we show light-
dependent control of GTPase activity and the cytoskeleton through localization of the 
DH/PH domains of ITSN and Tiam1.  
3.3 Materials and Methods 
3.3.1 Design and Construction of Computationally Directed Library 
The pmut_scan protocol in the Rosetta molecular modeling suite was used to 
evaluate all possible point mutations in AsLOV2 (PDB: 2v0u). The set of all possible point 
mutations was filtered to include only mutations that decreased the Rosetta score or 
increased it by less than 1 REU (Rosetta Energy Unit). For a few positions on the PAS β 
sheet mutations with ΔΔG’s of +2 REU’s were allowed.  The list was then filtered to only 
include mutations that were within 6Å of the Jα helix. The resulting library contained 743 
mutations at 49 positions (additional mutations were allowed due to degenerate primer 
design).  The Rosetta-biased point-mutant library was constructed using a comprehensive 
mutagenesis protocol 133.  Mutagenic oligos with degenerate codons flanked by 15-18 bases 
were pooled. 200 picomoles of the oligo pool were incubated with 20 units of T4 
Polynucleotide kinase (NEB) for 1 hour at 37°C in the presence of 1x T4 PNK buffer.  The 
enzyme was heat-inactivated at 65°C for 20 minutes.  Single-stranded template uracil-DNA 
encoding TorA-LovSsrA-pIII_C-terminal domain was amplified and purified as described 134. 
 65 
One microgram of template DNA (0.75 picomoles) were combined with 2-fold excess 5’-
phosphorylated oligo pool.  Template-oligo annealing followed by polymerase extension and 
ligation of the mutagenic strand was performed as described 133.  Template DNA was 
degraded with 5 units of Uracil DNA Glycosylase (NEB) and 2 units of Exonuclease III (NEB) 
before desalting and electroporation into SS320 cells.  The experimental library size was 5 x 
107, which most likely samples all possible point-mutants and a large fraction of double-
mutants. 
3.3.2 Construction of the shuffled library  
Mutagenic oligos encoding substitutions suggested by the primary ELISA screens of 
the point-mutant library were pooled and assembled using a gene-assembly protocol.  
Gene-SOE PCR was performed with Q5 DNA Polymerase (NEB), 1 µM total oligo (31 total 
oligos) and the following cycling conditions: 20 cycles of (98°C 10s, 52°C 30s, 72°C 10s) in 
50 µL.  One µL of the assembled product was PCR-amplified using outside primers for 
restriction cloning. Two µg’s of linearized and gel purified pFNOM6-tat-pIII plasmid was 
ligated to 1 µg of shuffled-lovssrA library insert (4:1 insert:vector ratio).  Ligated DNA was 
ethanol precipitated and electroporated into SS320 cells.  The number of total transformants 
was 2 x 108, which partially covers the designed sequence space (1.2 x 108). 
3.3.3 Phage Display Selection Against SspB 
The LOV library was expressed as an N-terminal fusion of the phage pIII coat protein 
using the tat secretion pathway, as export via the DsbA signal peptide pathway was not 
possible (Figure 3.1). All libraries were subjected to four rounds of panning prior to ELISA 
screening.  Maxisorp 96-well plates were coated overnight at 4°C with 100 µg/mL of 5 
micrograms/mL His-MBP-SspB fusion in the presence of 50 mM sodium bicarbonate pH 9.6 
buffer.  Coated wells were washed with PBS-0.1% (v/v) Tween (PBST) and blocked at room 
temperature for 2 hours with 200 µL of PBST-BSA (5 mg/mL).  Blocked wells are washed 
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with PBST and incubated with 1011 – 1012 library phages for 1 hour under a collimated blue 
LED array (1.2 mW*cm-2  at 450nm).  Wells were washed 10-times with PBST while keeping 
the plate under blue light.  Plates were moved into dark and incubated in the dark for 10 
minutes.  Dissociating phages were collected with PBST buffer.  Early log SS320 cells 
(OD600: 0.2-0.5) were infected with eluted phage and infected cells were grown in 25 mL 
2xTY media supplemented with 100 µg/mL of ampicillin.  When cells reach early log phase, 
M13KO7 helper phage was added with 20:1 multiplicity of infection.  Following a 20-minute 
incubation at 37°C without shaking, 0.1 mM IPTG and 5 µM flavin mononucleotide (FMN) 
were added and the culture was moved to a 30°C shaker covered with foil to ensure dark 
conditions.  After 1.5 hour, kanamycin was added to 25 µg/mL and the culture was grown 
overnight.  The following day, the phage was PEG-precipitated and quantified using A268 
values 134. Gene pool post-Round-4 selection was PCR amplified and cloned into a 
previously modified pET21b vector that introduces an N-terminal FLAG epitope.  The 
ligation reaction was directly transformed into BL21(DE3)pLysS cells for protein expression 
and ELISA screening.  
3.3.4 Photoswitch Evaluation by Soluble Protein ELISA 
BL21(DE3)pLysS cells carrying pET21b_FLAG_LovssrA clones were plated on 
LB/Amp plates.  Next day, 96-well growth blocks containing 500 µL LB medium 
supplemented with 25 µg/mL chloramphenicol, 100 µg/mL ampicillin, and 0.6 mM IPTG 
were inoculated with individual colonies and grown overnight in the dark at 30°C.  One well 
per plate was reserved for the parent for comparison.  200 µl of cells were lysed in the dark 
with 10 µl Popculture reagent and 1 unit of Benzonase nuclease for 15 minutes.  Lysates 
were centrifuged and supernatant diluted 5-10 fold in PBST with 1mM DTT was used for the 
assays.  Duplicate Maxisorp plates (96-well or 384-well) were coated with His-MBP-SspB as 
described above.  Plates were blocked with PBS-3% (m/v) BSA and incubated with the 
 67 
lysate supernatant for 1 hour in the dark and under blue-light (1.2 mW*cm-2  at 450nm, 
collimated blue LED array).  Plates were washed 5 times with PBST and incubated for 30 
minutes with 1:20,000 diluted anti-FLAG antibody HRP conjugate (Sigma A8592). Plates 
were washed 3 times with PBST and twice with PBS.  100 µl TMB was added and color was 
developed for 15 minutes.  The reaction was quenched with 100 µl 0.5 M sulfuric acid before 
measuring A450.  LovssrA variants for the positive clones were PCR amplified using 4 µl cells 
as template and sequenced. 
3.3.5 Growth and Purification of Recombinant Proteins 
All expressed and purified proteins were cloned into the pQE-80L protein expression 
vector.  All LOV clones contained an N-terminal 6x(His) tag and SspB clones contained an 
N-terminal 6x(His)-MBP-TEV site tag.  Sequence-verified clones were transformed into 
BL21(DE3)pLysS E.Coli cells.  Cultures were grown to an OD of 0.6 at 37°C, then induced 
with 333 mM IPTG and moved to 18°C for 16 hours.  Cell pellets were resuspended in 
loading buffer (50 mM sodium phosphate pH 7.5, 500 mM NaCl, 20 mM Imidazole, 100 μM 
PMSF).  Resuspended cells were sonicated and lysate spun down for 30 minutes at 20,000 
rpm.  Proteins of interest were isolated via Ni2+ affinity chromatography using HisTrap HP 
columns (GE), and eluted with elution buffer (50mM phosphate pH 7.5, 500 mM NaCl, and 
500 mM imidazole).  Proteins expressed as MBP fusions were then cut with TEV, dialyzed 
overnight into loading buffer, and re-run over the HisTrap HP column, collecting the tag-less 
protein.  Finally, size exclusion chromatography with a Superdex 75 column (GE) was used 
for a final cleanup step and buffer exchange to final binding buffer, PBS (10 mM dibasic 
sodium phosphate, 1.8 mM monobasic potassium phosphate, 137 mM NaCl, 2.7 mM KCl).  
Protein concentration was determined via BCA protein assay (Pierce).  Expression (E.coli & 
mammalian) constructs of iLID and SspB variants used can be found in Table 3.6 and will 
be available on Addgene. 
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3.3.5 Fluorescence Polarization Binding Assays 
Fluorescence polarization experiments were conducted with a Jobin Yvon Horiba 
FluoroMax3 spectrofluorometer in a 1 cm quartz cuvette.  Polarization of the TAMARA-SsrA 
peptide was measured through excitation at 555 nm and emission at 584 nm.  For direct 
binding experiments between SspB and TAMARA-SsrA, starting peptide concentration was 
25 nM in PBS.  For competitive binding assays, 25 nM TAMARA-SsrA and 40 nM SspB (in 
PBS) were incubated prior to titrating LOV fusions.  At each titration, the sample was 
irradiated with 6.0 mW*cm-2 blue light for 1 minute, turned off and a lit state polarization was 
measured.  After 5 minutes in the dark, a second measurement was taken, representing the 
dark state population.   
3.3.6 Thermal Reversion Assay 
Purified iLID protein was dialyzed against 4L of PBS buffer twice before measuring 
reversion kinetics.  Protein samples were prepared at 10μM and allowed to equilibrate to 
room temperature in a 1cm quartz cuvette.  Samples were then irradiated with blue light (6.0 
mW*cm-2 at 450nm, collimated blue LED array) for 30 seconds.  Recovery of absorbance at 
450nm was then measured every 0.1 seconds for 5 minutes.   
3.3.7 Crystallization and Structural Determination of iLID 
Initial crystals of iLid were grown using hanging drop vapor diffusion.  Drops 
consisted of 2 μL well solution (800 mM lithium chloride, 100 mM TRIS:HCl pH 8.5, 32% 
(m/v) PEG 4000) and 1 μL iLid protein (10 mg/mL in 100mM ammonium acetate).  Initial 
conditions were optimized by microseeding.  Final crystal drops were 2 μL well solution, 1 μL 
iLid (10 mg/mL), 0.5 μL microseed solution.  Crystals grew to maximum size in 3 days.  X-
ray diffraction data was collected at Southeast Regional Collaborative Access Team (SER-
CAT) 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory.  Data 
was indexed with XDS and scaled with Scala 135–137.  The structure of iLid was determined 
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using PAS fold residues N414-D515 of PDB id 2v0u as a molecular replacement model in 
Phaser 138.  Phenix and Coot were used to iteratively refine the final structure 139,140.  
3.3.8 Mammalian Cell Culture and Transfection 
IA32 mouse fibroblast cells were cultured at 37° C and 5% CO2 in DMEM 
supplemented with 10% FBS (HyClone), 100U/ml penicillin, 100 μg/ml streptomycin and 292 μg/ml L-glutamine. Cells were transiently transfected using NanoJuice (EMD Millipore) as 
recommended by manufacturer. 
3.3.9 Mammalian Cell Localization/GEF Microscopy and Image Analysis 
IA32 mouse fibroblasts were transfected in 6 well tissue culture plates with equal 
amounts of 2 vectors, each containing a component of the switch (ex. 0.5 μg pll7.0 Venus-
iLID-CAAX : 0.5 μg  pll7.0 tgRFPt –Nano; See Table 3.6 for vector information). 24 hr after 
transfection and 24 hr before image aquisition, cells were plated on No. 0 glass bottomed 
dishes (MatTek) coated with a 10 μg/ml solution of Fibronectin. Image acquisition was 
performed using a FluoView FV1000 scanning confocal inverted microscope equipped with 
a 1.30 N.A. 40 x oil immersion objective, a Hamamatsu PMT, environmental chamber 
(Precision Plastics) and controlled by Fluoview software (Olympus, Version 3.1b).  A 25 mW 
argon laser provided the 488 nm and 515 nm laser lines while a 15 mW diode laser provided 
the 559 nm laser line.  The environmental chamber was used to continue culture at 37° C 
and 5 (v/v) CO2 throughout image acquisition.  The software Time Controller was used to set 
a timeline of image acquisition and LOV domain excitation within a predefined region of 
interest.  During periods of excitation, the ROIs were continuously scanned with 488 nm light 
except during the time it took to aquire an image (< 3 sec).  1% power of the 488 nm laser 
was used for all LOV domain excitation.  During all experiments, images were acquired 
every 10 sec before and after excitation while image acquisition times varied during each 
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type of excitation, due to the difference in excitation area.  For spot activation and whole cell 
activation LOV excitation and image acquisition required 7.6 sec 14.7 sec respectively.  
All images were analyzed using FIJI software 141. For spot activation, the average tgRFPt 
fluorescence intensity within the activated ROI was measured for each frame and the 
background subtracted.  The values for each image set were normalized to the average of 
the first three frames before excitation.  For half-cell activation, ROIs of similar tgRFPt 
fluorescence were manually chosen within the activated area and outside the activated 
area. Mean values were acquired for each frame and background subtracted.  The reported 
values are a ratio of the fluorescence inside to outside the activated area.  For whole cell 
activation, analysis was automated.  For each frame, ROIs were produced by applying the 
default Auto Threshold function to the Venus channel(Mito ROI).  To produce a Cyto ROI 
the Mito ROI was expanded by 10 pixels and then removed from the new ROI. The average 
tgRFPt intensity was then measured for each ROI and frame. The ratio of mitochondrial to 
cytoplasmic signal was then calculated for each frame like so: (Mito – Cyto)/Cyto.  The 
cytoplasmic signal was first subtracted from the mitochondrial signal to remove any signal 
that was contributed to the mitochondrial ROI from the cytoplasm above and below the 
mitochondria.  
3.3.10 Mammalian Cloning and Vector Information 
All mammalian constructs were cloned into pLL 7.0 lentiviral vectors. Therefore, a 
CMV promoter drives expression. Mammalian constructs were assembled through PCR 
amplification and subsequent restriction enzyme digestion and ligation. The constructs were 
verified by sequencing. See Table 3.6 for more information and Addgene numbers. 
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3.4 Results 
3.4.1 Computational library screened by phage display and protein ELISA 
In our original light-inducible dimer (oLID) there was appreciable binding in the dark, 
~800 nM. Previous studies suggest that a major source of dark state “leakiness” comes from 
transient undocking and unfolding of AsLOV2’s Jα-helix, and mutations that increase the 
intrinsic stability of the Jα helix have proven successful in reducing dark state activity of 
light-activated AsLOV2 switches 90,128. We sought to extend this approach and use 
molecular modeling combined with high-throughput screening to find mutations throughout 
the domain that stabilize the docked state of the Jα-helix. The pmut_scan protocol in 
Rosetta 142 was used to model and score all possible point mutations within 6 Å of the Jα 
helix using the crystal structure of AsLOV2 in its dark state (PDB: 2v0u). All mutations that 
were predicted to be stabilizing or neutral (within 1 kcal / mole of the wild type residue) were 
considered potential mutations that might stabilize the dark state and were used as the 
basis for creating a directed library. The final point mutant library consisted of 743 mutations 
at 49 positions (Table 3.4), and used the oLID sequence as the starting sequence.  
The oLID library was fused with the phage pIII coat protein and an N-terminal Tat 
(twin-arginine translocation) secretion sequence for display on the surface of phage 143. The 
Tat secretion pathway was used because it maintains proteins in the folded state during 
secretion, which allows them to remain bound to cofactors. In this case this was critical, as 
FMN binding is needed for LOV domain activity (Figure 3.1, Figure 3.2B). We screened the 
library by rounds of positive and negative selection; binding under blue light to immobilized 
MBP-SspB and subsequent elution in the dark (Figure 3.2C). After 4 rounds of lit and dark 
screening, individual sequences were tested by soluble protein ELISA (Figure 3.2D). We 
ranked mutations by change in dynamic range, defined as ELISA signal under blue 
light/ELISA signal in darkness. Single point mutant LOV variants had minimal improvement 
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to overall switching. The top mutations were pooled and recombined with each other to yield 
a recombined library. Screening of the recombined library was repeated as before (Figure 
3.2E). The top 60 sequences had dynamic ranges ranging from 2.4 to 35.4 (Figure 3.3). 
Four sequences with the highest dynamic ranges were chosen for further characterization 
(Figure 3.4).  
3.4.2 In vitro Characterization  
We measured the binding affinity of our four top sequences for SspB in the dark and 
after irradiation with blue light using a competitive fluorescence polarization binding assay. 
All four had improved dynamic ranges compared to the parent clone oLID (Figure 3.5A,B) 
and switched roughly over the same affinity range, ~100nM to <5µM (Figure 3.6). Clones D5 
and F2 had the highest dynamic range of the clones tested, 43-fold and 36-fold changes 
respectively. D5 switched from 77 nM under blue light to 3.4 µM in the dark and F2 switched 
from 132 nM under blue light to 4.7 µM in the dark. As dark state activity can be the limiting 
factor in the usefulness of light-inducible tools, we chose to move forward with clone F2, 
naming it our improved Light Inducible Dimer, iLID (Figure 3.5C,E)  
The concentration threshold required for activity varies for different signaling proteins 
within a cell. Having tools that switch over different ranges of affinities may allow a wider 
range of targets to be controlled. In order to create an alternate affinity range for iLID as well 
as retain our improved switching, we made a point mutant, R73Q to SspB, reducing the 
peptide/protein affinity to 900 nM (Figure 3.7). In the context of SspB R73Q, iLID has an 
affinity of 800 nM for SspB R73Q under blue light and a dark state affinity of 47 µM, which is 
a 58-fold change in binding affinity (Figure 3.5D). Thus, two sets of tools are available for 
light-inducible heterodimerization, iLID nano (makes use of WT SspB) and iLID micro 
(makes use of SspB R73Q). Comparisons of the affinity ranges of these tools to their 
predecessors can be seen in Figure 3.5F.  
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3.4.3 Structural Characterization of iLID 
iLID contains 10 mutations when compared to oLID. Four of the mutations are 
clustered in the hinge loop that connects the PAS domain to the Jα helix, four are located in 
the Jα helix, and two are in the PAS domain. To investigate how these mutations are 
improving the dynamic range of the switch, we solved the crystal structure of iLID in its dark 
state to a resolution of 2.05 Å (Figure 3.8). In general, there are very few structural 
perturbations when comparing iLID to AsLOV2. Within the core PAS domain (residues 413-
516), the Cα RMSD between iLID and AsLOV2 is 0.42 Å, and the hinge loop showed almost 
no movement in the protein backbone (0.23 Å Cα RMSD)(Figure 3.8B). Several of the side 
chains in the hinge region are forming interactions that may be important for the stabilizing 
the dark state of the switch. R519 is packed against W491 from the PAS domain. The 
isoleucine replacing valine 520 is buried against sidechains from the Jα helix and the PAS 
domain and packs against a valine at position 493 that is a leucine in AsLOV2. The last 
residue in the hinge, position 522, is an aspartic acid in AsLOV2 and a glycine in iLID. This 
is the last residue before the Jα helix and has a positive phi angle, phi = 49.0°, psi = -126°. 
Aspartic acids are observed in this region of the ramachandran plot, but glycine is by far the 
most common amino acid in this region of the plot. In a set of high-resolution crystal 
structure, 47% of the residues with phi near 50° and psi near -130° are glycine, while only 
7% are aspartic acids. This suggests that there may be some strain that is relieved when the 
aspartic acid is mutated to a glycine.  
The largest conformational change in the iLID structure was in the N-terminal 
residues and the A'α helix. The first two resolved residues, T406 and T407, point toward the 
Jα helix instead of the Dα helix as in AsLOV2 and the A'α helix is shifted by 3 Å (Figure 
3.8C). A smaller, ~1 Å movement, is seen in the last 12 residues of the Jα helix toward the 
A'α helix, allowing for tighter packing between the two. The slight unwinding of the A'α helix 
allows for the terminal nitrogen of the helix to be capped by E546 of the SsrA sequence. 
 74 
Additionally, the side chain of E409 forms a hydrogen bond with the tyrosine from the SsrA 
sequence.  
Finally, the structure of iLID revealed the location and conformation of the caged 
SsrA peptide. The designed C-terminal phenylalanine, F549 fits into a hydrophobic pocket 
on the surface of the PAS domain made up of I417, I428, F429 and Y508 (Figure 3.8D). 
SsrA makes three hydrogen bonds with the rest of the LOV domain, all within the A'α helix. 
The carboxyl group of D545 interacts with the hydroxyl of T406, the carboxyl group of E546 
with the backbone amide of L407, and the hydroxyl of Y548 with the carboxyl of E409. In 
comparison with AsLOV2, F549 occupies the same area as the C-terminal L546. Due to 
extra residues in iLID, the last turn of the Jα helix buckles out and wraps back in to make 
this placement of F549 possible. iLID atomic coordinates and structure factors have been 
deposited to the Protein Data Bank (PDB ID code 4WF0).   
3.4.4 Reversion and paired down iLID 
Based on the structure of iLID, we chose 6 mutations to revert to determine their role 
or necessity in the improved switching of iLID (Figure 3.9, 3.10, Table 3.2). Reversion of 
R519 and D522, led to a lower dynamic range and weaker caging, which is apparent as 
tighter affinities under blue light and in the dark. Removal of F537 had a similar effect on 
dynamic range, but weakened blue-light and dark state affinities for SspB to the micromolar 
range. The remaining three reversions, Y502Q, H521R, and C530M, had little effect on the 
dynamic range. The double reversion mutant Y502Q/H521R, binds about 3 fold tighter in 
both states. In addition to keeping the improved dynamic range, C530M has very little effect 
on the affinity range or reversion kinetics of the switch and can be removed without 
consequence (Figure 3.11). 
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3.4.5 Subcellular recruitment 
As oLID was previously untested in mammalian cell culture, we were interested in 
how well it would function and if the improvements of iLID, measured in vitro, would be 
apparent in cells. To test LID function in cells, we designed constructs by fusing the LIDs to 
the yellow fluorescent protein, Venus, and a well-characterized peptide sequence that would 
anchor the protein to specific subcellular localizations (CAAX = Cell Membrane, Mito = 
Mitochondria). Further, SspB (Nano) and SspB R73Q (Micro) were fused to the red 
fluorescent protein, TagRFP-T 144. IA32 mouse fibroblasts 145 transiently expressing the LID 
protein pairs were imaged using a confocal microscope and activated with a 488 nm laser. 
To assay whole cell activation, cells expressing TagRFP-T-SspB and the Mito anchored LID 
pairs were imaged during a time course of intermittent whole cell 488 nm light stimulation. 
Cells expressing each pair of switches showed rapid recruitment of TagRFP-T to the 
mitochondria during stimulation followed by dissociation into the cytoplasm with the removal 
of stimulus (Figure 3.12A top row, Video S1). Recruitment for each pair was quantified and 
compared between switches by measuring the ratio of Mitochondrial/Cytoplasmic TagRFP-T 
fluorescence intensity throughout time (Figure 3.12B). To prevent bias, mitochondrial and 
cytoplasmic regions of interest (ROIs) were automatically identified for each frame using the 
Venus channel and the default Threshold function in FIJI software. The recruitment phase 
was fit to a single phase exponential and we determined that the iLID/Nano and iLID/Micro 
pairs showed a 4.4 and 4.3 fold change in comparison to a 2.4 fold change seen for 
oLID/Nano in this assay; each with a half-life < 30 s. Further, we hypothesized that the ratio 
of Mitochondrial/Cytoplasmic TagRFP-T fluorescence in the dark state would be 
representative of the dark state binding affinities observed in vitro. As expected, the 
iLID/Nano dark state ratio is higher than the ratio for iLID/Micro. However, while the in vitro 
evidence would suggest that oLID/Nano would have the tightest binding affinity in the dark, 
their dark state Mitochondrial/Cytoplasmic TagRFP-T fluorescence ratio is the lowest.  
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To test if the LID proteins could be used to recruit protein to a subcellular localization 
based on a region of interest (ROI), the CAAX fused LID pairs were expressed and imaged 
in fibroblasts (Figure 3.12A bottom row, Video S2). The optical sections obtained using the 
confocal were thick enough to capture light emitted from both apical and basal membrane 
bound proteins. This allowed us to stimulate a region of interest on these membranes and 
image the re-localization of TagRFP-T to these regions of the cell. Again, we imaged cells 
with intermittent stimulation at a ROI. During stimulation the TagRFP-T signal increased 
within the ROI while diminished outside the ROI. From this assay it is difficult to determine 
differences in dark state binding as we do not know what portion of TagRFP-T-SspB is 
membrane bound versus cytoplasmic. However, by quantifying the TagRFP-T fluorescence 
intensity in a relatively small ROI (260 um2) the cytoplasmic concentration of TagRFP-T-
SspB should remain constant before and after 488 nm light stimulation. Therefore by 
calculating pre:post stimulation ratio of TagRFP-T fluorescence intensity within the ROI we 
determined the relative fold change of binding in the light and dark. These values correlate 
with in vitro measured dynamic ranges (Figure 3.13). These experiments led us to realize 
that by anchoring the switching half of the dimer pair we obtained a relatively tight spatial 
resolution of activation. Combined with the minute time scales of association and 
dissociation we were able to exemplify these attributes of the switch by sequentially writing 
the letters i,L,I, and D on the membrane of a cell (Figure 3.12C, Video S3). 
3.4.6 Light induced GTPase signaling through GEF localization 
One area of interest for the use of light-inducible dimers is to control and study cell 
signaling. The Rho family of small GTPases (consisting of RhoA, Rac1, and Cdc42) are 
signaling proteins involved in many aspects of cell physiology including actin cytoskeleton 
remodeling. In general GTPase signaling is considered active when the GTPase is bound to 
GTP and inactive after the GTPase hydrolyzes GTP to GDP. Canonically, active Rac1 leads 
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to branched actin formation and lamellipodial morphology; active Cdc42 leads to bundled 
actin and filopodial morphology; and active RhoA leads to bundled actin and actin stress 
fiber formation. Other groups have found that small GTPases can be controlled through the 
localization of guanine nucleotide exchange factor (GEF) Dbl homology (DH) / pleckstrin-
homology(PH) domains to the membrane 101,146. At the membrane the DH/PH domains are 
colocalized with GTPases where they can aid in exchange of GDP for GTP, activating the 
GTPases. We hypothesized that the LID switches could be used to locally activate GTPase 
signaling, leading to a change in actin dynamics and a visible change in cell morphology 
(Figure 3.14A). Therefore we fused the DH/PH domains of Intersectin (ITSN, Cdc42 GEF) 
and Tiam1 (Rac GEF) to the N-terminus of the TagRFP-T-SspB constructs (Figure 3.14B). 
Fibroblasts were transiently transfected with each construct in combination with Venus-iLID-
CAAX using a 1:1 ratio of DNA.  As each construct is under the control of a CMV promoter 
we expect that on average each construct is expressed at equal levels. Two days later the 
cells were imaged and stimulated in a similar manner to the spot stimulation previously 
described. Here, stimulated areas were at the edge of the cell. As expected, the cells 
expressing the Tiam1 fusions, within minutes of stimulation, began to ruffle and formed a 
lamellipodia at the site of recruitment (Figure 3.15A, Video S4). Surprisingly, the cells 
expressing the ITSN fusions displayed a similar phenotype in the area of stimulation (Figure 
3.15B, Video S5). While we would expect a filopodial morphology to form, our results may 
be explained in two ways; crosstalk between GTPase pathways that leads to an increase in 
Rac GTPase signaling or a direct catalytic effect on a Rac GTPase such as RhoG from the 
ITSN DH/PH 147,148. In addition to forming lamellipodia, most cells displayed increased 
appearance of vesicles in the stimulated area consistent with the role of Cdc42 in 
endocytosis (Figure 3.15B arrowheads, Video S6).  
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3.5 Discussion 
A novel aspect of our study was the use of high throughput screening and selection 
to improve the dynamic range of a photoactivatable protein switch. A specific challenge of 
engineering a switch is that the selection protocol should be sensitive to protein activity in 
both the on and off state. In our case, it was critical that the LOV domain be presented on 
the surface of the phage in a functional form. In phage display it is common to use signal 
sequences that direct a protein to the Sec-mediated translocation pathway, which transports 
proteins through membranes in an unfolded state. This was not appropriate for our 
application because we needed the LOV domain to remain folded during translocation so 
that it would remain bound to the flavin cofactor. Therefore, we made use of the Tat- 
secretion pathway that maintains proteins in a folded and cofactor-bound state during 
secretion. Once the LOV domain was on the surface of phage, we were able to find 
functional switches by selecting for binding under blue light, and then collecting phage that 
unbound when the light was turned off. The phage protocol was useful as a first filter in the 
search for better switches, but explicit screening in the light and dark with the ELISA-based 
binding assay allowed us to identify the top performing variants. The ELISA assay was 
particularly informative because the binding properties of single variants could be 
characterized side-by-side in the light and dark. This allowed us to detect small 
improvements in switching, which allowed us to select variants to include in the 
recombination library.  
In creating the directed library we used molecular modeling to find mutations 
predicted to be compatible with the dark state of the switch. We used this approach because 
we were interested in stabilizing the closed state of the switch. Ideally modeling would be 
used to find mutations that are compatible with the dark and lit state. This was not possible 
because there is not detailed structural information about what happens to the PAS domain 
when it is photoactivated. It is informative to see where the final mutations were located in 
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iLID. The cluster of mutations in the hinge loop indicates that it has an important role in the 
docking and undocking of the Jα helix. In a multiple sequence alignment of the LOV domain, 
there is variability in the hinge loop suggesting that LOV-domain homologs may have 
different switching properties. 
Previous studies have highlighted the role of the A'α helix in stabilizing the docked 
state of the Jα helix in the dark and releasing it in the light 24.  In the iLID structure the A'α 
helix rearranges to form several contacts with the Jα helix and the embedded SsrA 
sequence. Interestingly, the alternate conformation of the A'α helix is almost identical to that 
of the A'α helix of PA-Rac1, another photoactivatable switch based on the AsLOV2 domain 
(Figure 3.8C).  A shared feature of the iLID and PA-Rac1 structures is the capping of the A'α 
helix. In the AsLOV2 structure, the A'α helix is capped by a water molecule, however in iLID, 
the carboxyl group of E546 in SsrA caps the helix and in PA-Rac1 it is capped by the 
carbonyl group of N595 in Rac1. These capping interactions in Pa-Rac1 and iLID may 
enhance cooperativity between folding of the A'α helix and caging, and therefore lead to 
effective switching.  
Our goal in creating iLIDs was to create a genetic tool for studying biochemical and 
cellular processes. We showed that both iLID pairs can be used in mammalian cell culture to 
form dimers and recruit fusion proteins to sub-cellular structures. Furthermore, the differing 
affinity ranges of iLID nano and iLID micro measured in vitro, translate to different in cell 
characteristics, and can be used accordingly. We postulate that this inherent tuneability of 
the switch will lead to use in a broader spectrum of applications. Here, we were able to 
control local GTPase activity by driving GEF DH/PH domains to a localized spot on the 
membrane and we expect that the small, modular nature of iLID nano/micro will open up 
control of a much wider variety of cellular targets.   
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3.6 Supporting Information 
3.6.1 Fasta Sequences of Phage Display Constructs 
>Fasta of Tat-oLID-p3 
MNNNDLFQASRRRFLAQLGGLTVAGMLGPSLLTPRRATAGSGEFLATTLERIEKNFVITDP
RLPDNPIIFASDSFLQLTEYSREEILGRNCRFLQGPETDRATVRKIRDAIDNQTEVTVQ 
LINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVRDAAEREAVMLIKKTAEEI 
DEAANDENYFSGLESRGPFSGDFDYEKMANANKGAMTENADENALQSDAKGKLDSVATD
YGAAIDGFIGDVSGLANGNGATGDFAGSNSQMAQVGDGDNSPLMNNFRQYLPSLPQSVE
CRPFVFSAGKPYEFSIDCDKINLFRGVFAFLLYVATFMYVFSTFANILRNKES 
 
>Fasta of DsbA-oLID-p3 
MKKIWLALAGLVLAFSASAAELAAAGSGEFLATTLERIEKNFVITDPRLPDNPIIFASDSFLQL
TEYSREEILGRNCRFLQGPETDRATVRKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPM
RDQKGDVQYFIGVQLDGTEHVRDAAEREAVMLIKKTAEEIDEAANDENYFLESRGPFEGKP
IPNPLLGLDSTRPFVCEYQGQSSDLPQPPVNAGGGSGGGSGGGSEGGGSEGGGSEGGG
SEGGGSGGGSGSGDFDYEKMANANKGAMTENADENALQSDAKGKLDSVATDYGAAIDGF
IGDVSGLANGNGATGDFAGSNSQMAQVGDGDNSPLMNNFRQYLPSLPQSVECRPFVFSA
GKPYEFSIDCDKINLFRGVFAFLLYVATFMYVFSTFANILRNKES 
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3.7 Tables 
 
Construct Blue Light Affinity Dark Affinity 
Starting LOV-SsrA 0.031 ± 0.006 µM* 0.057 ± 0.005 µM* 
LOV-SsrAC 0.120 ± 0.01 µM* 0.9 ± 0.07 µM* 
iLID nano 0.132 ± 0.005 µM 4.7 ± 0.7 µM 
iLID micro 0.8 ± 0.1 µM 47 ± 13 µM 
SspB R73Q - 0.9 ± 0.2 µM 
*Previously published values 
Table 3.1. Beginning and Improved iLID affinities 
 
Construct Blue Light Affinity Dark Affinity Fold Change 
iLID nano 0.132 ± 0.005 µM 4.7 ± 0.7 µM 36 
502/521 0.043 ± 0.005 µM 1.60 ± 0.05 µM 37 
519 0.024 ± 0.004 µM 0.49 ± 0.05 µM 20 
522 0.032 ± 0.01 µM 0.88 ± 0.04 µM 28 
530 0.113 ± 0.004 µM 4.6 ± 0.6 µM 41 
537 1.4 ± 0.1 µM 37.3 ± 0.7 µM 27 
Table 3.2. Reversion Mutation Affinities 
 
Construct Blue Light Affinity Dark Affinity 
D5 77 ± 0.001 µM* 3.4 ± 0.02 µM* 
C11 97 ± 0.001 µM* 1.7 ± 0.03µM* 
H10 123 ± 0.001 µM* 2.0 ± 0.02 µM* 
F2 (iLID nano) 0.132 ± 0.005 µM 4.7 ± 0.7 µM 
*Error shown is standard error to binding curve fit 
Table 3.3. Top ELISA Sequence Affinities 
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Residue # Mutations WT AA Rosetta Predicted Library 
404 13 L ACDEGKMNQRSTY 
406 1 T S 
407 17 T ACDEFGIKLMNPQRSVY 
408 3 L MTV 
411 5 I KLQRV 
413 11 K ACDEHMNQRSW 
414 3 N AHS 
415 1 F H 
417 4 I VTLA 
428 14 I ACEGHKLMNQRSTV 
429 4 F HKRY 
431 1 S A 
475 9 E ACKMQRSTV 
477 3 T CAV 
479 2 Q EI 
493 13 L ACDEGHIMNQSTV 
497 6 Q AEHKMR 
499 14 M ACDEFHKNQRSTWY 
500 9 R ACEIKMQTV 
502 15 Q ACDEGHIKLMNRSTV 
508 7 Y ACFHKMR 
510 4 I VTLC 
512 1 V T 
514 3 L MQY 
519 16 H ACDEFIKMNPQRSVWY 
520 13 V ACDFHKLMNRSTY 
521 13 R ACEGHKMNQSTVY 
522 15 D ACEFGHKLMNQRSWY 
523 15 A CDEGIKLMNQRSTVY 
524 11 A CDEGKLMNQRS 
525 10 E AFHKLMQRWY 
526 17 R ACDEFGIKLMNQSTVWY 
527 16 E ACDGIKLMNQRSTVWY 
529 15 V ACDEFHIKMNQRTWY 
530 18 M ACDEFGHIKLNQRSTVWY 
531 18 L ACDEFGHIKMNQRSTVWY 
532 5 I AMSTV 
533 10 K AEHLMQRTVY 
534 17 K ACDEFGILMNQRSTVWY 
535 18 T ACDEFGHIKLMNQRSVWY 
537 12 E ACDIKLMNQRTV 
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539 3 I LTV 
540 16 D ACEFGHKLMNQRSTWY 
541 14 E ACDIKLMNQRSTVY 
 
Table 3.4. Rosetta predicted point mutations included in library 
 
 4WF0 Crystallography Statistics  
Wavelength (Å)  1.0 
Resolution range (Å)  31.08  - 1.95 (2.02  - 1.95) 
Space group  P 21 21 21 
Unit cell  62.156  70.339  80.378  90  90  90 
Total reflections  158984 
Unique reflections  26276 (2574) 
Multiplicity 6.0 
Completeness (%)  99.8 (100.00) 
Mean I/sigma(I)  9.63 (2.41) 
Wilson B-factor  25.4 
R-merge  0.088 
R-meas  0.038 
R-work  0.231 (0.356) 
R-free 0.244 (0.398) 
Number of non-hydrogen atoms  2711 
Macromolecules 2392 
Ligands  63 
Water                256 
Protein residues  288 
RMS(bonds)  0.013 
RMS(angles)  1.26 
Ramachandran favored (%) 99 
Ramachandran outliers (%) 0 
Clashscore  6.36 
Average B-factor  29.5 
Macromolecules  28.4 
Ligands 30.6 
Solvent  39.8 
Statistics for the highest-resolution shell are shown in parentheses. 
Table 3.5. Data collection and refinement statistics 
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Construct Description Addgene ID 
E. coli Expression 
iLID pQE-80L: iLID (C530M) 60408 
SspB Nano pQE-80L: MBP-SspB WT 60409 
SspB Micro pQE-80L: MBP-SspB R73Q 60410 
Mammalian Cell 
Venus-iLID-CAAX pLL7.0: Venus-iLID-CAAX (from KRas4B) 60411 
Venus-oLID-CAAX pLL7.0: Venus-oLID-CAAX (from KRas4B) 60412 
Venus-iLID-Mito pLL7.0: Venus-iLID-Mito (From ActA) 60413 
Venus-oLID-Mito pLL7.0: Venus-iLID-Mito (From ActA) 60414 
tgRFPt-Nano pLL7.0: tgRFPt-SSPB WT 60415 
tgRFPt-Micro pLL7.0: tgRFPt-SSPB R73Q 60416 
Tiam DH/PH-tgRFPt-Nano pLL7.0: mTiam1(64-437)-tgRFPt-SSPB WT 60417 
Tiam DH/PH-tgRFPt-Micro pLL7.0: mTiam1(64-437)-tgRFPt-SSPB R73Q 60418 
ITSN DH/PH-tgRFPt-Nano pLL7.0: hITSN1(1159-1509)-tgRFPt-SSPB WT 60419 
ITSN DH/PH-tgRFPt-Micro pLL7.0: hITSN1(1159-1509)-tgRFPt-SSPB 
R73Q 
60420 
Table 3.6. Construct Information 
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3.8 Figures 
 
 
 
 
 
Figure 3.1 Binding of LIDs expressed via Tat and SRP pathways to SspB.  Secretion of 
LID constructs via the TAT pathway yields functional protein that binds immobilized SspB in 
a light-dependent fashion.  Using the DsbA signal sequence, the secreted protein does not 
bind SspB tighter under blue light than in darkness. 
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Figure 3.2 Schematic overview of selection and screening protocol for improved LOV 
variants. (A) Using Rosetta’s pmut_scan, we generated a library of point mutations at 49 
positions within the AsLOV2 domain (blue residues). (B) Phage-display construct illustration. 
(C) The phage library was added to plates coated with MBP-SspB (gray-blue) in the 
presence of blue light and washed. Plates were moved to the dark and eluted phages were 
collected. (D) Top single-mutation sequences were recloned as flag tag fusions and 
individually expressed. Binding of soluble protein to MBP-SspB coated plates was measured 
after exposure to blue light and sequestration in the dark by ELISA. (E) Mutations with the 
highest dynamic range were recombined to generate a new library of LOV variants, which 
was screened using the procedure shown in C and D. 
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Figure 3.3 ELISA recombined point mutant ratios.  Lit/Dark signal ratios for top 
sequences out of recombined library.  C11, D5, H10, and F2 were selected to characterize 
(red columns). 
 
 
 
 
 
 
Figure 3.4 Sequence alignment of top four sequences. Residues left unmutated are 
shown in black (*), mutations having similar character to original amino acid are shown in 
grey ( ), all other mutations are shown in white. Positions that converged to a single 
mutation in all 4 sequences have been marked with a red triangle (▲). 
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Figure 3.5 Characterization of iLID nano and iLID micro. Competitive fluorescence 
polarization binding assays measure affinities of heterodimerization under blue light (○) and 
in the dark (●). (A) Incorporation of SsrA into final turn of the AsLOV2 Jα helix. (B) Addition 
of helix-strengthening mutations (G528A, N538E) and C-terminal phenylalanine. (C) Top 
sequence from phage display and screening, iLID, has a 36-fold change in affinity for SspB 
because of light. (D) A mutation to SspB (R73Q) yields a heterodimer pair that switches over 
the micromolar range of affinities with a 58-fold change in affinity. (E) Sequence alignment 
of starting, oLID, and iLID. Black, unmutated; gray, similar amino acid mutation. Gray dots 
indicate iLID mutations that converged in all top four sequences. (F) Comparison of lit (○) 
and dark (●) affinities between the original heterodimer pairs and our two new pairs, iLID 
nano and iLID micro. 
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Figure 3.6 In vitro binding data for top four sequences. Florescence polarization 
competition binding assays for the top four sequences (shown in Fig. S2).  All four have a 
greater fold change in affinity than their parent oLID (Fig. 2B).  Binding affinities can be 
found in Table S3. 
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Figure 3.7 Binding of SspB R73Q to ssrA peptide. Fluorescence polarization binding of 
ssrA labeled peptide to SspB R73Q (Micro).  Affinity was measured to be 900 nM ± 200 nM. 
 
 
 
 
 
 
 
 
 
 
SspB R73Q Binding to ssrA
0 5000 10000 15000 20000 25000
0.0
0.1
0.2
0.3
[SspB R73Q] (in nM)
Po
la
riz
at
io
n
91 
 
 
 
 
 
Figure 3.8 Structure of iLID yields insight to role of mutated residues. (A) Overall 
topology iLID (green) remains unchanged from AsLOV2. Boxes surround three areas of 
interest to be shown in B, C, and D. (B) Alignment with AsLOV2 (PDB ID code 2V0U, 
purple) reveals no major backbone rearrangement of the hinge region due to mutations. (C) 
Close up view of A'α helix from iLID (green), AsLOV2 (purple), and PA-Rac1 (PDB ID code 
2WKP, dark green), show different orientation in caged LOV variants from uncaged. (D) 
SsrA epitope (blue) contains an extra helical turn before wrapping back and interacting with 
the PAS fold. Designed C-terminal phenylalanine (green) packs nicely into a hydrophobic 
pocket of the LOV domain. 
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Figure 3.9 In Vitro Binding of Reverted iLID Mutants. Florescence polarization 
competition binding assays for point mutation reversions show that only C530 can be 
removed without substantially affecting dynamic range or affinity range.  Binding affinities 
can be found in Table 3.2. 
 
 
Figure 3.10 Affinities of Reverted iLID Mutations. Reversion of iLID mutations elucidate 
role each plays in switch improvement. Left: structure of iLID with six mutations shown 
(boxes, dark blue). Right: Blue light and dark binding affinities due to the reversion of each 
of the mutations shown on left. C530 appears to have little to no effect on overall switching 
or range of affinity. 
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Figure 3.11 Thermal Reversion of iLID and iLID C530M. Reversion of iLID C530M (right) 
yields similar reversion kinetics as iLID (left).  Experiments were performed at room 
temperature. 
 
 
 
Figure 3.12 iLID provides improved local recruitment in cell culture. (A) IA32 fibroblasts 
expressing membrane (CAAX) and mitochondrial anchored Venus-iLID and cytoplasmic 
TagRFP-T-Nano. Localized activation (denoted by blue markings) caused relocalization of 
TagRFP-T-Nano. (Scale bar, 50 µm.) (B) A ratio of mitochondrial to cytoplasmic TagRFP-T 
signal intensity during a time course of whole-cell activation as shown in row 1 of A for each 
pair of mitochondria anchored switches. (C) Patterned activation of Venus-iLID-CAAX 
shows tight spatial and temporal control of TagRFP-T-Nano localization within a cell. (Scale 
bar, 50 µm.) 
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Figure 3.13 The maximum recruitment of sspB to activated LIDs in cells. Measurements 
were made from a time course of localized activation as shown in Fig. 4A, Row 2. The 
maximum tgRFPt signal intensity in an activated region of a cell, normalized to the intensity 
before activation was measured. 
 
 
 
 
Figure 3.14 Activating GTPase pathways through GEF recruitment. (A) A schematic, 
demonstrating that in the absence of blue light, Micro fused to a DH/PH domain remains 
cytoplasmic and inactive. In the presence of blue light, Micro fused to the DH/PH domain 
binds to iLID, localizing the DH/PH to the membrane, where it increases the rate of GTPase 
nucleotide exchange to induce signaling. (B) Schematic of constructs made and tested. 
 
 
0
2
4
6
8
iLID-CAAX
tgRFPt-Micro
(n = 7)
iLID-CAAX
tgRFPt-Nano
(n = 8)
oLID-CAAX
tgRFPt-Nano
(n = 6)
No
rm
ali
ze
d
Ma
xim
um
 tg
RF
Pt
 S
po
t In
ten
sit
y
Spot Activation of CAAX 
Labeled Proteins
A
iLID
GTPase
D
DH/PH
SspB
DH/PHsspB
iLID
GTPase
T
B
mVenus iLID Caax
mVenus SSrAC Caax tgRFPt sspBMicroITSN DH/PH
tgRFPt sspBNanoITSN DH/PH
tgRFPt sspBMicroTiam1 DH/PH
tgRFPt sspBNanoTiam1 DH/PH
95 
 
 
 
 
 
 
 
 
 
Figure 3.15 Spatial control of GEF DH/PH domains by iLID produces localized control 
of Rac and Cdc42 activity. IA32 cells expressing Venus-iLID-CAAX and (A) Tiam DH/PH-
TagRFP-T-Nano or (B) ITSN DH/PH-TagRFP-T-Nano. iLID was activated in the regions 
highlighted in blue. White arrowheads mark vesicles. Images are representative (n > 5). 
(Scale bars, 50 µm.) 
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Chapter 4 
Correlating the in vitro and in vivo activities of light induced dimers: a guide 
for applications in cellular optogenetics 
This chapter covers our efforts to compare in vitro affinities and kinetics to in vivo 
activity of three light inducible heterodimer systems.  Hayretin Yumerefendi performed the 
yeast gene transcription.  Seth Zimmerman performed the mammalian cell colocalization 
experiments.  This chapter is currently being revised for publication.   The work was 
overseen and funded by the guidance of Brian Kuhlman and James Bear. 
4.1 Overview 
Light inducible dimers are powerful tools for cellular optogenetics as they can be 
used to control the localization and activity of proteins with high spatial and temporal 
resolution.  Despite the generality of the approach, application of light inducible dimers is not 
always straightforward as it is frequently necessary to test alternative dimer systems and 
fusion strategies before the desired biological activity is achieved.  To better inform this 
engineering process we establish correlations between the biophysical properties and the in 
vivo activities of variants of three blue-light inducible dimers: cryptochrome2 (CRY2)/CIB1, 
iLID/SspB, and LOVpep/ePDZb.  We find that the switches vary dramatically in their dark-
state and lit-state binding affinities, and that these affinities correlate with activity changes in 
a variety of in vivo assays including transcription control, intra-cellular localization studies 
and control of GTPase signaling.  Additionally, for CRY2 we observe that light induced 
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changes in homooligomerization can have large effects on activity that are sensitive to 
alternative fusion strategies.   
4.2 Introduction 
Optogenetics originally described the use of the light sensitive cation channel, 
Channelrhodopsin-2, to manipulate the action potential of neurons 6,7. More recently, 
optogenetics has extended into the realm of cell biology with the development of cellular 
optogenetic tools.  These tools are not limited to the manipulation of action potentials, but 
encompass any genetically encoded and light dependent system that can be used to 
manipulate many cellular processes.  Particularly successful has been the use of light 
induced dimerization to control a variety of processes such as gene transcription, GTPase 
signaling, protein degradation, and organelle transport 72,76,85,92,101,149–151.    For example, by 
fusing one half of an inducible dimer to a protein anchored in the plasma membrane and the 
other half to a guanine nucleotide exchange factor (GEF) it is possible to localize the GEFs 
to the membrane with light and activate GTPase signaling.   
While light inducible dimerization has proven to be a general approach for regulating 
biological processes, it is frequently necessary to test alternative dimer systems and fusion 
strategies to determine which approach will be most robust and appropriate for a given 
application 75. Part of the challenge is that there are a variety of light inducible dimers that 
have been described in the literature, but few studies have compared switches side-by-side 
or characterized their intrinsic biophysical properties.  Here, we establish correlations 
between the in vitro and in vivo activities of three blue-light inducible dimers: cryptochrome2 
(CRY2)/CIB1, iLID/SspB, and LovPep/ePDZb 46,128,152.  These results should provide 
valuable input for future efforts to control biological pathways with light inducible 
dimerization.  
 98 
As a family, blue light inducible dimers provide a powerful experimental platform.  
Their photosensitive cofactor is abundant in nature making them broadly applicable to many 
organisms, and the single wavelength of light necessary to manipulate their dimerization 
makes for a simple experimental setup.  CRY2/Cib is a naturally occurring light-dependent 
heterodimer from Arabidopsis thaliana.  Additionally, it has been shown that CRY2 forms 
homooligomers when activated with light 153. Both CRY2/CIB1 dimerization and CRY2 
homooligomerization have been used to control a variety of cellular processes 45,47,83,88,127,154. 
However, neither the dark state nor lit state binding affinities between CRY2 and CIB1 have 
been measured, nor the stoichiometry of oligomerization been determined.   
The TULIP (LOVpep/ePDZb) 128 and iLID (iLID/SspB) 152 systems are engineered 
heterodimer pairs built upon the light-induced conformational change of the Avena sativa 
(As) phototropin LOV2 domain 19. In the TULIP system a PDZ binding motif was encoded in 
the Jα helix of AsLOV2, sterically caged from binding an engineered PDZ (ePDZ) domain in 
the dark 128. Blue light induces a conformational change within AsLOV2, relieving this 
occlusion and increasing affinity to ePDZ. The iLID system works in a similar fashion, caging 
the E. coli ssrA peptide from its binding partner, SspB 132,152. Despite the mechanistic 
similarities between TULIPs and iLID, the lack of molecular characterization prevents direct 
comparison and empirical switch selection when developing a new application.  
Recently, the Tucker group began the process of benchmarking light inducible 
dimers by comparing CRY2/Cib, TULIPs, and Phy/Pif in a set of standardized yeast 
functional assays 84.  The Phy/Pif pair is a light induced dimer that rapidly forms under red 
light and rapidly dissociates when illuminated with far red light.  The Phy/Pif system requires 
a cofactor, phycocyanobilin (PCB), which is not readily available in some organisms.  These 
studies demonstrated a wide range of activities when using the switches to co-localize DNA 
binding and activation domains for control of reporter gene transcription in yeast.  To better 
understand these variations and extend the results to mammalian systems, we continue the 
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benchmarking process by measuring binding constants for the dimers in the lit and dark 
states, and performing a variety of activity assays including: co-localization experiments in 
mammalian cell culture, transcription-control assays in yeast, and the activation of small 
GTPases via the sub-cellular recruitment of guanine nucleotide exchange factors.  In 
general, we find that the measurements made in vitro correspond to what we observe in 
cells.  The switches with the largest changes in in vitro binding affinities upon light 
stimulation make the most effective switches for the in-cell benchmarks.!!!!!!
4.3 Methods 
4.3.1 Cloning, Expression, and Purification 
All clones are available via Addgene. iLID, LOVpep, and WT AsLOV2 were all cloned 
into pQE-80L BamH1 and HindIII sites for E. coli expression with an N-terminal 6x His tag.  
The respective binding partners, SspB Nano & Micro, and ePDZb were cloned into a 
modified pQE-80L vector (BamH1/HindIII sites) with an N-terminal 6xHis-MBP-TEV tag.  
Both full length AtCRY2 as well as the PHR domain alone was cloned into the SalI site of 
the pFastBac HT A vector for insect cell expression.  Recombinant bacmid DNA was made 
in DH10Bac E. coli cells and virus amplified in Sf9 insect cells. CIB1N was cloned into the 
BamH1 and HindIII sites of pQE-80L for expression in E. coli with a 6xHis-tag. All 
mammalian constructs were cloned into the pLL7.0 lentiviral vectors. Expression is therefore 
driven by a CMV promoter. The constructs were assembled by PCR based overlap 
extension, enzyme restriction, and ligation or through Gibson assembly. 
Bacterial expression was performed as follows: BL21(DE3) cells were transformed 
through heat shock with each of the expression vectors.  For each construct, 1.5L of LB 
media was inoculated and grown at 37°C to OD 0.6 and induced with 333mM IPTG.  iLID, 
LOVpep, AsLOV2, SspB nano & micro, and ePDZb were expressed at 18°C for 16 hours.  
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CIB1N was expressed at 25°C for 6 hours.  After expression, cells were spun down at 3500 
rpm for 10 minutes and pellets were frozen until purification.  Insect cell expression was 
performed as follows:  SF9 cells were inoculated with baculovirus at an MOI of 10 and 
expressed at 27°C for 48 hours according to 155.  After 48 hours, cells were spun down at 
2000 rpm, washed with cold PBS buffer and frozen at -80°C until purification.  Bacterial cell 
pellets of LOV based switches and their binding partners were resuspended in phosphate 
lysis buffer (50 mM sodium phosphate pH 7.5, 500 mM NaCl, 20 mM Imidazole, 100 µM 
PMSF) and sonicated.  Cell lysates were spun down for 30 minutes at 20,000 rpm.  Cell 
supernatants were filtered with a 5 µm filter, run over HisTrap HP columns (GE) and eluted 
with elution buffer (50 mM sodium phosphate pH 7.5, 500 mM NaCl, 500 mM Imidazole, 100 
µM PMSF).  Proteins expressed as 6xHis-MBP fusions were dialyzed overnight in PBS with 
TEV protease and re-run over HisTrap columns to separate the protein of interest from His-
MBP.  Finally, all proteins were passed over at Superdex 75 column (GE) as a final clean up 
and buffer exchange to PBS (10 mM dibasic sodium phosphate, 1.8 mM monobasic 
potassium phosphate, 137 mM NaCl, 2.7 mM KCl, pH 7.4) for characterization.  AtCRY2 
and CIB1N purification was similar to the above protocol except Tris buffers were used 
instead of phosphates buffers as previously published 155.  Insect cells were lysed by 
sonication without detergents to prevent contamination.  The final size exclusion buffer for 
both AtCRY2 and CIB1N was 50 mM Tris-HCl pH 7.4, 250 nM NaCl, 5 mM BME.  We also 
expressed the PHR domain (domain necessary for dimerization) of AtCRY2 alone, but poor 
yields precluded in vitro experiments with this variant.  Most of the dimer systems expressed 
highly and we had little handling or solubility issues with them.  The notable exception was 
AtCRY2, which precipitated at concentrations above 20 µM. 
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4.3.2 Fluorescent Probe Generation   
To measure direct binding between AtCRY2-CIB1N, CIB1N was labeled with 5(6)-
TAMRA (Anaspec) at the single cysteine residue.  Purified proteins were buffer exchanged 
on PD-10 desalting columns (GE) into 20mM Tris-HCl pH 7.5, 150mM NaCl, 1mM TCEP.  
Ten-fold excess dye was added to the prep and was left on a rotator at 4°C overnight.  
Labeled proteins were then passed through another PD-10 column to remove free dye.  
Absorbance at 555 nm (ε=65,000 M-1 cm-1) was used to quantify dye concentration and BCA 
assay (Thermo Scientific) was used to quantify protein concentration.  Competitive binding 
assays were used to measure binding for the iLID and LovPep systems.  The sequence for 
the LovPep competitor peptide was 5(6)TAMRA-EEIDKAVDTWV and the sequence for the 
iLID competitor peptide was 5(6)TAMRA-QIEEAANDENY. 
4.3.3 Fluorescent Polarization Binding Assay 
Fluorescence polarization measurements were recorded using a Jobin Yvon Horiba 
FluoroMax3 fluorescence spectrometer.  All binding assays except CRY2/CIB1N were 
performed in PBS buffer in either a 1 cm or 1 mm quartz cuvette at 25°C.  CRY2/CIB1N 
binding was performed in a Tris (20mM Tris-HCl, pH 7.4, 200 mM NaCl, 5 mM BME) buffer 
due to solubility issues.  Polarization of TAMRA was measured with excitation at 555 nm 
and emission at 584 nm. For AtCRY2-CIB1N binding, the concentration of TAMRA-CIB1N 
started at 200 nM and AtCRY2 was titrated in. At each titration point, the sample chamber 
was illuminated with 6.0 mW cm-2 blue light using a collimated blue led array.  A lit state time 
point was taken immediately after removal of the blue light and another 5 minutes later for 
AsLOV2 binding and 10 minutes later for AtCRY2 binding.  Initial affinities of the iLID and 
LovPep competitor peptides were measured through direct binding titrations.  Starting 
peptide concentrations were 25 nM for the iLID peptide and 250 nM for the LovPep peptide.  
For iLID nano competitive binding assays, 25 nM peptide and 40 nM SspB nano were 
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incubated with enough competitor to bind approximately 60% of peptide prior to titration.  
Competitive binding titrations were illuminated with blue light as in the direct binding assays 
and dark state measurements were taken after 5 minutes of darkness. 
4.3.4 Multi-Angle Light Scattering 
SEC-MALS experiments were performed on a Wyatt DAWN HELEOS II light 
scattering instrument interfaced to an Agilent FPLC System with a Superdex S200 column, 
Wyatt T-rEX refractometer and Wyatt dynamic light scattering module.  CRY2 samples were 
prepared at 15 µM (in 50 mM Tris-HCl pH 7.4, 250 nM NaCl, 5 mM BME) and run through 
the S200 either in the presence of blue light (~3 mW cm-2, blue led array) or in darkness. 
4.3.5 Dynamic Light Scattering 
CRY2 oligomerization was measured in a DynaPro Dynamic Light Scattering Plate 
Reader at room temperature.  CRY2 at 15 µM was illuminated with blue light (6.0 mW cm-2 
blue light, collimated blue led array) for 1 minute and placed in the instrument.  
Measurements were taken every 5 seconds for 20 minutes. 
4.3.6 Absorption Recovery after Activation 
Excited state recovery times were measured using a Cary 50 UV-Visible 
Spectrophotometer.  Samples were irradiated with blue light (6.0 mW cm-2 blue light, 
collimated blue led array) and absorbance at 450 nm was recorded until recovery. 
4.3.7 Yeast Plasmids Generation  
Clontech pGBKT7 vector was modified to substitute the 2µ origin with CEN4 origin of 
replication by restriction digest with SacI and XmaI introduced from primers of a vector PCR 
and CEN4 from pNIA-CEN-MBP156 yielding pGBKT7-CEN. CRY2PHR (1-498) was cloned 
with NdeI and NotI, ePDZb with NdeI and BamHI and finally, SspB Nano and Micro were 
cloned with EcoRI and BamHI into the newly generated pGBKT7-CEN plasmid. Additionally, 
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CIB1N (1-170) was cloned in the original pGBKT7 vector using NdeI and BamHI. CIB1N 
was cloned in pGADT7 with NdeI and BamHI, LOV-pep and variant were cloned as well as 
oLID and iLID were cloned with EcoRI and BamHI. Finally, CRY2PHR was cloned in 
pGADT7 via NdeI and NotI restriction digest as well.  All plasmids were sequence verified 
using Eurofins DNA sequencing service. 
4.3.8 Yeast Transformation and Mating 
The resultant plasmids were transformed via high efficiency lithium acetate 
transformation157 in Y187 for pGADT7-derived plasmids and Y2HGold for pGBKT7-derived 
plasmids. After about 72 hours, single colonies for each were isolated and inoculate 0.5 mL 
YPD culture overnight in order to mate them and generate the respective diploids. The next 
day, the mated yeast were pelleted at 3000 rpm for 5 minutes and plated on douple dropout 
plates (SC-Leucine/-Tryptophane). 
4.3.9  -Galactose Assay  
-Galactose assay were performed as follows: Freshly mated yeast colonies were 
grown for about 36h at 30°C in 5 ml SC-Leu/-Trp. Cell density was measured at OD600 and 
2.5 mL cultures were diluted to OD600 = 0.2 in duplicates – one for a light and another for a 
dark condition (falcon tubes were wrapped in aluminium foil). Cultures were grown at 30°C 
in a shaking incubator (250 rpm) for 3 hours in the dark and then for another 4 hours under 
blue light (465 nm) at 500 µW/cm2 via LED strip light wrapped around the tube rack. The 
resulting cultures were pelleted in triplicates and -Galactose assay using CPRG for a 
substrate was performed according Clontech yeast handling protocols. 
4.3.10 Yeast Growth Assays 
Survival assays were performed as follows: Fresh colonies were grown for about 36 
h at 30°C in 5 ml SC-Leu/-Trp. Cell density was measured at OD600 and cultures diluted in 
 104 
200 µl of OD600 = 1, followed by 8 5-fold serial dilutions. Then, 2 µl of each of the dilutions 
were pipetted and spotted using a multichannel pipette (Gilson) onto respective dropout 
plates. The dark condition plates were wrapped in aluminum foil and placed in the same 
incubator as the lit condition at 30°C. Continuous blue light (465 nm) at 500 µW/cm2 was 
provided with LED strip lights attached at the incubator. Yeast plates were imaged after 70 
hours incubation, the resulting images were cropped and arranged using Adobe Photoshop. 
4.3.11 Mammalian Cell Culture and Transfection 
Mouse IA32 fibroblasts were cultured in DMEM supplemented with 10% (vol/vol) 
FBS (HyClone), 100 U/ml penicillin, 100 µg/mL streptomycin, and 292 µg/mL L-glutamine. 
Cells were cultured at a constant 37 °C and 5% (vol/vol) CO2. Cells were transiently 
transfected in 6 well cell culture dishes using 1 µg total DNA at 1:1 ratio and NanoJuice 
(EMD Millipore) transfection reagent as recommended by manufacturer. 
4.3.12 Mammalian Cell localization/GEF Microscopy 
Experiments were performed according to the methods found in Guntas et al. Briefly, 
cells were co-transfected with two vectors containing the sequences encoding each 
component of the switch in equal parts. 24 hr later tranfected cells were trypsonized and 
transferred to 3.5 cm MatTek glass bottom dishes coated with a 10 ug/ml solution of 
fibronectin. 24 – 48 hr later cells were imaged and photo-activated with an Olympus FV1000 
confocal microscope equipped with a 1.30 N.A. 40x oil immersion objective. The Fluoview 
software Time Controller was used to produce a timeline of image acquisition and photo-
activation using the same parameters found in Guntas et al. 
4.3.13 Image analysis and quantification 
All images were analyzed using FIJI software. Spot localization was quantified 
according to Guntas et al. Briefly the tgRFPt fluorescence intensity was measured within the 
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activated ROI and an initial intensity and size matched area outside the activated ROI. A 
ratio of In : Out was analyzed throughout time. The values that correspond to the period of 
activation were fit to the equation Y= 1 + Ymax*(1-exp(-K*X)). The values that correspond to 
the period of reversion were normalized to the maximum values and fit to the equation 
Y=(Y0 - Plateau)*exp(-K*X) + Plateau. Whole cell activation was quantified with an improved 
version of the method described in Guntas et al. The cytoplasmic ROIs are more accurately 
determined by removing a small subset of pixels that are representative of the background 
but previously included. The values described in the paper are the average tgRFPt 
fluorescence intensities from the algorithmically determined ROIs expressed as (Mito-
Cyto)/Cyto. Cytoplasmic values were first subtracted from mitochondrial values to remove 
any fluosecence signal contributed by the cytoplasm above and below the mitochondria. 
Curves were fit to the values during the activation and reversion periods using the equations 
Y=S+Ymax*(1-exp(-K*X)) & Y=(Y0 - Plateau)*exp(-K*X) + Plateau respectively. The fold 
change was determined by (S+Ymax)/S. All curve fittings were performed using Prism 
(GraphPad) software. The protrusion distance reported in the Tiam DH/PH localization 
experiments was measured by kymography. A line one pixel thick was drawn through each 
of the activated ROIs. The image values through time along that line were concatenated to 
form a new image. This image was then used to determine the initial and maximal position 
of the membrane within the time of activation to determine the maximum protrusion 
distance.  
4.4 Results 
4.4.1 Dark and Lit-state Binding Affinities 
We used fluorescence polarization binding assays to measure lit and dark state 
affinities of each pair. For the TULIPs and iLID this was performed using a competitive 
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binding experiment.  The photoactivable domains were used to compete off fluorescently 
labeled peptides from the binding partners.  The interaction between AtCRY2 and CIB1N 
(the N-Terminus of CIB1 necessary for dimerization) was not amenable to this experimental 
format, so CIB1N was covalently labeled with a fluorescent dye and direct binding was 
measured.  As we previously reported, the iLID binding partner SspB comes in two 
variations, Nano and Micro; each with a different affinity range. The iLID Nano system has 
an affinity of 0.13 µM under blue light and 4.7 µM in the dark. The iLID Micro pair has an 
affinity of 0.8 µM under blue light and 47 µM in the dark (Figure 4.1B, Table 4.1) 152.  The 
TULIP switches we examined function over a weaker range of affinities.  The LOVpep 
construct binds to ePDZb with an affinity of 12 µM under blue light and 72 µM in the dark, for 
a 6-fold change.  The presence of additional “caging” mutations, T406-7A + I532A 
(LOVpep+), weaken the lit state affinity to 18 µM and the dark state affinity to 150 µM, for an 
8 fold change (Figure 4.1B, Table 4.1).  The different affinity ranges sampled by the TULIP 
and iLID switches reflects the affinities of the peptides that are being caged in each case.  
The SsrA peptide used to create iLID binds to its partner, SspB (Nano), with an affinity of 35 
nM 82.  The PDZ binding peptide used in TULIP binds to ePDZb with an affinity of 14 µM.     
We were not able to observe a light-dependent change in binding affinity for in vitro 
purified CRY2 and CIB1N.  In our direct binding assay, we observed low micromolar binding 
(~4µM) with and without blue-light stimulation (Figure 4.1B, Table 4.1).  This result is 
consistent with the previous observation that CRY2 purified from insect cells did not show 
differential affinity for CIB1 in pull-down assays performed in the light and the dark 42.  It has 
been hypothesized that insect cell purified CRY2 is missing an important chromophore, 
5,10-methylenetetrahydrofolate (MTHF). However, even in the presence of saturating MTHF 
concentrations, we did not observe a significant change in binding affinity due to light 
(Figure 4.2).  We ran an electrophoretic mobility shift assay with CRY2 and CIB1N and 
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found the same result.  CRY2 binds CIB1N similarly under blue light as in the dark, both in 
the low micromolar range (Figure 4.3).   
4.4.2 Light-dependent CRY2 Homo-oligomerization 
Although in vitro purified CRY2 did not show light-dependent changes in CIB1N 
binding, we did observe robust homo-oligomerization of CRY2 with light stimulation as 
probed by multi-angle light scattering (SEC-MALS).  A single symmetric peak was observed 
both in the light and the dark, with the retention time being delayed in the dark.  The light 
scattering indicated a species with a molecular weight of 75 kD in the dark and 301 kD in the 
light (Figure 4.4A).  The expected molecular weight of monomeric CRY2 is 71 kD, so these 
results are consistent with the formation of a monomer in the dark and a tetramer in the 
light.  Saturating amounts of MTHF did not change the elution times or molecular weight fits 
(Figure 4.5).  Using dynamic light scattering (DLS), we were able to measure the kinetics of 
the lit state oligomer to dark state monomer transition.  In this assay, there is a 60 second 
delay between removal of blue light and the first DLS reading, as shown in grey (Figure 
4.4B). Factoring in this dead time, the reversion to dark state has a half-life of 90 ± 20 
seconds. We also ran co-elution experiments of CRY2 and CIB1N in gel filtration 
experiments (Figure 4.6).  Samples of CRY2 and CIB1N (2:1 molar ratio) were run in the 
light and dark, however in both states CIB1N did not co-elute with CRY2.  This is consistent 
with the micromolar binding affinities that we observed in the fluorescence experiments.  
4.4.3 Reversion Kinetics 
We used our purified protein samples to also measure the reversion kinetics of the 
photoactivated states.  All proteins were extensively dialyzed into 50 mM Tris-HCl pH 7.5, 
250 mM NaCl buffer for these experiments. Using an absorbance recovery after 
photoactivation assay, we determined the lit state half-life for each of our photosensitive 
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domains. In order of fastest to shortest, the half-lives were measured to be 18 ± 2 s for iLID, 
23 ± 1 s for LOVpep, 51 ± 2 s LOVpep+, and 92 ± 10 s for CRY2 (Figure 4.7, Table 4.1).  
4.4.3 Controlling Sub-cellular Localization 
Next, we examined how effective the photoswitches were at recruiting proteins to a 
specified region of the cell.  In particular, we were curious if the in vitro binding properties of 
the dimers would correlate with in-cell behavior.  Each half of the switches were fused to a 
fluorescent protein (Venus or tgRFPt) with spectral properties distinct from the excitation 
wavelength of the photoactive domain. The Venus labeled half of the switch was also fused 
to a membrane-anchoring domain (N-Myristoylation (Myr) or C-Farnesylation (CAAX)). The 
two proteins were then co-expressed in mouse fibroblasts and continuously imaged with a 
confocal laser-scanning microscope. During imaging a region of interest (ROI) was activated 
with a 488 nm laser, and changes in protein localization were quantified as a function of time 
by measuring the ratio of tgRFPt fluorescence intensity inside the activated ROI to the 
intensity in a ROI of the same size outside the area of activation.  The analysis produces a 
maximum intensity ratio as well as the half-life of activation and reversion (Table 4.2). 
The iLID Nano and Micro switches were previously analyzed by this method but our 
findings are reiterated here. For each of these assays the iLID half of the switch was 
anchored to the membrane with a Caax motif while Nano and Micro were diffuse in the 
cytoplasm. Upon activation the tgRFPt-Nano and micro fluorescence intensity increased to 
produce an average maximum ratio value of 6.36 and 4.88 respectively (Figure 4.8A, B).  
Our first experiments with the TULIP system used a similar approach, LOVpep+ was 
fused to Venus and a Caax motif while ePDZb was fused to tgRFPt. However, with 
LOVpep+ fused to a Caax motif the C-terminal PDZ binding motif was prevented from 
binding to ePDZb and no change in fluorescence intensity at the activated ROI was 
observed (Figure 4.9A). Therefore, we fused the LOVpep+ to an N-Terminal myristoylation 
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sequence, freeing the PDZ binding motif. Upon expression, we found that the myristoylated 
sequence localized to the plasma membrane but also localized to other membrane bound 
organelles. For these experiments we chose ROIs that predominantly consisted of only 
plasma membrane bound LOVpep+. Upon light stimulation, we observed a small increase in 
protein localization (average maximum ratio value = 1.34) (Figure 4.8A, B). 
Others have reported difficulties in maintaining a functional switch upon anchoring 
CRY2 to the plasma. However, Pathak et. al. recently maintained functionality in yeast by 
fusing CRY2PHR to the C-terminus of Mid2, a membrane anchored protein 84. We therefore 
tested 3 additional experimental approaches varying the switch positions as follows: Venus-
CRY2PHR-Caax, tgRFPt-CIB1N; Myr-Venus-CRY2PHR, tgRFPt-CIB1N; and Venus-CIB1N-
Caax, tgRFPt-CRY2PHR. While the Caax fused CRY2PHR localized to the plasma 
membrane, the tgRFPt fluorescence intensity did not increase upon activation within the 
ROI (Figure 4.9A).  Myr-Venus-CRY2PHR had a similar localization pattern as Myr-Venus-
LovPep and upon activation induced an increase in tgRFPt intensity within the ROI (Figure 
4.8A, B). We measured the average maximum ratio value to be 1.52. Additionally, upon 
activation Myr-Venus-CRY2 formed large clusters at the membrane (Figure 4.8A inset). To 
better understand CRY2 cluster formation and dissociation we performed the same ROI 
analysis on the Venus channel. During activation, we observed an increase in Venus 
fluorescence intensity within the ROI, which represents cluster formation. Interestingly, we 
observed a persistent increase in intensity for ~1 min after the light was turned off, 
suggesting that the clusters continue to form after the blue light is turned off (Figure 4.10B).  
In the experiments with Venus-CIB1N-Caax anchored to the membrane, tgRFPt-
CRY2PHR is diffuse throughout the cytoplasm before activation. Upon activation with blue 
light the tgRFPt intensity increases within the ROI and in some cases small tgRFPt-
CRY2PHR clusters begin to form (Figure 4.8A inset). Surprisingly, we measured the 
average maximum ratio value to be 4.98; significantly higher than when CRY2PHR is 
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anchored to the membrane.  However, we hypothesized that CRY2PHR oligomerization 
alone may be responsible for a portion of the increase in fluorescence measured at the ROI. 
The idea being that once oligomerized, diffusion of tgRFPt-CRY2PHR would slow while 
recruiting more monomers, increasing the signal. We tested this hypothesis by expressing 
and activating tgRFPt-CRY2PHR alone in cells and found that this was indeed the case. 
CRY2PHR alone had a maximum ratio value of 2.67 (Figure 4.10C and D) Furthermore, we 
hypothesized that expression of CRY2PHR (the half of the switch that undergoes 
conformational change upon blue light stimulation) in the cytoplasm would provide less 
spatial control as compared to membrane anchored CRY2PHR. Our reasoning was that 
once activated the CRY2PHR could more easily diffuse through the cytoplasm and bind to 
CIB1N outside of the ROI. However, the gradient of tgRFPt intensity outside the periphery of 
the ROI was similar to what we measured for the iLID switches where the photoactive 
domain was anchored to the membrane. (Figure 4.10A).  
For all of the switches, the reversion half-lives in cells were longer than the in vitro 
measured half-lives. However, the measurements parallel the in vitro patterns and what has 
been previously observed. The LOV2-based switches are all similar at about 60 sec while 
the CRY2PHR/CIB1N switches are slower. Interestingly the CRY2PHR/CIB1N reversion 
half-lives are dependent on the orientation of the switch. The Myr-Venus-CRY2 has a faster 
half-life at 132 s while the tgRFPt-CIB1N-Caax is significantly slower with a half-life of 242 s 
(Figure 4.8C).  
Except in the case of Venus-CIB1N-Caax with tgRFPt-CRY2PHR the activation half-
life seems to correlate with the dynamic range of the switch (larger dynamic range takes 
longer to reach equilibrium after activation) and not on the kinetics of the protein 
conformational change (Figure 4.8B). This suggests that the rate-limiting step is diffusion. 
While we are unsure what causes the slower rate of Venus-CIB1N-Caax with tgRFPt-
CRY2PHR, a hypothesis will be presented in the discussion.  
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4.4.4 Mitochondrial re-localization assay 
A limitation of the membrane localization assay is that is difficult to accurately 
determine the portion of tgRFPt labeled protein that is at the plasma membrane prior to 
activation due to the axial spatial resolution of the microscope (~600nm). In the relatively flat 
cultured fibroblasts we used for these experiments, the apical and basal membrane 
fluorescence values are captured but cannot be distinguished from the cytoplasmic 
fluorescence. By anchoring the Venus labeled half of the switch to the mitochondrial 
membrane we were able to more accurately determine the initial amount of tgRFPt labeled 
protein at the mitochondria relative to the cytoplasm and monitor its change during and after 
activation. Proteins were anchored to the mitochondrial membrane by fusion to TOM20 at 
the N-terminus or Mito anchor sequence from Listeria monocytogenes ActA protein158 at the 
C-terminus. After co-expression of each half of the switch, whole cells were activated with 
488 nm light and imaged. Using an automated ImageJ macro, we measured the ratio of 
mitochondrial to cytoplasmic fluorescence intensity throughout activation and reversion. For 
each switch this assay produces parameters describing the half-life of activation and 
reversion, a starting mito/cyto intensity (representative of dark state binding), a maximal 
mito/cyto intensity and the fold change in intensity (Table 4.3). 
Again, the data for the iLID switch has been previously reported. However, the data 
was reanalyzed using an improved ImageJ macro, which was able to better differentiate the 
cytoplasm from background. In this assay iLID was fused to the Mito anchoring domain of 
ActA while Micro and Nano were cytoplasmic. We measured the average fold change for 
iLID-Nano and Micro to be 5.4 and 5.2 respectively (Figure 4.11A, B). As expected, the 
initial relative mitochondrial fluorescence intensity for iLID-nano is higher than iLID-micro, 
paralleling the in vitro measured dark state affinity being tighter (Figure 4.11B). 
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To test the TUPLIP switch we fused Venus labeled LovPep T406,7A I532A to 
TOM20 at the N-terminus to preserve an accessible C-Terminal PDZ binding motif. Upon 
co-expression with tgRFPt-ePDZb and activation, the switch produces an average 2.4 fold 
change in relative mitochondrial tgRFPt fluorescence intensity (Figure 4.11A, B). This fold 
change parallels the smaller in vitro measured dynamic range of binding in comparison to 
the iLID switches. TULIP also showed a lower starting mitochondrial tgRFPt intensity (0.59); 
again paralleling TULIP’s lower in vitro dark state affinity (Figure 4.11B). 
We tested the CRY2PHR/CIB1N switch in both orientations. We first tested TOM20-
Venus-CRY2PHR with tgRFPt-CIB1N. Unfortunately, TOM20-Venus-CRY2PHR appeared 
to be toxic to the cells and therefore expression levels in the surviving cells were 
significantly lower than all other constructs to the extent that the laser power of the 
microscope had to be substantially increased to obtain a clear image. Additionally, the 
distribution of mitochondria within the surviving cells was abnormal. Upon activation the cells 
did not produce a measureable increase in mitochondrial tgRFPt intensity (Figure 4.9B). We 
therefore reversed the orientation of the switch. By co-expressing and activating Venus-
CIB1N-Mito and tgRFPt-CRY2PHR we measured an average 3.1 fold change in relative 
mitochondrial tgRFPt fluorescence intensity (Figure 4.11A, B). The average initial value of 
mito/cyto tgRFPt was also high (2.88) compared to the other switches (Figure 4.11B). This 
suggests a relatively tight dark state binding affinity. 
4.4.5 Light Controlled Transcription in Yeast 
To examine if our findings from the in vitro binding assays and the localization 
studies correlate with outcomes in a functional assay, we used the light dimerization pairs to 
control transcription in yeast.  The yeast two-hybrid approach has previously been used to 
demonstrate light dependent transcription for CRY2PHR with CIB1N as well as ePDZb1 and 
LOVpep84,86. We used diploids generated from mating Y187 and Y2HGold strains to test for 
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the activation of the lacZ, his3 and ade2 reporter genes (Figure 4.12A) transformed with the 
split Gal4 transcription factor constructs (Figure 4.12B). We observe an assortment of 
induced transcription levels dependent on the protein pair used and the reporter gene 
observed. We identified strong light dependent transcription using β-galactose expression as 
readout for iLID with Nano (19.5 fold) and iLID with Micro (9.4 fold) (Figure 4.12C and D, 
Table 4.4). We previously showed that iLID had an improved dynamic range when 
compared to its parental construct, oLID, by a multitude of measurements. However, we 
were curious how the two switches compared in their ability to control yeast transcription. As 
expected light dependent transcription was not detected for the oLID paired with either Nano 
or Micro (Figure 4.13).  In our hands there was also no detectable β-galactose expression 
for ePDZb paired with LOVpep or LOVpep+. 
In addition to monitoring β-galactose expression, we also tested for light-dependent 
survival on histidine and histidine/adenine dropout plates.  Interestingly, iLID when paired 
with Nano or Micro conveyed growth in the light and dark for single and double dropout 
plates.  In contrast, yeast expressing the LOVpep did not survive in the dark, but there was 
growth on histidine dropout plates in the light (Figure 4.14).  These results are consistent 
with the survival assays being more sensitive to low levels of expression. iLID Nano and 
Micro have stronger binding affinities in the dark than LOVpep, and in this context this 
“leakiness” is sufficient to allow growth even when the switch is in the inactive/dark state.   
In previous studies CRY2-DBD paired with CIB1 or CIB1N has been shown to 
activate transcription in yeast 84,86, although the overall levels of transcription with these 
constructs were low when compared to results with full-length CRY2.  To date the inversed 
orientation has not been reported to our knowledge. When we paired CIB1N-DBD with 
CRY2PHR-AD we observed strong light dependent expression of lacZ achieving about 9 
fold difference, similar to when combining Micro with iLID, but overall lower levels for both 
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light and dark levels. On the contrary, when testing CRY2PHR-DBD with CIB1N-AD we saw 
no significant transcriptional activation of lacZ but only of his3 reporter genes, which as 
expected was in light-dependent manner.  Our assay appears less sensitive than the work 
by Kennedy and co-workers, perhaps because different ß-galactose substrates were used 
(ONPG vs. CPRG).  
4.4.6 Manipulation of lamellipodial protrusion 
To test each pair’s ability to functionally manipulate a mammalian cell we targeted 
the Rho GTPase family. The Rho family of small GTPases is known to regulate the 
dynamics of the actin cytoskeleton and therefore the cells shape. Canonically, activation of 
the membrane bound Rac family member produces highly branched actin, leading to 
dynamic lamellipodial protrusions. The inactive/active state of GTPases is determined by the 
state of the bound nucleotide (GDP/GTP respectively). Guanine nucleotide exchange 
factors (GEFs) activate GTPase by aiding in the exchange of GDP for GTP 147,159. Using iLID 
we have previously shown that by localizing the catalytic DH/PH domain of a Rac GEF 
(Tiam) to a portion of the plasma membrane we can induce lamellipodial protrusions in that 
region 77. We therefore used this approach as a functional test of the CRY2PHR/CIB1N or 
TULIP switches. To this end, we fused the Tiam DH/PH domain to each of the tgRFPt 
labeled halves of the switch. The Tiam constructs were then co-expressed with the 
appropriate membrane bound switch half. Cells were imaged and activated in a similar 
manner to the previous membrane localization experiments, though here the activation ROIs 
were located at the edge of the cell. For each cell, the maximal protrusion distance at the 
ROI was then quantified by kymography. iLID-Nano and Micro produced on average a 
maximal protrusion distance of 12.0 and 14.5 µm respectively (Figure 4.15A, B). The TULIP 
switch caused an average protrusion distance of 1.5 µm, significantly less than the iLID 
switches (Figure 4.15A, B). The CRY2PHR/CIB1N switches were again tested in both 
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orientations (CRY2PHR or CIB1N anchored at the membrane) and produced an average 
protrusion distance of 4.2 and 2.2 µm respectively (Figure 4.15A, B).  
4.5 Discussion 
The protein switches tested here cover a wide range of dark and lit state affinities; 
each with different dynamic ranges. For the LOV2 based switches, we found a reasonable 
correlation between in vitro affinities and behavior in living cells.  Consistent with previous 
results, the iLID switches had the largest fold-change in binding affinity upon light stimulation 
and were the most effective at localizing protein to the plasma membrane and inducing 
cellular protrusions via localization of Tiam.  However, the iLID switches also had tighter 
dark state affinities than the TULIP switch, LOVpep+/ePDZb, and this was evident in the 
mitochondrial localization assay where more dark-state localization was observed for both 
iLID pairs than for the TULIP switch.  Also, the iLID pairs exhibited more dark-state activity in 
the yeast two-hybrid survival assays.  These results suggest that use of the TULIP switch 
may be more appropriate when it is critical to avoid background activity.   
The results for CRY2 and CIB1 present a more complicated story.  First, we did not 
observe a light dependent change in CIB1N binding with full-length CRY2 purified from 
insect cells.  However, robust homooligomerization of CRY2 with blue-light stimulation was 
observed.  As previously reported, we found that the CRY2/CIB1 system could be used to 
localize proteins within the cell, but this functionality was dependent on how the protein 
fusions were constructed and which partner was anchored to the membrane.  When CIB1N 
was fused to the plasma membrane, there was robust recruitment of CRY2PHR to the 
membrane with light stimulation.  When CRY2PHR was fused to the membrane, only small 
small amounts of CIB1N were recruited with light activation.  There may be multiple factors 
at play here.  When CIB1N is fused to the membrane, CRY2PHR oligomerization may allow 
for multivalent interactions between the CRY2 oligomers and CIB1N, which is already co-
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localized via membrane anchoring (Figure 4.16).  This multivalency would lead to increased 
increased affinity between CRY2 and CIB1.  Conversely, when CIB1 is cytoplasmic it is 
monomeric and there is no way to generate a multivalent interaction with CRY2PHR 
oligomers.  This line of thinking would also explain why the light-dependent mitochondrial 
localization was only observed with CIB1 anchored in the mitochondria.  Another possible 
explanation for the observed behavior is that the large clusters that form when membrane 
anchored CRY2PHR is light-activated may preclude robust CIB1 binding.   
Avidity effects may also help explain the yeast two-hybrid results with CRY2/CIB1.  
We observed more robust light-dependent changes in transcription when CIB1N was fused 
to the DNA binding domain.  The Gal4 DNA binding domain forms a dimer when bound to 
DNA, and therefore CIB1N fused to the DNA binding domain is presented as a dimer to 
CRY2PHR.  This may allow for a multivalent interaction when CRY2PHR oligomerizes and 
therefore enhance the affinity between CRY2PHR and CIB1N.  The same multivalent 
interaction would not be created when CIB1N is fused to the DNA activation domain.  When 
taken together, our results and results from previous studies indicate that CRY2 
homooligomerization is likely to play a significant role in the activity of the switch, and this 
can be used to enhance light-dependent signaling if multivalent interactions can be created.   
4.5.1 Reversion Kinetics 
The activation and reversion kinetics of the switches become important when 
planning experiments as they determine how often you must expose the proteins to blue 
light in order to maintain dimerization.  In the context of a cell this may be important in 
avoiding phototoxicity. In turn, this needs to be balanced with the rate at which the switch 
needs to be fully off in the context of the experiment. The CRY2 switch reverted with the 
slowest kinetics.  The quicker kinetics of iLID and the LOVpep switches give more precise 
temporal resolution, allowing for less lag time between light removal and dissociation.  One 
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important point to note is the photocycle of AsLOV2 switches can be tuned with some 
previously discovered mutations 25,121, so these switches can be altered to fit a variety of 
contexts.  These mutations haven’t been tested in the heterodimerization context, but it is 
likely they would have little impact on dynamic range as they don’t directly interact with the 
Jα helix.  The in cell rate of binding, except in one CRY2PHR/CIB1N orientation, seems to 
be limited by diffusion. The rates of dissociation maintain the same rank order as the in vitro 
measurements but are longer in both assays. This is most likely due to rates of diffusion out 
of the measured ROIs. Interestingly, in the membrane localization assay, the 
CRY2PHR/CIB1N reversion rates are orientation dependent. 
We hypothesize that the CRY2PHR/CIB1N kinetic inconsistencies mentioned above 
are due to CRY2PHR’s light dependent oligomerization.  The Venus-CIB1N-Caax / tgRFPt-
CRY2PHR produced a maximal plasma membrane recruitment level similar to the iLID 
switches. However the rate of activation was significantly slower. This is surprising, as the 
other switches recruitment half-life were proportional to their dynamic range. This suggests 
that in addition to CRY2PHR – CIB1N binding a second slower step is driving the increase 
in tgRFPt fluorescence intensity, such as CRY2 oligomerization.  The orientation dependent 
rate of membrane dissociation may also be explained by oligomerization.  In the case where 
tgRFPt-CIB1N is free in the cytoplasm, we monitored the dissociation of the monomeric 
CIB1N from the CRY2 clusters. On the other hand, the tgRFPt-CRY2 may have formed 
oligomers in the ROI, gaining an avidity interaction with the membrane bound CIB1N, 
slowing the rate of diffusion and increasing the reversion half-life relative to tgRFPt-CIB1N. 
These results suggest that while the CRY2/Cib switches can function to robustly manipulate 
in cell protein interactions, many factors need to be considered and significant optimization 
may be necessary 
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4.5.2 Functional Considerations 
In the functional yeast transcription and Tiam experiments each of the switches was 
used to manipulate cell biology to varying degrees. These sets of experiments highlight the 
advantages and limitations of each switch. 
TULIPs have been shown to be effective in yeast gene transcription and MAPK 
activation 79,84. While low levels of transcription were reported using the higher affinity TULIP 
(i.e. ePDZb1 paired with LOVpep) 84 for both lacZ and his3, our results indicate that 
weakening further the interaction affinity negatively affects the level of transcriptional 
activation in yeast. In our hands, ePDZb-DBD paired only with LOVpep-AD exhibited light 
dependent growth in the absence of histidine in the growth medium. The weak interaction 
appeared insufficient to induce the ade2 and lacZ reporter genes. When ePDZb-DBD was 
paired with the LOVpep+ – AD no transcription was seen under any condition. 
Similarly, with the TULIP switch we were unable to produce significant lamellipodial 
protrusions by recruiting TIAM DH/PH to the membrane. We hypothesize that this could be 
due to three factors. First, TULIPs work over a weaker range of affinities and we did not 
observe robust localization of Tiam to the membrane.  Second, Rac is localized to the 
plasma membrane by a Caax motif. We have tagged LOVpep with a myristoylation motif 
due to the limitation of not being able to tag it on the C-Terminus. Therefore, in the case of 
TULIPS, Tiam DH/PH may be recruited to sub-compartment of the membrane that does not 
contain Rac. Lastly, the linker length may not optimally position the Tiam DH/PH for 
activation of Rac. 
As opposed to the oLID, which exhibited no light dependence but strong 
transcriptional activation, iLID demonstrated high levels of blue light dependent transcription 
achieving a ~20 fold increase of transcription in the presence of light for the iLID-Nano pair. 
In correspondence with the yeast transcriptional assays, both iLID-Nano and iLID-Micro 
produced robust lamellipodia in the Tiam DH/PH localization assay. 
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In both orientations CRY2PHR/CIB1N produced smaller lamellipodial protrusions 
than the iLID switches. We propose that this could be caused by four factors. Like TULIPS 
CRY2PHR is anchored to the membrane by myristoylatation. Second, the CRY2PHR 
oligomerization may inhibit Tiam function and has in fact been previously used to inhibit 
GEFs and GTPases 80. Third, as we have shown in the membrane recruitment assay, a 
portion of the increase in tgRFPt-CRY2PHR signal that we see upon stimulation may only 
be due to oligomer formation and not necessarily recruitment to the membrane. Therefore 
we obtain a less robust activation of Rac than expected for the amount of signal increase 
observed. Fourth, the Tiam DH/PH may not be optimally positioned by our constructs and 
could be further optimized by linker length adjustment. 
Each switch contains other characteristics that we found to influence experimental 
design. While both components of iLID can be tagged on either the N-or C-terminal, we 
have found that both CRY2 and LOVpep C-terminal fusions inhibit binding to their partners. 
These stipulations have hindered particular applications in the past 92.  Although untested, a 
further consideration for the TULIP switch in cells is the use of a PDZ domain and peptide, 
which could theoretically interfere with endogenous PDZ interactions.  In conclusion, 
through rigorous benchmarking we have determined in vitro, in vivo and functional 
characteristics of three sets of blue light inducible dimers. This information can be used to 
guide future efforts aimed at using light inducible dimerization to control biological pathways. 
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4.7 Figures 
 
 
 
 
 
 
 
 
 
Figure 4.1 Construct schematic and binding affinities of heterodimer pairs.  Binding 
affinities of lit and dark states highlight difference in photoswitch dynamic range. A) 
Constructs used in this chapter. B) Fluorescence polarization binding plots for LOVpep 
constructs and ePDZb (left) iLID nano and micro (middle) and CRY2 and CIB1N (right).  C) 
Affinity values from binding data plotted on a Dynagram to highlight dynamic range of each 
tool.  
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Figure 4.2 CRY binding to CIB1 with MTHF.  Addition of MTHF does not significantly 
change CRY2-CIB1N binding. 
 
 
 
 
 
 
Figure 4.3 CRY2/CIB1 native gel shift binding assay.  Binding measured by native gel 
shift indicates weak binding. 
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Figure 4.4 CRY2 multi-angle light scattering and dynamic light scattering. Light 
induces CRY2 oligomerization. Size exclusion chromatography multi-angle light scattering 
traces for full length CRY2 run under blue light (blue line) or darkness (black line). Fit 
molecular weight from MALS data for each peak is shown for lit (blue dots) and dark (black 
dots) peaks. 
 
 
 
Figure 4.5 CRY2 multi-angle light scattering with MTHF. Addition of MTHF does not 
change CRY2 oligomerization. Size exclusion chromatography multi-angle light scattering 
traces for full length CRY2 with saturating MTHF cofactor added run under blue light (blue 
line) or darkness (black line). Fit molecular weight from MALS data for each peak is shown 
for lit (blue dots) and dark (black dots) peaks.  Elution traces from Figure 4.4 are shown in 
grey dashed lines for comparison. 
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Figure 4.6 CRY2 and CIB1N size exclusion chromatography. CRY2 and CIB1N do not 
fully co-elute in size exclusion chromatography. 
 
 
 
 
Figure 4.7 Photoreceptor reversion kinetics. Thermal reversion kinetics of the excited 
state for each photoreceptor show differences in timescale of deactivation.  Reversions were 
measured at room temperature in Tris-HCl buffer. 
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Figure 4.8 Photoswitch membrane localization kinetics. Targeted localization to the 
plasma membrane shows differences in switch dynamic range and kinetics.  A) 
Representative images of the data analyzed in B and C. Cells transfected with each 
membrane bound switch pair were visualized and activated by confocal microscopy. Venus 
labeled constructs are bound to the plasma membrane while tgRFPt labeled constructs are 
cytoplasmic.  The activated ROI is identified by the blue arrow. The activation and post 
activation images represent the final image of the specified time frame. (Bar = 50 µm) B) A 
ratio of tgRFPt fluorescence intensity inside the activated ROI to outside the activated ROI 
during the period of activation as shown in A. C) A normalized ratio of tgRFPt fluorescence 
intensity inside the activated ROI to outside the activated ROI during the period of activation 
as shown in A. 
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Figure 4.9 Orientation specific localization for CRY2 and TULIPs. For CRY2PHR/CIB1N 
and TULIPs, orientation matters for function. a) CRY2 and TULIP switches do not function in 
particular orientations in respect to the plasma membrane localization. b) CRY2PHR 
anchored to the mitochondria is toxic to cells and does not function in binding CIB1N upon 
activation. (Bar = 50 µm) 
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Figure 4.10 CRY2PHR oligomerization effects switching in unexpected ways A) 
CRY2PHR in the cytoplasm has similar spatial resolution of activation to the iLID switches 
anchored to the membrane. B) Myr-Venus-CRY2PHR clusters form slower than CIB1N 
binding occurs and continues to form after stimulation. C) Representative images of tgRFPt-
CRY2PHR alone signal increase upon activation. (Bar = 50 µm)  D) Quantification of 
tgRFPt-CRY2PHR alone signal increase upon activation as compared to CRY2PHR in 
combination with CIB1N.  
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Figure 4.11 Photoswitch mitochondrial localization. Targeted mitochondrial localization 
identifies differences in dark state binding dynamic range and kinetics.  A) Representative 
images of the data analyzed in B. Cells transfected with each mitochondrial bound switch 
pair were visualized and activated by confocal microscopy. Venus labeled constructs are 
bound to the plasma membrane while tgRFPt labeled constructs are cytoplasmic.  The 
entire field of view is activated. The activation and post activation images represent the final 
image of the specified time frame. (Bar = 50 µm)  B) A ratio of mitochondrial to cytoplasmic 
tgRFPt fluorescence intensity throughout the experiments shown in A.  
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Figure 4.12 Yeast two hybrid transcription comparison A) A schematic of the genome 
reporters. B) A schematic of the constructs tested. C) ß-galactose transcription induced with 
the iLID paired with Nano or the Micro (triplicates from 3 independent experiments, 
p<0.0001) and D) CIB1N with CRY2PHR (triplicates from 3 independent experiments, 
p<0.0001) (Blue Bars – growth under continuous blue light at 465nm, Black  Bars – growth 
in the dark). 
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Figure 4.13 oLID yeast two-hybrid. oLID does not allow light dependent transcription in 
yeast 
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Figure 4.14 Light dependent yeast growth. Light dependent yeast growth on dropout 
plates demonstrates that low-level transcription is achieved for ePDZb-LOVpep and 
CRY2PHR-CIB1N A) Y2H positive control p53-DBD paired with Large T-antigen-AD, B) Y2H 
negative control empty pGBKT7 and pGADT7 vectors, C) CRY2PHR-DBD paired with 
CIB1N-AD, D) CIB1N-DBD paired with CRY2PHR-AD, E) ePDZb-DBD paired with LOVpep, 
F) ePDZb-DBD paired with LOVpep+, G) Nano-DBD paired with iLID-AD, H) Micro-DBD 
paired with iLID-AD. 
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Figure 4.15 DHPH domain targeting to membrane. Targeting Tiam DH/PH domains to the 
plasma membrane with each switch causes varying degrees of protrusion.  A) 
Representative images of the data analyzed in B. Cells transfected with each membrane 
bound Tiam DH/PH switch pair were visualized and activated by confocal microscopy. 
Venus labeled constructs are bound to the plasma membrane while tgRFPt labeled 
constructs are cytoplasmic.  The activated ROI is is represented by the blue square. (Bar = 
50 µm) B) Protrusion distances for each cell were measured by kymography. 
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Figure 4.16 Proposed avidity mechanism for CRY2 binding to CIB1N. A) CIB1N 
imbedded in the membrane has increased affinity for oligomers of CRY2.  B) CRY2 
clustering on the membrane has minimal increased for affinity for CIB1N and possible 
occludes CIB1N binding. 
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Figure 4.17 Incomplete P2A cleavage activates transcription in yeast two-hybrid. 
Light-inducible dimers are not functional if expressed with p2a self-cleavage peptide in yeast 
transcription.
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Chapter 5 
Light Mediated Ubiquitin Transfer 
We aim for iLID to become widely available and useful; a generalizable 
heterodimerization tool used to modulate and study as many pathways and organisms as 
possible.  However, from onset we have sought to use this pair in a very specific application, 
the development of a light-controlled ubiquitin pathway.  This chapter covers our 
unpublished and ongoing efforts to engineer this pathway.  Joseph Harrison aided in design 
and choice of E3 ligases.  The LOV Trap is currently unpublished and was developed in the 
laboratory of Klaus Hahn.  This work was funded by and performed under the direction of 
Brian Kuhlman. 
5.1 Introduction 
One of the most robust methods for determining protein function in vivo has simply 
been to remove expression at the genetic level and look for observable changes in cell 
function.  As making knockout cell lines tends to be costly and time consuming, 
considerable effort has been directed toward developing simpler methodologies like 
CRISPR/Cas9 and RNA interference (siRNA or shRNA) that allow for quicker turnaround 
times160,161.  However, even with these next generation methods there is a need for a set of 
tools that allows for the control of protein levels in real time.  This is especially apparent 
when probing the function of embryonic lethal genes where knockouts do not live long 
enough to conduct experiments.  Methods to conditionally control protein degradation afford 
the ability to probe protein function in normal healthy cells162.  Conditional control has the 
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added benefit of working on a short enough time scale to minimize compensation form 
alternate pathways.  An ideal tool to control protein levels inside cells would have a short 
response time, be reversible, not interfere with native pathways and target endogenous 
proteins.   
 Initial attempts at conditional control of protein stability have been achieved through 
fusions with conditionally stable proteins (temperature sensitive DHFR, N-end rule 
sequences), localization with ubiquitin E3 ligases, and localization with the proteasome163–
166.  As changes in temperature can alter cellular function and N-end rule instability is 
irreversible, we have chosen to create a tool that causes localization with an ubiquitin E3 
ligase to induce degradation165,167,168.  This route has the added benefit of being useful to 
probe the differences in E3 ligase function and activity.  Previous methods of induced 
localization with an E3 ligase have used protein-protein interactions induced by small 
molecules to control degradation165,169.  In one example a chimeric small molecule that binds 
FKBP12 was fused to a peptide that binds the VHL E3 ligase169.  Upon addition of the small 
molecule, the group was able to localize a target protein fused to FKB12 with the E3 
ligase169.  In this way, a target protein can be conditionally targeted for ubiquitination and 
subsequent degradation.  The limitation of this approach is that the interaction is irreversible 
once the small molecule is added.  To increase the temporal and spatial resolution of this 
approach we aim to replace the FKBP/small molecule/E3 ligase interaction with the light 
inducible heterodimer interaction developed in the previous chapters (LOV-SsrA/oLID and 
iLID) as well as a second AsLOV2 based heterodimer, LOV Trap82,152.   
 Both LOV-SsrA (or iLID) and LOV Trap are light mediated heterodimeric interactions, 
however they work in opposing ways.  LOV-SsrA forms a heterodimer with its partner, SspB, 
upon irradiation with blue light and dissociates back to monomers in the dark82,152.  LOV 
Trap is a heterodimeric interaction between AsLOV2 and an engineered Z-domain, ZA127.  
In the dark AsLOV2 binds ZA127 and upon irradiation with blue light, dissociates into 
 138 
monomers (unpublished, Hahn lab). We have chosen these photoreceptors for their small, 
modular nature, and their known mechanism of action.  Additionally, each of the binding 
partners, ZA127 and SspB, only have a few lysine residues, allowing us to remove them to 
prevent self-ubiquitination.  Finally, both of these switches could be used together since 
AsLOV2 doesn’t bind SspB and ZA127 doesn’t bind LOV-SsrA (unpublished data).  We 
have chosen to fuse E3 RING ligases from three proteins IAP2, UHRF1, and RNF8 to the 
binding partners.  The protein of interest will then be fused to the respective AsLOV2 
photoreceptor.  In this way we hope to achieve light activated ubiquitin transfer with LOV-
SsrA (or iLID) and light de-activated ubiquitination with LOV Trap (Figure 5.1). 
 We have demonstrated with in vitro ubiquitination assays that both the LOV-SsrA 
and LOV Trap switches allow for increased ubiquitination in their heterodimer state over the 
monomeric state.  Thus far we have not seen light mediated ubiquitin transfer or 
degradation in mammalian cells, however, this work is ongoing.  We hope to complete this 
work in the future and create both light induced and light inactivated degradation tools as 
well as probe the function of each E3 ligase.   
5.2 Materials and Methods 
5.2.1 Protein Expression & Purification  
All AsLOV2 clones were expressed as MBP fusions in a modified pQE-80L vector.  
In these constructs, MBP is N-terminal to AsLOV2 separated by a TEV protease cleavage 
site. SspB or ZA127 / Ring E3 fusions were expressed with N-terminal 6xHis tags in the 
pQE-80L vectors.  In cases where expression was poor, they were re-cloned and expressed 
as MBP fusions.  All proteins were expressed in BL21 E. coli cells for approximately 16 
hours overnight.  Post-expression, cells were spun down at 3000rpm and frozen until 
purification.  Cells were resuspended in phosphate lysis buffer and purified via nickel affinity 
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chromatography as described in previous chapters.  MBP-AsLOV2 and MBP-LOV-SsrA 
remained uncleaved, while any ring fusion was cleaved from a MBP tag with TEV protease, 
and re-run over a nickel column to remove MBP, TEV, and uncleaved fusion.  As a final step 
of purification and buffer exchange, size exclusion chromatography on a S75 column 
equilibrated in HEPES buffer compatible with ubiquination assays (25 mM HEPES, 150 mM 
NaCl, pH 7.5) was performed.   
5.2.2 In vitro Ubiquitination Assays 
All in vitro ubiquitination assays were performed in 25 mM HEPES, 150 mM NaCl, 
pH 7.5 buffer at 25° C.  Reactions consisted of 0.2 µM  Uba1 (E1), 0.5 µM  Ubc5A (E2), 0.2 
µM  (IAP2 Fusion), 16 µM flag-ubiquitin, 50 mM ATP, 1 mM DTT, and 0.05 µM target protein 
(MBP-AsLOV2 or MBP-SsrA).  This assay was loosely based on previous ubiquitination 
experiments123.  Enough reaction mixture for 2 full experiments, minus ATP, was added to a 
0.5 mL tube.  The mixture was then split into two clear tubes, one placed under blue light 
and one in darkness. Once ATP was added, time points were taken at intervals shown and 
quenched in 6x SDS-loading buffer.  Samples were run on 12% SDS-PAGE gels, 
transferred to nitrocellulose membrane at 30 volts overnight and probed with fluorescent 
anti-Flag or anti-MBP antibodies.  Gels were imaged with a GE lifesciences Typhoon imager 
and quantified with Image Quant software. 
5.2.3 Mammalian Clones and Methods 
Mammalian clones were generated according to Figure 5.2.  A single plasmid system 
was devised with the following scheme; [SspB Nano/Micro]-HA-[IAP2ring/UHRF1ring/ 
RNF8ring]-2A peptide-[mKate2]-[6xHis MBP]-[iLID/SsrA/Empty] or [SspB Nano/Micro]-HA-
[IAP2ring/UHRF1ring/ RNF8ring]-2A peptide-[N-terminal Stargazin fragment]-[ iLID/SsrA/Empty]-
[C-terminal stargazing fragment]-[mCherry] (Figure 5.2).  Note, thus far only the positive 
(SsrA) and negative (empty) controls have been tested with RNF8 and IAP2 rings.  HEK 
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293T cells were transfected with 1 µg plasmid using lipofectamine 2000 (Invitrogen).  After 
16 hours, cells were checked for fluorescence to indicate successful transfection.  In order 
to prepare for flow cytometry, cells were trypsinized for 5 minutes at 37° C, and then 
quenched with FBS containing serum.  Cells were gently mixed to break up clumping and 
then transferred to a 15 mL conical to pellet.  Cells were pelleted at 1000 rpm for 3 minutes, 
decanted, and resuspended in phosphate buffered saline supplemented with 10 µg/mL 
DNAse, 100 units/mL penicillin, 100 µg/mL streptomycin and 5 mM EDTA.  Resuspended 
cells were passed through a 30 µM CellTrics sterile filter.  Fluorescence was measured on a 
BioRad S3 Cell Sorter and data was analyzed with BioRad ProSort software.  
5.3 Results 
5.3.1 In Vitro Ubiquitination Assays 
The IAP2 RING domain SspB and ZA127 fusions were well behaved and functional 
in in vitro ubiquitination assays.  In both fusions we noticed the formation of poly-ubiquitin 
chains in reactions missing the target protein, however this background activity was small in 
comparison to the total ubiquitination seen when target protein was present.  In both cases, 
we demonstrated preferential light mediated ubiquitin transfer in the heterodimer state, 
under blue light for LOV-SsrA and in darkness LOV Trap.  For MBP-LOV-SsrA/SspB-IAP2 
RING, we saw depletion of unmodified MBP-LOV-SsrA in between 120 and 180 seconds 
when under blue light (Figure 5.3).  The same time points had approximately 55% and 35% 
unmodified target remaining when left in darkness (Figure 5.3, 5.4).  Not only did the 
unmodified target band disappear, we noticed the time dependent appearance of higher 
molecular weight species indicating that ubiquitin was being covalently attached to the 
target.  We were able to confirm the presence of FLAG-ubiquitin in these higher molecular 
weight species by western blot (Figure 5.3, bottom).  For the LOV Trap heterodimer system, 
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we saw the opposite change due to light just as expected (Figure 5.5).  Probing for MBP, we 
noticed almost complete depletion of MBP-AsLOV2 in the dark after 120 seconds (Figure 
5.5).  In comparison, after 120 seconds > 55% of MBP-AsLOV2 remained unmodified when 
kept under blue light (Figure 5.6).  Again, an anti-FLAG western confirmed the presence of 
ubiquitin in the higher molecular weight species (Figure 5.5, bottom).  Unfortunately, RNF8 
suffered from poor expression both when fused with SspB and ZA127.  Purification of both 
clones yielded almost no protein at all.  We re-cloned both as MBP-fusions (for stability and 
increased expression), however, upon cleavage of the MBP tag, both crashed out of 
solution again.  The UHRF1 clones are cloned but remain untested in the in vitro assays. 
5.3.2 Mammalian Ubiquitination 
We transfected HEK 293T cells with the mammalian expression clones shown in 
Figure 5.2.  It is expected that the polypeptide chain will be cleaved into two pieces during 
translation at the 2A peptide leaving an N-terminal fragment containing SspB-IAP2 RING 
and a C-terminal fragment containing the target protein, mKate2-MBP-iLID/SsrA/Nothing.   
After confirmation of successful transfection we quantified mKate2 fluorescence with flow 
cytometry (Figure 5.5).  However, we did not see the expected change in fluorescence 
levels for the mKate2-MBP-SsrA and mKate2-MBP targets (Figure 5.7A).  In fact, it appears 
that the SsrA tagged target protein is found at higher levels than its untagged counterpart.  
We were also able to test a second fluorescent target, the transmembrane Stargazin-
mCherry fusion (+ or - SsrA tag), with a set of SspB-RNF8 E3 ligase fusions (Figure 5.2).  In 
this case, the SsrA tagged Stargazin-mCherry was slightly higher in fluorescence than the 
untagged version (Figure 5.7B).  In this experiment, we also transfected the Stargazin-
mCherry clone without an E3, to determine if the SspB-Ring fusions were having any effect.  
It does appear that the fluorescence is higher without an E3 present; however, this could 
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simply be due to the expression of a single protein instead of two (Figure 5.7B). None of the 
LOV Trap clones or UHRF1 clones have been cloned or tested currently.      
5.4 Discussion 
The in vitro ubiquitination assays performed are encouraging in that the switches 
appear to function in the intended fashion.  Our LOV-SsrA system preferentially transfers 
ubiquitin in the light and the LOV Trap system preferentially transfers ubiquitin in the dark.  
The two systems switch over different binding affinity ranges, which gives credence to this 
as a robust process in vitro and likely to work for other light-inducible heterodimerization.  In 
vitro binding affinities measure the LOV Trap dark state interaction to be 9 ± 2 nM and 600 ± 
200 nM under blue light, a sixty fold change in affinity (unpublished, communication with 
Ryan Hallett).  The LOV-SsrA/SspB lit state interaction has been measured at 120 nM, 
which drops to 900 nM in the dark, an 8-fold change82.  As such we would expect the LOV 
Trap to have a higher Lit/Dark fraction of unmodified target at each timepoint than the 
corresponding LOV-SsrA Dark/Lit fraction of unmodified target.  This appears to be the case 
(Figure 5.6 bottom and Figure 5.4 bottom), as the LOV-SsrA ratios lag behind the LOV Trap 
ratios.  Since these experiments were performed, new versions of LOV-SsrA, iLID micro and 
iLID nano, have been developed with increased dynamic ranges.  Due to increased dark 
state caging, we would expect iLID switches would outperform its predecessor.  One 
interesting artifact of the different affinity ranges appears to be that the tighter affinity of dark 
and lit state binding of LOV Trap leads to longer ubiquitin chain formation (Figure 5.5).  In 
the LOV-SsrA assays, MBP-LOV-SsrA’s with one, two, and three ubiqutins are visible 
(Figure 5.3).  These bands are not seen at all in the LOV Trap experiments.  We 
hypothesize that for a tight affinity complex with a slow koff, residence time near the E3 will 
be increased leading to longer poly ubiquitin chains.  This subtle, but interesting, difference 
in the two switches highlights the information that could be revealed with a working set of 
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light mediated ubiquitin transfer components.  The iLID micro pair has the weakest affinity 
range we have developed to day and would be perfect to test this hypothesis.  The instability 
of purified RNF8 fusions prevented any direct comparisons between the E3 components.  
Most likely, the fragment of RNF8 used in these experiments is unstable alone and may 
need more of the native protein to properly fold.  
 Despite the successful in vitro light-mediated ubiquitin transfer, we have not seen a 
robust degradation phenotype.  The cytometry data in Figure 5.7 is preliminary.  We have 
yet to probe for expressed proteins by western blot analysis, so it is unclear even if and to 
what efficiency the 2A peptide system is working as intended.  Additionally, we have not 
tested any of the LOV Trap constructs in vivo yet.  However, even without adding the light 
conditional control, the positive (SsrA tag) and negative (no tag) controls do not behave as 
expected (Figure 5.7A).  This is very discouraging because these constructs should be 
constitutively localized to the E3 or not localized to it at all.  We do see lower fluorescence 
when the E3 is absent as compared to when it is present (Figure 5.7B), indicating the E3 is 
doing something, however it is unclear what that might be.  These data suggest that the 
RING E3 ligases chosen may not be suitable for an in vivo degradation pathway.   
 The attempts at developing a light-mediated ubiquitin transfer pathway have been a 
mix of success and failure.  The IAP2 RINGS are excellent mediators of ubiquitin transfer in 
vitro, however do not appear to be fully modular, as the same constructs do not induce 
degradation in vivo.  The in vitro assays shown could be an interesting way to probe E3 
ligase function, especially as a function of affinity to substrate proteins, however it is limited 
to E3 ligases that can be expressed.  Moving forward with the light-induced ubiquitination 
and degradation pathway, new E3 proteins from a variety of families should be attempted as 
well as E3 ligase degrons as seen in previous work165,169.  As we have shown in vitro and in 
vivo activities do not necessarily correlate, an in vivo selection strategy should be devised to 
rigorously test E3s as well as linkers and target proteins.   
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5.5 Figures 
 
 
 
Figure 5.1 Light Mediated Ubiquitination Schematic. Light mediated ubiquitin transfer 
through co-localization of an RING E3 ligase with a target protein by light induced (top) or 
light disrupted (bottom) heterodimer.  
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Figure 5.2 Clone schematic. Clone schematic for in vitro (Top) and in vivo (Bottom) 
ubiquitination assays.   
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Figure 5.3 LOV-SsrA in vitro ubiquitination assay.  Blue bar denotes samples irradiated 
with blue light, black bar denotes those kept in darkness.  Arrow marks weight of unmodified 
target. Top) anti-MBP blot probing the decrease of unmodified of MBP-LOV-SsrA as 
ubiquitin transfer continues.  Bottom) anti-Flag blot probing showing presence of ubiquitin in 
higher molecular weight species.  
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Figure 5.4 Quantification of LOV-SsrA in vitro ubiquitination assay.  LOV-SsrA 
preferentially transfers ubiquitin to MBP protein in the light compared to the dark. 
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Figure 5.5 LOV Trap in vitro ubiquitination assay.  Blue bar denotes samples irradiated 
with blue light, black bar denotes those kept in darkness.  Arrow marks weight of unmodified 
target. Top) anti-MBP blot probing the decrease of unmodified MBP-AsLOV2 as ubiquitin 
transfer continues.  Bottom) anti-Flag blot probing showing presence of ubiquitin in higher 
molecular weight species.  
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Figure 5.6 Quantification of LOV Trap in vitro ubiquitination assays. LOV TRAP 
preferentially transfers ubiquitin to MBP protein in the dark compared to the light. 
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Figure 5.7 Flow cytometry of mammalian cell constructs.  As measured by 
fluorescence, SsrA tagged substrates are not degraded when expressed with SspB-E3 
RING fusion 
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Chapter 6 
Conclusions and Final Thoughts 
6.1 Light Inducible Peptide Caging  
Light inducible caging has been shown to be an effective method of controlling 
functional protein surfaces, peptide sequences, and entire protein domains.  Peptide caging 
thus far has relied primarily on the undocking of the Jα helix of the AsLOV2 domain. The 
work described in chapters 2, 3, and 4 shows functional peptide caging for three peptide 
sequences.  In each case, peptide binding to its target protein is substantially increased in 
the presence of light and this change in affinity can be used to induce specified phenotype 
changes in an organism or cell.  This method is highly versatile, as the iLID and TULIP 
switches come in a variety of dynamic ranges and switch over multiple affinity ranges.  
These factors are critical when choosing the appropriate tool for a specific application.  The 
variety of peptide-based switches available directly translates to a greater number of 
pathways that can be targeted and studied.  
However, this methodology is largely limited by sequence identity to the protein it is 
to be incorporated within.  As such, this technique does not have the power to study the 
biology of any given peptide simply by attachment to AsLOV2.  Peptides hung off the end of 
the Jα helix have no change of affinity/activity as a function of light.  Peptide caging in other 
regions of AsLOV2, namely the A’α helix and the hinge connecting the PAS fold to Jα helix, 
do not appear to be generalizable sites of caging in our hands.  One way around this 
limitation may be to specifically engineer AsLOV2 for a peptide with low sequence identity.  
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Our work in chapter 3, demonstrates AsLOV2 to be tolerant to a number of mutations, 
allowing for our modest 2-fold LOV-ssrA switch to be improved to over 50-fold as seen in 
iLID micro.  Using a similar method of high-throughput library screening, it may be possible 
to engineer a set of compensatory mutations allowing for incorporation of any given peptide, 
but this most likely be more trouble than it’s worth.  
We believe the true power of peptide caging lies in the generalizable heterodimer 
tool generated in the process of caging the SsrA peptide.  Our iLID nano and micro systems 
allow for precise colocalization of two proteins on the second timescale.  This system can be 
used for light induced protein activation by fusing a functional domain of interest to one half 
of the switch and localizing the other half to the site of activity.  The reverse, light induced 
sequestration is just as easily achieved by localizing the second half to an inactive area of 
the cell.  The proteins have no restrictions N- or C-terminal fusions, resulting in a broad 
applicability with little to no use-to-use optimization.  The iLID system has the added benefit 
of being orthogonal in higher organisms, meaning they won’t interact with endogenous 
pathways and create experimental artifacts.  All of these factors combined with one of the 
largest dynamic ranges measured (Chapter 3 & 4), indicate iLID nano & iLID micro to be 
some of the most powerful and versatile light-inducible heterodimer pairs to date.  
6.2 Computationally Guided Improvement of Functional Protein Domains  
 In chapter 3, we used a protocol of computational library design, phage display, and 
ELISA screening to improve a light activated heterodimer from an 8-fold change in affinity to 
36-fold.  This method was very successful for improving our photoswitch, as all 4 of the top 
clones selected showed considerable improvement of dynamic range over the parental 
sequence.  This is actually quite impressive as there were around a hundred rational 
designs tested with this same goal, but none were able to increase the dynamic range 
above 12-fold.  This is an incredibly difficult protein design problem due to the lack of 
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structural information known about the lit state of AsLOV2.  When analyzing the mutations 
that ended up in iLID, we get the picture that there are factors we don’t fully understand that 
govern AsLOV2’s allosteric mechanism.  When looking at the Rosetta score of the final 
mutations, we noticed that half were predicted to be stabilizing and half as destabilizing.  
When reverting these mutations one by one, we see that they are all actually contributing to 
the improvement, however even by solving the structure of iLID, their specific function 
remains unknown.  This explains the failure of rational or discrete computational design; 
however, highlights the strength for the computationally directed library and selection 
strategy.   
 Moving forward, there seems to be room for even greater improvement.  We’ve only 
touched roughly a third of the residues in AsLOV2, leaving many more to optimize.  We 
focused our initial library on regions within interacting distance of the Jα helix; however, 
many of the mutations in iLID don’t appear to directly contact the Jα helix or SsrA sequence.  
One feature that may have contributed to success was the tight localization of the library, 
allowing for mutations to pack together as seen between the mutations in the hinge and Hβ 
strand.  Future libraries could focus on alternate regions of AsLOV2, the A’α helix for one or 
FMN binding pocket for another.   
This protocol could be extended to further improve AsLOV2 based photoswitches or 
other allosteric protein switches for which there is little known mechanistic information.  The 
dual selection strategy, a single mutation library followed by recombination of top mutations, 
allows for increased coverage of protein sequence.  The high-throughput phage display 
followed by low-throughput ELISA was useful in narrowing down the library to top clones.  In 
a case where information about mechanism is missing, and most mutations will ablate 
function, this is especially important.  Key requirements are an assay sensitive enough to 
measure small increases in improvement and a starting construct that with enough signal 
difference between states to optimize from.  In the case with LOV-SsrAC, both of these were 
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satisfied, and mutations that conferred beneficial properties could be enriched. As many 
labs are using LOV domains to power optogenetic tools with a variety of functions, this 
method could be a useful way to improve that desired functionality, whatever it may be.   
6.3 Leveling the Optogenetic Playing Field; Is LOV All You Need? 
Our look into alternative blue-light mediated heterodimer pairs was enlightening.  The 
CRY2 and TULIP switches, which have been used in a number of cell biology applications, 
work in a much weaker affinity range than expected and have lower dynamic ranges than 
expected.  The side-by-side comparison from in vitro to yeast to mammalian cell gives us an 
idea of what biophysical characteristics make for the best tool.  In applications where you 
expect a phenotypic change quickly, it appears that tighter affinity switches will have a larger 
effect.  However, in a multi-day experiment such as yeast colony growth, a weak lit state 
affinity is much better.  In both of these cases, the limiting factor is background activity in the 
off state.  Over the course of a few seconds or minutes, micromolar interactions will 
contribute little to overall effect, however on a longer timescale, even weak micromolar 
affinities are enough to elicit responses on par with the active state.  Finally, this work gives 
valuable insight to the mechanism of CRY2 heterodimerization and oligomerization.  With so 
many labs using the CRY2 system, both with and without CIB1N, careful understanding of 
how the tool is inducing activity is paramount.  For this reason, in the head-to-head tests the 
iLID switches demonstrate the utility of a simple, well-characterized mechanism in multiple 
formats and organisms.  Together, this work clearly demonstrates that while LOV isn’t all 
you need, everyone could use a little more of it. 
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